[
    {
        "pmid": "40544728",
        "title": "Targeting MAP kinase for inhibiting Leishmania promastigotes and amastigotes stages by L-alanine derived molecules and their anticancer potential against PANC-1 cancer cell lines.",
        "abstract": "Home quarter global population World Health Organizations SouthEast Asia Region bear substantial burden Neglected Tropical Diseases NTDs Identifying mean eliminate NTDs region flagship priority since 2014 India Nepal Bangladesh committed eliminating Kalaazar Visceral Leishmaniasis VL sooner end 2026 WHO 2023a context vanillinderived molecule well established inhibiting several kinase present cancer cell high LDsub50sub value along broad therapeutic window view demand suitable oral candidate controlling Leishmania parasitic proliferation human body here reporting ortho vanillin lAlanine amino acid derived ligand molecule t2E2hydroxy3methoxyphenyl methylidene amino propanoate L CuII conjugate Lsub1sub  Lsub3sub watersoluble nontoxic drug candidate treatment Visceral Leishmaniasis silico binding study potential chemotherapeutic target MAP kinase MitogenActivated Protein Kinase PDB id 4QNY undertaken significant binding shown molecules compound demonstrated significant inhibition amastigote proliferation L donovani Lsub1sub exhibited ICsub50sub 1544 μgmlsup1sup Lsub3sub ICsub50sub 1691 μgmlsup1sup L mexicana ICsub50sub value 1750 μgmlsup1sup Lsub1sub 1748 μgmlsup1sup Lsub3sub result comparable standard reference drug Amphotericin B exhibited ICsub50sub 1450 μgmlsup1sup L donovani 1532 μgmlsup1sup L mexicana toxicity study undertaken macrophage THP1 cell line ICsub50sub value quite higher comparison AmphotericinB Additionally potential molecule checked PANC1 cancer cell line comparison normal HPNE cell lines complex caused doublestrand DNA nicks consistent higher cytotoxic activity observed Cancer cell lines Furthermore cell cycle result also confirmed Lsub1sub arrested PANC1 cell G1S phase cell cycle followed increase subG1 phase Lsub1sub shown population latesecondary cellular apoptotic cell increased 235  9356  whereas population earlyprimary apoptotic cell increased 013  control 1208  finding suggest Lsub1sub cause apoptosis cell death programmed",
        "mesh_terms": [
            "Humans",
            "Antineoplastic Agents",
            "Cell Line, Tumor",
            "Protein Kinase Inhibitors",
            "Alanine",
            "Structure-Activity Relationship",
            "Drug Screening Assays, Antitumor",
            "Cell Proliferation",
            "Antiprotozoal Agents",
            "Mitogen-Activated Protein Kinases",
            "Dose-Response Relationship, Drug",
            "Molecular Structure",
            "Leishmania",
            "Molecular Docking Simulation",
            "Parasitic Sensitivity Tests",
            "Benzaldehydes",
            "Leishmania donovani"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40544728/"
    },
    {
        "pmid": "40435187",
        "title": "Impact of Vgsc-1014 mutations on the feeding pattern of Phlebotomus argentipes.",
        "abstract": "Knockdown resistance allele kdr alleles within para voltagegated sodium channel gene Vgsc common mechanism DDT pyrethroid resistance insect vectors primary Asian visceral leishmaniasis vector Phlebotomus argentipes two kdr allele codon 1014 Vgsc associated insecticide resistance potentially presenting challenge vector control effort Indian subcontinent Here screened Vgsc1014 allele blood meal origin P argentipes female collected September 2013 August 2015 Bangladesh Mymensingh understand Vgsc1014 allele could impact feeding patterns sand fly collection took place parallel vector control agencys biannual indoor residual spraying IRS programme region wildtype leucine wtleucine common allele 667 followed mutant serine 194 phenylalanine allele 139 55 sand fly blood meal 13 came humans bovine origin 61 However sand fly fed human showed strongly contrasting Vgsc1014 genotypic frequency compared feeding blood sources Whilst 81 P argentipes human blood possessed kdr genotype two mutant alleles 81 sand fly feeding blood source possessed genotype wtleucine allele P  0001 Significant spatial variation kdr frequency detected clear temporal trend effect sampling year results significant impact recent IRS analyses association human feeding kdr allele parallel pyrethroid spraying indicates new mechanism kdr allele might impact VL control programs",
        "mesh_terms": [
            "Animals",
            "Phlebotomus",
            "Mutation",
            "Female",
            "Feeding Behavior",
            "Insecticide Resistance",
            "Voltage-Gated Sodium Channels",
            "Alleles",
            "Humans",
            "Insect Vectors",
            "Cattle",
            "Bangladesh",
            "Insect Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40435187/"
    },
    {
        "pmid": "40168975",
        "title": "The Lifecycle of Phlebotomus argentipes (Diptera: Psychodidae) Sand Fly in a Newly Developed Colony in Bangladesh.",
        "abstract": "Laboratoryestablished sand fly colony provide important material leishmaniasis research however establishment maintenance colony complicated study colony Phlebotomus argentipes P argentipes established using wildcaught sand fly Bangladesh following standard procedure described published literature colony initiated controlled laboratory environment total 430 female P argentipes sand fly collected develop colony multiple generation F0 F6 1034 P argentipes sand fly laid eggs number egg successfully emerged differed significantly wildcaught generation generations except F1 F6 generations significant difference observed incubation period wildcaught F0 laboratoryreared sand fly F1 F6 mean mortality rate highest first instar 139 lowest pupa stage 19 development pupa adult sand fly 98 successful observed copulation much frequent female taken blood meal first successful attempt colonize sand fly Bangladesh laboratory settings studys finding contribute better understanding role P argentipes vector Leishmania parasite Bangladesh well region colony also used xenodiagnoses insecticide resistance monitoring experimental infection generate necessary evidence",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Female",
            "Phlebotomus",
            "Male",
            "Life Cycle Stages",
            "Insect Vectors",
            "Leishmaniasis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40168975/"
    },
    {
        "pmid": "40005522",
        "title": "Detection of <i>Leishmania donovani</i> DNA from Oral Swab in Visceral Leishmaniasis.",
        "abstract": "Visceral leishmaniasis VL severe form leishmaniasis fatal left untreated 95 cases Leishmaniasis one neglected tropical disease tend thrive developing region world inadequate access healthcare make difficult people even receive diagnosis study examined usefulness oral swab specimen VL diagnosis detecting iLeishmania donovanii DNA oral swab VL patient iL donovaniiinfected mice Eighty oral swab OS blood buffy coat BC sample collected suspected VL case Bangladesh sample evaluated using iLeishmania kinetoplast minicircle DNAi ikDNAi realtime PCR result showed 625 5080 675 5480 case tested positive BC specimen OS respectively OS positivity statistically comparable BC iL donovanii DNA also detected oral swab infected BALBc mouse conventional PCR targeting ilarge subunit ribosomal RNA genei iLSUrRNAi negative uninfected mice study highlight potential practical method molecular diagnosis VL using oral swab noninvasive simple accurate approach",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Animals",
            "Leishmania donovani",
            "Humans",
            "DNA, Protozoan",
            "Mice",
            "Mice, Inbred BALB C",
            "DNA, Kinetoplast",
            "Real-Time Polymerase Chain Reaction",
            "Female",
            "Bangladesh",
            "Male",
            "Mouth"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40005522/"
    },
    {
        "pmid": "39700671",
        "title": "Diagnostic techniques for visceral leishmaniasis: An overview of methods used in East Africa.",
        "abstract": "Leishmanias parasitic infection caused protozoan belonging genus Leishmania transmitted sand fly Phlebotomus fly old world Lutzomyia New world disease prevalent tropics subtropics Southern Europe affect 15 million 2 million people annually India Bangladesh Sudan South Sudan Brazil Ethiopia account 90 VL cases Leishmania case Asia declining case East Africa especially Somalia Sudan South Sudan Ethiopia Kenya increasing rise East African case partially attributed ongoing armed conflict especially Somalia Sudan Southern Sudan displaced people increased exposure sand fly bites Migration endemic nonendemic regions misdiagnosis famine malnutrition climate change increase HIV case contributing factors clinical diagnosis Leishmania East Africa combine patients clinical sign either serological parasitological test rK39 strip microscopy major method used Diagnosis condition remains challenging current technique limitations including inability detect parasite tissue need specialized expertise prohibitive cost testing equipment low antibody titers risk misdiagnosis due coinfections disease HIV tuberculosis malaria typhoid Various techniques including serological molecular parasitological methods employed attempt address challenges limited success article therefore review technique used Leishmania diagnosis East Africa discusses available new technique aim overcoming current challenges",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Africa, Eastern",
            "Diagnostic Tests, Routine",
            "Leishmania",
            "Animals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39700671/"
    },
    {
        "pmid": "39617937",
        "title": "Rapid test for Mycobacterium leprae infection: a practical tool for leprosy.",
        "abstract": "Detection infection Mycobacterium leprae allows timely prophylactic treatment thereby reducing transmission well risk permanent leprosyassociated nerve damage However since worldwideimplemented standard test M leprae infection detection infection asymptomatic individual remains major challenge control program endemic areas previous studies developed fieldtested lateral flow assay LFA quantitatively detecting human IgM M lepraespecific phenolic glycolipid antiPGLI marker active past infection rapid test utilizes luminescent backgroundfree upconverting reporter particle UCP immunochromatography ie UCPLF test platform accurate quantitation antiPGLI IgM without operator bias aim study evaluate final version quantitative UCPbased rapid test ie PGLI QURapid using serum fingerstick blood FSB test comprises lateral flow strip standard plastic biodegradable cassette provided humanized recombinant control monitor test performance calculate accurate antiPGLI IgM levels performance QURtest assessed using serum FSB patient leprosy n  214 tuberculosis n  20 buruli ulcer n  19 leishmaniasis n  14 nontuberculous mycobacterial n  35 infections well healthy Dutch individual n  710 humanized recombinant antiPGLI IgM antibodies Plot receiver operating characteristic curve created sensitivity Sn specificity Sp area curve calculated evaluate test performance Test result classified multibacillary leprosy patient 950 Sn 100 Sp using serum 915 Sn 998 Sp using FSB Qualitative test result could read 2 min flow time accurate quantitation 10 min onwards new antiPGLI IgM control support production batch predetermined seropositivity threshold monitoring PGLI QURtest various settings operational version PGLI QURapid pointofcare applicability meet target product profile criteria Thus QURtest ready public health implementations",
        "mesh_terms": [
            "Humans",
            "Mycobacterium leprae",
            "Leprosy",
            "Male",
            "Female",
            "Immunoglobulin M",
            "Adult",
            "Antibodies, Bacterial",
            "Middle Aged",
            "Sensitivity and Specificity",
            "Antigens, Bacterial",
            "Glycolipids",
            "Young Adult",
            "Aged",
            "Adolescent",
            "Chromatography, Affinity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39617937/"
    },
    {
        "pmid": "39559700",
        "title": "Atypical cutaneous leishmaniasis: a new challenge to VL elimination in South-East Asia.",
        "abstract": "Visceral leishmaniasis VL caused iL donovanii SouthEast Asian endemic country including India Nepal Bangladesh primary focus ongoing VL elimination program major reduction VL case resulting elimination program last two decades effort focused challenge posed potential reservoir within asymptomatic cases HIVcoinfection VL case Post Kalaazar Dermal Leishmaniasis PKDL case continue sustain parasite transmission cycle known newer endemic zones article brings attention new potential parasite reservoir form atypical cutaneous leishmaniasis ACL case caused novel iL donovanii genetic variants iL donovanii mediated ACL emerging phenomenon recent endemic site justify need implementing molecular surveillance tool identify regionspecific iL donovanii variant dermotropic capability potential revert visceral disease timely detection novel ACL causing iL donovanii genetic lineage SouthEast Asian endemic region necessary halt spread ACL potentially crucial sustainability advance made VL elimination",
        "mesh_terms": [
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Asia, Southeastern",
            "Leishmaniasis, Visceral",
            "Disease Eradication",
            "Genetic Variation",
            "Coinfection",
            "Disease Reservoirs"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39559700/"
    },
    {
        "pmid": "39179149",
        "title": "Post kala-azar dermal leishmaniasis burden at the village level in selected high visceral leishmaniasis endemic upazilas in Bangladesh.",
        "abstract": "post kalaazar Dermal Leishmaniasis PKDL threatens success Visceral Leishmaniasis VL elimination initiative aimed investigate PKDL burden including active search PKDL leprosynegative skin lesion cases also investigated healthseeking behavior perceived level stigma crosssectional survey among inhabitant VLendemic village five VLendemic upazilas VL expert trained medical officer Upazila Health Complexes UHCs leprosy facility PKDL management Frontline worker conducted housetohouse surveys referring PKDL suspect designated centers Data analysis involved Epi Info version 7 IBM SPSS Statistics 25 Among 472435 screened individuals 4022 past VL 085  Among screened population 82 PKDL suspects 62 PKDL case confirmed overall PKDL burden 13 95  CI 1017 10000 population endemic villages Male predominance macular form PKDL observed Thirtynine PKDL patient perceived stigma different levels 27 62 44  received PKDL treatment Medicines unavailability side effect major reason behind treatment interruption Active screening among 137 leprosynegative PKDL suspect yielded 10 73  PKDL cases existence PKDL case VL endemic area concern interepidemic reservoirs per roadmap PKDL burden must reduced 70  100  respectively 2026 2030 NKEP take current burden 13 per 10000 people VL endemic village baseline Integrating active case detection PKDL leprosy hospital screening center feasible worth deploying nationwide",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Female",
            "Cross-Sectional Studies",
            "Adult",
            "Leishmaniasis, Cutaneous",
            "Adolescent",
            "Child",
            "Bangladesh",
            "Young Adult",
            "Middle Aged",
            "Endemic Diseases",
            "Child, Preschool",
            "Infant",
            "Social Stigma",
            "Patient Acceptance of Health Care",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39179149/"
    },
    {
        "pmid": "39162927",
        "title": "The Elimination Status of Visceral Leishmaniasis in Southeast Asia Region.",
        "abstract": "Visceral leishmaniasis VL caused intracellular parasite transmitted human sandfly bites prevalent throughout Asia Africa Americas Mediterranean area 147 million people risk contracting illness manifestation heterotrophic illness relies Leishmania implicated hosts immunological response ranging asymptomatic severe leishmaniasis potentially lethal effects reviewed literature published till 31st December 2023 worldwide situation leishmaniasis standard novel detection techniques traditional modern treatment strategy endeavor eliminate VL Moreover epidemiological data collected World Health Organizations publicly available databases GraphPad Prism Version 8 used analyze produce figure based epidemiological data Diagnosis parasite tissue serology commonly employed Diagnosis identifying parasite DNA using molecular technique becoming popular Despite recent finding L donovani resistance pentavalent antimoniate medications continues cornerstone medical management VL Amphotericin B lipid formulations injectable paromomycin oral miltefosine among new therapy option researched number reported VL case reduced remarkably last decade due human intervention made eliminate VL Particularly country South East Asian region experienced momentous progress reducing VL case eliminating disease region Owing robust elimination programs country Bangladesh eliminated VL public health concern India Nepal verge elimination Rapid diagnosis effective inexpensive treatment simple access newly discovered medications appropriate vector control welldesigned vaccine required elimination disease burden impoverished area globe",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Humans",
            "Asia, Southeastern",
            "Antiprotozoal Agents",
            "Disease Eradication",
            "Leishmania donovani",
            "Animals",
            "Amphotericin B"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39162927/"
    },
    {
        "pmid": "39023122",
        "title": "Ophthalmic adverse effects of miltefosine in the treatment of leishmaniasis: a systematic review.",
        "abstract": "Miltefosine stand sole oral medication approved treatment leishmaniasis appearance severe ophthalmic toxicity induced miltefosine context leishmaniasis treatment matter significant concern main objective study present comprehensive summary ophthalmic adverse effect associated miltefosine used treatment leishmaniasis systematic search performed PubMed ScienceDirect Embase Scopus Google Scholar covering article inception June 2023 without language restrictions identify relevant study documenting ocular toxicity following miltefosine treatment leishmaniasis total eight study involving 31 leishmaniasis patient developed ocular toxicity undergoing miltefosine treatment included analysis study conducted various regions five originating India two Bangladesh one Nepal Patients presented spectrum ophthalmic complications including uveitis keratitis scleritis Moorens ulcer Commonly reported symptom included pain redness excessive tearing partial vision impairment permanent blindness light sensitivity appearance white spot eye average patient received miltefosine treatment duration 47 day experiencing onset ocular problems important note risk ocular toxicity increase prolonged use miltefosine Therefore mitigate potential irreversible damage eyes imperative individual undergoing miltefosine therapy undergo regular eye examinations",
        "mesh_terms": [
            "Humans",
            "Antiprotozoal Agents",
            "Phosphorylcholine",
            "Leishmaniasis",
            "Eye Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39023122/"
    },
    {
        "pmid": "38995021",
        "title": "Discovery of new antigens for serodiagnosis of visceral leishmaniasis in humans and dogs adds valuable tools to our arsenal.",
        "abstract": "Surveillance sustained control visceral leishmaniasis VL require reliable serodiagnostic tools rK39 gold standard antigen VL diagnosis limited documented poor sensitivity certain endemic regions East Africa longevity antibodies making difficult distinguish active cured infections recent publication imBioi Roberts et al A J Roberts HB Ong S Clare C Brandt et al mBio 15e0085924 2024 httpsdoiorg101128mbio0085924 identified new immunogenic iLeishmaniai candidate dog humans dogs combined antigen LdBPK2907901  LdBPK3627001 D4 D46 distinguished symptomatic asymptomatic infections humans LdBPK3236001 D36 antigen produced shortlived antibody performed well patient cohort Bangladesh Ethiopia Kenya study add promising new candidate serodiagnostic toolbox highlight need antigen discovery study may focused regional performance",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Dogs",
            "Animals",
            "Antigens, Protozoan",
            "Serologic Tests",
            "Humans",
            "Dog Diseases",
            "Antibodies, Protozoan",
            "Sensitivity and Specificity",
            "Ethiopia"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38995021/"
    },
    {
        "pmid": "38900786",
        "title": "A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh.",
        "abstract": "Southeast Asia treatment recommended patient postkalaazar dermal leishmaniasis PKDL Adherence firstline regimen twelve week miltefosine MF low ocular toxicity observed exposure period assessed safety efficacy two shortercourse treatments liposomal amphotericin B LAmB alone combined MF openlabel phase II randomized parallelarm noncomparative trial conducted patient parasitologically confirmed PKDL 6 ≤60 years Patients assigned 20 mgkg LAmB total dose five injection 15 days alone combined allometric MF 3 weeks primary endpoint definitive cure 12 months defined complete resolution papular nodular lesion 80 repigmentation macular lesions Definitive cure 24 month secondary efficacy endpoint 118126 patient completed trial Definitive cure 12 month observed 29 1863 patient receiving LAmB 30 1963 receiving LAmBMF mITT increasing 58 66 respectively 24 months lesion resolvedimproved 12 24 month patient receiving LAmB 90 83 LAmBMF 85 88 qualitative assessment One death unrelated study drugs reported study drugrelated serious adverse event observed frequent adverse drug reaction MFrelated vomiting nausea LAmBrelated hypokalaemia infusion reactions adverse event mild ocular adverse event occurred regimen suitably safe efficacious alternative longcourse MF PKDL South Asia CTRI201704008421",
        "mesh_terms": [
            "Humans",
            "Amphotericin B",
            "Phosphorylcholine",
            "Bangladesh",
            "Male",
            "Antiprotozoal Agents",
            "Adult",
            "Adolescent",
            "Female",
            "Middle Aged",
            "Young Adult",
            "Child",
            "India",
            "Leishmaniasis, Visceral",
            "Treatment Outcome",
            "Leishmaniasis, Cutaneous",
            "Drug Therapy, Combination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38900786/"
    },
    {
        "pmid": "38727613",
        "title": "Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL arises dermal complication following visceral leishmaniasis VL infection Current treatment option PKDL unsatisfactory knowledge gap regarding distribution antileishmanial compound within human skin present study investigated skin distribution miltefosine PKDL patients aim improve understanding pharmacokinetics skin target site PKDL Fiftytwo PKDL patient underwent treatment liposomal amphotericin B 20 mgkg plus miltefosine allometric dosing 21 days Plasma concentration miltefosine measured study day 8 15 22 30 punch skin biopsy taken day 22 physiologically based pharmacokinetic PBPK model developed evaluate distribution miltefosine skin Following allometric weightbased dosing regimen median miltefosine concentration day 22 4373 µgg IQR 21946065 µgg skin 3329 µgmL IQR 2594258 µgmL plasma median individual concentration ratio skin plasma 119 IQR 07919 87 4552 patients skin exposure suggested EC90 PK target 106 mgL associated vitro susceptibility Simulations indicated residence time miltefosine skin would 2fold longer plasma estimated mean residence time 604 versus 266 hours respectively study provides first accurate measurement miltefosine penetration skin demonstrating substantial exposure prolonged retention miltefosine within skin finding support use miltefosine cutaneous manifestation leishmaniasis combination parasitological clinical data result critical future optimization combination therapy miltefosine treatment PKDL",
        "mesh_terms": [
            "Humans",
            "Phosphorylcholine",
            "Antiprotozoal Agents",
            "Male",
            "Adult",
            "Leishmaniasis, Cutaneous",
            "Female",
            "Skin",
            "Leishmaniasis, Visceral",
            "Middle Aged",
            "Young Adult",
            "Amphotericin B",
            "Adolescent",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38727613/"
    },
    {
        "pmid": "38669211",
        "title": "Successful treatment of recurrent visceral leishmaniasis relapse in an immunocompetent adult female with functional hypopituitarism in Bangladesh.",
        "abstract": "Currently available treatment option mostly effective achieving longterm cure visceral leishmaniasis VL patients However report recurrence illness immunosuppressed immunocompetent patients report first case recurrent VL relapse 19yearold immunocompetent female functional hypopituitarism hypogonadotropic hypogonadism central hypothyroidism Bangladesh treated three time previously optimal dosage duration liposomal amphotericin B LAmB alone combination miltefosine treated patient successfully modified treatment regimen 10 mgkg body weight LAmB two consecutive day along oral miltefosine seven day loading dose secondary prophylaxis patient received 3 mgkg body weight LAmB along oral miltefosine seven day monthly five dos followed hormonal replacement patient remained relapse free 12 month treatment completion absence protective vaccine Leishmania specie standard treatment regimen modified treatment regimen could help management recurrent relapse cases",
        "mesh_terms": [
            "Female",
            "Humans",
            "Young Adult",
            "Amphotericin B",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Hypopituitarism",
            "Leishmaniasis, Visceral",
            "Phosphorylcholine",
            "Recurrence",
            "Treatment Outcome",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38669211/"
    },
    {
        "pmid": "38639536",
        "title": "A panel of recombinant <i>Leishmania donovani</i> cell surface and secreted proteins identifies LdBPK_323600.1 as a serological marker of symptomatic infection.",
        "abstract": "Visceral leishmaniasis deadly infectious disease one worlds major neglected health problems symptom infection similar endemic diseases accurate diagnosis crucial appropriate treatment Definitive diagnosis using splenic bone marrow aspirate highly invasive so serological assay preferred including direct agglutination test DAT rK39 strip test tests however either difficult perform field DAT lack specificity endemic region rK39 making development new test research priority availability iLeishmaniai spp genome present opportunity identify new diagnostic targets Here use genome data mammalian protein expression system create panel 93 protein consisting extracellular ectodomains iLeishmania donovanii cell surface secreted proteins use panel serum murine experimental infection model natural human canine infection identify new candidate serological diagnosis observed concordance immunoreactive antigen different host specie transmission settings antigen encoded iLdBPK3236001i gene diagnose iLeishmaniai infection high sensitivity specificity patient cohort different endemic region including Bangladesh Ethiopia longitudinal sampling treated patients observed reduction immunoreactivity LdBPK3236001 suggesting could used diagnose treatment success summary identified new antigen could contribute improved serological diagnostic test help control impact deadly tropical infectious disease Visceral leishmaniasis fatal left untreated patient often displaying mild nonspecific symptom early stage infection making accurate diagnosis important Current method diagnosis require highly trained medical staff perform highly invasive biopsy liver bone marrow pose risk patient Less invasive molecular test available suffer regional variation ability accurately diagnose infection identify new diagnostic marker visceral leishmaniasis produced tested panel 93 protein identified genome parasite responsible disease found pattern host antibody reactivity protein broadly consistent across naturally acquired infection human patient dogs well experimental rodent infections identified new protein called LdBPK3236001 could accurately diagnose visceral leishmaniasis infection humans",
        "mesh_terms": [
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Animals",
            "Humans",
            "Mice",
            "Dogs",
            "Antigens, Protozoan",
            "Antibodies, Protozoan",
            "Protozoan Proteins",
            "Serologic Tests",
            "Biomarkers",
            "Female",
            "Recombinant Proteins",
            "Mice, Inbred BALB C",
            "Membrane Proteins",
            "Sensitivity and Specificity",
            "Dog Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38639536/"
    },
    {
        "pmid": "38630832",
        "title": "Perceived needs of disease vector control programs: A review and synthesis of (sub)national assessments from South Asia and the Middle East.",
        "abstract": "Systems disease vector control effective efficient flexible able tackle contemporary challenge threat control elimination vectorborne diseases priority activity towards strengthening vector control systems advocated country conduct vectorcontrol need assessment review carried perceived need disease vector control program among eleven country subnational state South Asia Middle East country state independent team conducted vector control need assessment engagement stakeholders Important weakness described malaria dengue leishmaniases regarding vector surveillance insecticide susceptibility testing monitoring evaluation operations entomological capacity laboratory infrastructure addition community mobilization intersectoral collaboration showed important gaps Countries state expressed concern insecticide resistance could reduce continued effectiveness interventions demand improved monitoring Moreover attainment disease elimination necessitates enhanced vector surveillance Vector control need assessment provided useful planning tool systematic strengthening vector control systems limitation conducting vector control need assessment time resourceintensive increase feasibility utility national assessments abridged version guidance focus operationally relevant topic assessment Similar review needed region different contextual conditions",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Asia, Southern",
            "Dengue",
            "Disease Vectors",
            "Insecticides",
            "Malaria",
            "Middle East",
            "Needs Assessment",
            "Vector Borne Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38630832/"
    },
    {
        "pmid": "38626228",
        "title": "Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL dermatosis occur successful treatment visceral leishmaniasis VL public health problem VL endemic areas conducted systematic scoping review assess characteristic published PKDL clinical studies understand scope research explore feasibility value developing PKDL individual patient data IPD platform systematic review published literature conducted identify PKDL clinical study searching following databases PubMed Scopus Ovid Embase Web Science Core Collection Global Index Medicus PASCAL Clinicaltrialsgov Ovid Global Health Cochrane Database CENTRAL International Clinical Trials Registry Platform prospective study human PKDL diagnosis treatment followup measurement January 1973 March 2023 included Extracted data includes variable patient characteristics treatment regimens diagnostic methods geographical locations efficacy endpoints adverse event statistical methodology total 3418 record screened 56 unique study n  2486 patients included review 56 studies 36 643 India 19832022 12 214 Sudan 19922021 6 107 Bangladesh 19912019 2 36 Nepal 20012007 Five 89 study published 19811990 n  193 patients 10 179 19912000 n  230 patients 10 179 20012010 n  198 patients 31 554 2011 onwards n  1865 patients Eight 143 randomised clinical trials 48 857 nonrandomised studies median posttreatment followup duration 365 day range 90540 days 8 RCTs 360 day range 282373 days 48 nonrandomised studies Disease diagnosis based clinical criterion 3 54 studies mixture clinical parasitological method 47 839 unclear 6 107 studies Major drug used treatment miltefosine n  636 patients liposomal amphotericin B LAmB n  508 patients antinomy regimen n  454 patients Ten drug regimen tested 270 patient less 60 patient per regimen review identified study limited sample size three major drug miltefosine LAmB pentavalent antimony number patient combined across study suggest IPD platform would valuable support relevant stakeholders global PKDL community sufficient financing PKDL IPD platform realised allow exploration different aspect treatment safety efficacy potentially guide future healthcare decision clinical practices",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Leishmaniasis, Cutaneous",
            "Antiprotozoal Agents",
            "Observational Studies as Topic",
            "Clinical Trials as Topic",
            "Feasibility Studies",
            "Treatment Outcome",
            "India",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38626228/"
    },
    {
        "pmid": "38353873",
        "title": "Portable smartphone-based molecular test for rapid detection of Leishmania spp.",
        "abstract": "Leishmaniasis caused parasite genus Leishmania neglected tropical disease endemic 60 countries SouthEast Asia Brazil East Africa mainly occurs kalaazar visceral leishmaniasis VL subsequently post kalaazar dermal leishmaniasis PKDL smaller portion cases stated per roadmap accessibility accurate diagnostic method essential step achieve elimination study aimed test accuracy portable minoo device small batterydriven multiuse fluorimeter operating isothermal technology molecular diagnosis VL PKDL Fluorescence data measured device within 20 min reported back mobile application or app via Bluetooth onward via internet backend allows anonymous analysis storage test data test result immediately returned app displaying user limit detection 112 genome copy 95 CI determined screening tenfold dilution range whole Leishmania donovani genome using isothermal recombinase polymerase amplification RPA Pathogens considered differential diagnosis tested crossreactivity observed diagnostic performance DNA extracted 170 VL PKDL cases comprising peripheral blood sample VL n  96 skin biopsy PKDL n  74 India n  108 Bangladesh n  62 screened Clinical sensitivity specificity 88 91 respectively Minoo device offer convenient cheaper alternative molecular diagnostics easy handling make ideal use lowresource setting identify parasite burden",
        "mesh_terms": [
            "Humans",
            "Smartphone",
            "Molecular Diagnostic Techniques",
            "Sensitivity and Specificity",
            "Leishmaniasis, Visceral",
            "Leishmania",
            "Nucleic Acid Amplification Techniques",
            "Leishmaniasis, Cutaneous",
            "Leishmania donovani"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38353873/"
    },
    {
        "pmid": "38301672",
        "title": "Bangladesh eliminates visceral leishmaniasis.",
        "abstract": "",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Bangladesh",
            "Humans",
            "Animals",
            "Disease Eradication"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38301672/"
    },
    {
        "pmid": "38132223",
        "title": "Evaluation of a Point-of-Need Molecular Diagnostic Tool Coupled with Rapid DNA Extraction Methods for Visceral Leishmaniasis.",
        "abstract": "rapid costeffective simple nucleic acid isolation technique coupled pointofneed DNA amplification assay desirable goal programmatic use diagnosis Visceral Leishmaniasis VL Recombinase Polymerase Amplification RPA rapid test detection Leishmania DNA versatile operational advantage qPCR facilitate delivery RPA test pointofneed VL diagnosis compared two rapid DNA extraction methods SwiftDx SX inhouse Boil Spin BS method coupled RPA amplification versus widely used method DNA extraction amplification namely Qiagen Q kit qPCR respectively total 50 confirmed VL patient 50 controls matched age gender recruited Mymensingh Bangladesh region highly endemic VL Blood sample collected participant DNA extracted using Q SX BS methods Following DNA extraction qPCR RPA assay performed detect iL donovanii downstream analysis significant difference sensitivity RPA assay observed DNA extraction methods 9400 95 CI 83459875 90 95 CI 78199667 88 95 CI 75699547 using Q SX BS respectively Similarly using qPCR significant difference sensitivity obtained using Q SX DNA extraction 9400 95 CI 83459875 9200 80779778 respectively encouraging RPA qPCR showed excellent agreement k 09190980 different extraction method used DNA impurity using BS inhibitory effect RPA assay Furthermore significantly higher DNA yield obtained using SX BS versus Q however significantly higher parasite load detected using qPCR DNA extracted using Q versus SX Considering cost execution time feasibility performance RPA assay rapid extraction method Boil Spin technique appear potential implementation resourcelimited endemic settings clinical research warranted prior broader application",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38132223/"
    },
    {
        "pmid": "38123228",
        "title": "Safety and efficacy of primaquine in patients with <i>Plasmodium vivax</i> malaria from South Asia: a systematic review and individual patient data meta-analysis.",
        "abstract": "optimal dosing primaquine prevent relapsing iPlasmodium vivaxi malaria South Asia remains unclear investigated efficacy safety different primaquine regimen prevent iP vivaxi relapse systematic review identified iP vivaxi efficacy study South Asia published 1 January 2000 23 August 2021 onestage metaanalysis available individual patient data cumulative risk iP vivaxi recurrence day 42 180 assessed primaquine total mgkg dose duration risk recurrence day 180 also determined twostage metaanalysis Patients 25 drop haemoglobin 70 gL absolute drop 50 gL day 1 14 categorised daily mgkg primaquine dose 791 patient 7 study onestage metaanalysis day 180 cumulative risk recurrence 611 95 CI 422 804 201 patients 25 recurrences treatment without primaquine 288 95 CI 82 741 398 patients 4 recurrences following low total 2 5 mgkg 0 96 patients 0 recurrences following high total dose primaquine ≥5 mgkg subsequent twostage metaanalysis nine study 3529 patients pooled proportion iP vivaxi recurrence day 180 121 95 CI 77 172 23 95 CI 03 54 07 95 CI 0 61 respectively patient 25 drop haemoglobin 70 gL Primaquine treatment led marked decrease iP vivaxi recurrence following low 35 mgkg high 7 mgkg total doses reported severe haemolytic events CRD42022313730",
        "mesh_terms": [
            "Humans",
            "Primaquine",
            "Malaria, Vivax",
            "Antimalarials",
            "Plasmodium vivax",
            "Recurrence",
            "Asia, Southern",
            "Hemoglobins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38123228/"
    },
    {
        "pmid": "38110894",
        "title": "A case report on para-kala-azar dermal leishmaniasis: an unresolved mystery.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL dermatosis occurs 23 year apparently successful treatment visceral leishmaniasis VL rare cases PKDL occurs concurrently VL characterized fever splenomegaly hepatomegaly lymphadenopathy poor nutritional status known Parakalaazar dermal leishmaniasis ParaKDL Coassociation active VL PKDL patient documented Africa case report found South Asia present case Parakalaazar Dermal Leishmaniasis ParaKDL 50yearold male patient history one primary Visceral Leishmaniasis VL 2 time relapse Visceral Leishmaniasis VL patient presented fever skin lesions hepatosplenomegaly Laboratory test revealed LD body slit skin smear splenic biopsy patient treated two cycle Amphotericin B Miltefosine cycle 12 week obtain full recovery case report serf reminder Parakalaazar dermal leishmaniasis develop consequence prior visceral leishmaniasis episodes even apparently effective therapy Since parakalaazar source infectious spread endemic cannot avoided unless effectively recognized treated",
        "mesh_terms": [
            "Male",
            "Humans",
            "Middle Aged",
            "Leishmaniasis, Visceral",
            "Leishmaniasis, Cutaneous",
            "Antiprotozoal Agents",
            "Amphotericin B",
            "Recurrence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38110894/"
    },
    {
        "pmid": "37951693",
        "title": "Vaccine value profile for leishmaniasis.",
        "abstract": "Leishmania infection global occurring 98 country World Health Organization WHO region 600 million 1 billion people risk infection Visceral leishmaniasis associated almost 20000 reported death annually child 5 year age greatest risk mortality Amongst WHOrecognised Neglected Tropical Diseases NTDs leishmaniasis one important term mortality morbidity increasing global burden disease growing threat climate change urbanisation drug resistance remains imperative develop leishmaniasis vaccines New tool understand correlate protection assess vaccine efficacy developed ease transition larger scale efficacy trial provide alternate route licensure Early indication suggest diverse portfolio manufacturer exists endemic country appetite develop leishmaniasis vaccines Vaccine Value Profile VVP provides highlevel comprehensive assessment currently available data inform potential public health economic societal value leishmaniasis vaccines leishmaniasis VVP developed working group subject matter expert academia public health groups policy organizations nonprofit organizations contributor extensive expertise various element leishmaniasis VVP collectively described state knowledge identified current gaps VVP developed using existing publicly available information",
        "mesh_terms": [
            "Child",
            "Humans",
            "Child, Preschool",
            "Leishmaniasis Vaccines",
            "Leishmaniasis",
            "Leishmaniasis, Visceral",
            "Public Health",
            "Morbidity",
            "Neglected Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37951693/"
    },
    {
        "pmid": "37943733",
        "title": "Assessment of the impact of implementation research on the Visceral Leishmaniasis (VL) elimination efforts in Nepal.",
        "abstract": "Nepal Bangladesh India signed Memorandum Understanding MoU 2005 eliminate visceral leishmaniasis VL public health problem Indian subcontinent 2015 2021 number reported VL case country declined 95 compared 2007 dramatic success achieved elimination programme implemented early case detection effective treatment vector control disease surveillance community participation operational research underpinned strategies experience offered opportunity assess contribution implementation research IR VL elimination Nepal Desk review stakeholder workshop conducted analyse relationship key research outputs major strategic decision national VL elimination programme annual number reported new case time 2005 2023 result indicated key decision across strategic elements throughout course elimination programme such appropriate tool diganostics treatment best strategy case finding vector management IR informed IR responded dynamically change resulted interventions addressing new question emerged field Close collaboration researchers programme managers implementers priority setting design conduct review study facilitated uptake evidence policy programmatic activities VL case number Nepal reduced 90 compared 2005 Although direct attribution disease decline research output difficult establish Nepal experience demonstrates IR critical enabler disease elimination lesson potentially inform IR strategy country disease targeted elimination",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Insect Control",
            "Nepal",
            "Public Health",
            "Disease Eradication",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37943733/"
    },
    {
        "pmid": "37862287",
        "title": "Dried Blood Spots (DBS): A suitable alternative to using whole blood samples for diagnostic testing of visceral leishmaniasis in the post-elimination era.",
        "abstract": "Serum whole blood collection processing transport storage still present significant challenge low resource setting mass surveillance required sustain disease elimination Therefore study explored diagnostic efficacy dried blood spot DBS minimally invasive potentially costeffective alternative sampling technique whole blood sampling procedure subsequent detection Leishmania donovani antibody DNA Archived serum DNA sample whole blood visceral leishmaniasis VL case healthy controls DBS corresponding case controls used molecular serological assay optimized detect L donovani antibody DNA DBS elute result compared obtained whole blood Serological assay both rK28 ELISA rK39 ELISA DBS sample showed sensitivity specificity 100 excellent agreement result whole blood sample kappa value ranged 0981 BlandAltman analysis OD value rK28ELISA DBS elute patients serum showed excellent agreement ICC  09 whereas good agreement ICC  08 observed case rK39ELISA However qPCR RPA DBS sample diminished sensitivity 76 68 respectively poor agreement observed whole blood samples result demonstrate DBS offer excellent diagnostic efficiency serological assay represent viable alternative whole blood sampling procedures",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Antigens, Protozoan",
            "Diagnostic Techniques and Procedures",
            "Sensitivity and Specificity",
            "Antibodies, Protozoan",
            "DNA",
            "Dried Blood Spot Testing"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37862287/"
    },
    {
        "pmid": "37741011",
        "title": "Assessment of treatment outcomes of visceral leishmaniasis (VL) treated cases and impact of COVID-19 on VL management and control services in Bangladesh.",
        "abstract": "COVID19 largely impacted management Visceral leishmaniasis VL like several Neglected Tropical Diseases impact particularly evident Lower MiddleIncome country already inadequate healthcare resource diverted managing COVID19 pandemic Bangladesh achieved elimination target VL 2016 sustain success early diagnosis treatment effective vector control periodic surveillance paramount However specific control measure VL Bangladesh hampered COVID19 extent unknown study aimed identifying gap challenge followup treated VL patient interviewing treated VL case health service providers followed VL case treated 2019 2020 five VL endemic subdistricts upazilas retrospectively prospectively monitor clinical improvement relapse consequences Moreover interview conducted health service provider assess impact COVID19 VL case detection treatment reporting vector control operations logistic supply chain management added delay VL diagnosis however VL treatment initiation reporting time increased almost twofold due COVID19 Indoor Residual Spraying activity significantly hampered due shortage insecticides 44 enrolled treated VL patients two relapsed 45  two developed Para KalaAzar Dermal Leishmaniasis 45  three 68  Post KalaAzar Dermal Leishmaniasis PKDL health service provider highlighted patients unwillingness visit hospital financial constraints distance hospital main reason missed followup visit 205  Building good communication community awareness schemes incentivebased approach suggested possible solution mitigate problems Longterm followup required early detection management VL relapse PKDL cases Effective vector control measures capacity development identification new VL hotspot pivotal VL endemic region sustain elimination goal",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Bangladesh",
            "Pandemics",
            "Retrospective Studies",
            "COVID-19",
            "Treatment Outcome",
            "Recurrence",
            "Leishmaniasis, Cutaneous",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37741011/"
    },
    {
        "pmid": "37722667",
        "title": "Long-Term Efficacy of Insecticidal Wall Painting for Controlling Visceral Leishmaniasis Vectors in Bangladesh.",
        "abstract": "success visceral leishmaniasis VL elimination program largely depends costeffective vector control measures goal investigate longevity efficacy insecticidal wall painting IWP new vector control tool compared routine indoor residual spraying IRS program reducing VL vector density Bangladesh study extension recent IWP study VL vector management Bangladesh undertaken seven highly VL endemic village Mymensingh district 12month followup 24months followup study collected sand fly additionally 15 18 21 24 month since intervention IWP control where program routine IRS cluster examine longevity efficacy IWP sand fly density reduction mortality differenceindifferences regression model used estimate effect IWP sand fly reduction Program IRS IWP showed excellent performance reducing sand fly density increasing sand fly mortality compared Program IRS effect IWP controlling sand fly statistically significant least 24 months mean female Phlebotomus argentipes density reduction ranged 56 83 P argentipes sand fly mortality ranged 81 995 24month followup period Considering duration efficacy IWP controlling VL vectors Bangladesh National Kalaazar Elimination Program may consider IWP best alternative IRS subsequent phase program",
        "mesh_terms": [
            "Animals",
            "Female",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Insect Control",
            "Bangladesh",
            "Follow-Up Studies",
            "Insect Vectors",
            "Phlebotomus",
            "Psychodidae",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37722667/"
    },
    {
        "pmid": "37716668",
        "title": "Epidemiological, serological, and entomological aspects of visceral leishmaniasis (VL) in suspected new VL foci in Bangladesh.",
        "abstract": "study aimed explore epidemiological serological entomological aspect visceral leishmaniasis VL suspected new VL focus assess knowledge attitude practice community living alleged new VL foci study investigated new visceral leishmaniasis VL case reported 2019 2020 four subdistricts Dharmapasha Hakimpur Islampur Savar tested 560 member using rK39 rapid test conducted vector collection six neighbouring house index case assess sandfly density distribution examined sandflies infection determined spatial relationship VL infection Furthermore highlighted importance early detection community awareness controlling spread disease study screened 1078 people 231 household four subdistricts fever history visceral leishmaniasis VL PKDLlike skin lesions Among subdistricts positivity rate rK39 rapid test highest 35  Savar Sandflies present across area except Dharmapasha 21 collected female P argentipes sandfly negative Leishmania parasite DNA found one person Islampur history VL one Islampur another one Savar PKDL awareness intervention people became familiar VL infection 912  knowledge concerning sandfly vector disease risk VL increased significantly 301  study found active case suspected new foci asymptomatic individual present sandfly vector exist areas National Kalaazar Elimination Programme NKEP consider area kalaazar endemic initiate control activity per national guidelines",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Female",
            "Leishmaniasis, Visceral",
            "Bangladesh",
            "Phlebotomus",
            "Psychodidae",
            "Fever",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/37716668/"
    },
    {
        "pmid": "36962767",
        "title": "Real Time PCR-based diagnosis of human visceral leishmaniasis using urine samples.",
        "abstract": "Diagnosis visceral leishmaniasis VL detection causative agent namely Leishmania donovani L infantum traditionally based immunochromatographic tests microscopy bone marrow spleen aspirates liver lymph node differential diagnosis first process low specificity later one carry risk fatal hemorrhage last decade multiple Polymerase Chain Reaction PCR based diagnosis developed using blood urine sample varying degree sensitivity specificity issue worth improving precision diagnosis Earlier reported PCRbased diagnosis L donovani peripheral blood using novel set PCR primer absolute specificity Using set primer PCR conditions describe diagnosis L donovani urine noninvasive rapid safe diagnosis Diagnosis VL carried using urine sample collected clinically diagnosed VL patient n  23 Bangladesh Real Time PCR Test result validated comparing blood sample set patients Sensitivity specificity diagnosis analyzed using retrospective bone marrow samples collected earlier confirmed VL patient n  19 method showed 100 sensitivity detecting L donovani urine corresponding blood retrospective bone marrow samples well 100 specificity control groups Real Time PCRbased molecular detection system using urine sample hereafter presented could a noninvasive approach VL detection precision perfection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36962767/"
    },
    {
        "pmid": "36948728",
        "title": "Food- and vector-borne parasitic zoonoses: Global burden and impacts.",
        "abstract": "Around 25 global population suffer one parasitic infections food vectorborne parasitic zoonotic disease major concern Additionally zoonosis communicable diseases common man animals drawing increased attention worldwide Significant change climatic conditions cropping pattern demography food habits increasing international travel marketing trade deforestation urbanization play vital role emergence reemergence parasitic zoonoses Although likely underestimated collective burden food vectorborne parasitic disease account ∼60 million disabilityadjusted life year DALYs 20 neglected tropical disease NTDs listed World Health Organization WHO Centres Disease Control Prevention CDC 13 disease parasitic origin 200 zoonotic disease listed eight neglected zoonotic disease NZDs year 2013 eight NZDs four diseases namely cysticercosis hydatidosis leishmaniasis trypanosomiasis caused parasites review discus global burden impact food vectorborne zoonotic parasitic diseases",
        "mesh_terms": [
            "Animals",
            "Parasites",
            "Zoonoses",
            "Parasitic Diseases",
            "Cysticercosis",
            "Echinococcosis",
            "Neglected Diseases",
            "Global Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36948728/"
    },
    {
        "pmid": "36878211",
        "title": "Assessment of Knowledge, Attitudes, and Practices toward Kala-azar in an Endemic District in Bangladesh: A Cross-Sectional Survey.",
        "abstract": "undertook study assess current knowledge attitudes practice related kalaazar advise national kalaazar elimination program Bangladesh communitybased crosssectional study conducted two endemic subdistricts upazilas Fulbaria Trishal Based upazila health complex surveillance data one endemic village selected randomly subdistricts total 511 household HHs 261 Fulbaria 250 Trishal included study adult HH interviewed using structured questionnaire Specifically data collected knowledge attitudes practice related kalaazar respondents 5264 illiterate study participant heard approximately kalaazar 3014 HHs neighboring HHs least one kalaazar case respondents 6888 knew kalaazar transmitted sick people 5653 study participant said mosquito transmitted kalaazar even though 9080 aware presence sand flies participants 4655 aware insect vector laid egg water Upazila Health Complex preferable healthcare facility 8814 villagers addition 6203 used bed net preventing sand fly bite 9648 family mosquito nets Based observations national program strengthen current community engagement activity increase knowledge kalaazar endemic communities",
        "mesh_terms": [
            "Animals",
            "Leishmaniasis, Visceral",
            "Cross-Sectional Studies",
            "Bangladesh",
            "Health Knowledge, Attitudes, Practice",
            "Family Characteristics",
            "India"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36878211/"
    },
    {
        "pmid": "36749281",
        "title": "South Asian Transplant Infectious Disease Guidelines for Solid Organ Transplant Candidates, Recipients, and Donors.",
        "abstract": "guideline discus epidemiology screening diagnosis posttransplant prophylaxis monitoring management endemic infection solid organ transplant SOT candidates recipients donor South Asia guideline also provide recommendation SOT recipient traveling region guideline based literature review expert opinion transplant physicians surgeons infectious disease specialists mostly South Asian country India Pakistan Bangladesh Nepal Sri Lanka well transplant expert countries guideline cover relevant endemic bacterial infection tuberculosis leptospirosis melioidosis typhoid scrub typhus viral infection hepatitis A B C D E rabies arbovirus including dengue chikungunya Zika Japanese encephalitis endemic fungal infection mucormycosis histoplasmosis talaromycosis sporotrichosis endemic parasitic infection malaria leishmaniasis toxoplasmosis cryptosporidiosis strongyloidiasis filariasis well travelers diarrhea vaccination SOT candidate recipient including traveler visiting region guideline intended overview topic detailed review published special supplement Indian Journal Transplantation ",
        "mesh_terms": [
            "Humans",
            "Diarrhea",
            "Travel",
            "Organ Transplantation",
            "Communicable Diseases",
            "Tissue Donors",
            "Transplant Recipients",
            "Zika Virus",
            "Zika Virus Infection"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36749281/"
    },
    {
        "pmid": "36720335",
        "title": "A review on new natural and synthetic anti-leishmanial chemotherapeutic agents and current perspective of treatment approaches.",
        "abstract": "Leishmaniases considered among neglected yet dangerous parasitic disease worldwide According recent report Weekly Epidemiological Record Sep 2021 200 country territory reported leishmanises case 2020 89 45 CL 79 40 VL endemic Indian subcontinent India Bangladesh Nepal one three ecoepidemiological hotspot VL currently reported 18 total case VL worldwide Eastern Mediterranean region Region Americas together reported 90 new CL cases 80 Afghanistan Algeria Brazil Colombia Iraq Pakistan Syrian Arab Republic considering current therapeutic options conventional antileishmanial drug long proved toxic andor expensive resulted extensive drug resistance India Recent search novel antileishmanial drug led find prime cellular target metabolic pathway bridge gap known fact unexplored data Cutting edge knowledge based drug designing simplified search novel molecule leishmanicidal efficacy identifying ligandreceptor interaction accelerated cost effective primary discovery molecule computational validation Leishmaniases review focus limitation conventional drugs discusses chemotherapeutic potential many novel natural synthetic antileishmanial agent reported since last decade also interpreted reported molecule might tested singly part combinatorial therapy preclinical clinical level",
        "mesh_terms": [
            "Humans",
            "Leishmania",
            "Leishmaniasis",
            "India",
            "Bangladesh",
            "Nepal",
            "Antiprotozoal Agents",
            "Leishmaniasis, Visceral"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36720335/"
    },
    {
        "pmid": "36662825",
        "title": "Revisiting the diagnosis and treatment of Para Kala-azar Dermal Leishmaniasis in the endemic foci of Bangladesh.",
        "abstract": "Para Kalaazar Dermal Leishmaniasis ParaKDL manifest concomitant presence Post Kalaazar Dermal Leishmaniasis Visceral Leishmaniasis work reservoir infection study discusses case management aim address gap within existing method diagnosis treatment retrospective crosssectional study discusses 16 ParaKDL case oneyear followup data treated 20122021 Surya Kanta Kalaazar Research Center Bangladesh collected data hospital record used STATA 16 analyze see frequency distribution variable means found five patient without history kalaazar infection patient treated 20 mgkg Liposomal Amphotericin B 4 divided dos except one history AmBisome hypersensitivity One year treatment patient free skin lesions hepatosplenomegaly observed significant improvement BMI hemoglobin levels ParaKDL patient challenging diagnose relapse treatment failure leishmania patient might belonged rare group contributing poor prognosis Therefore developing appropriate diagnostic workflow new drug regimen essential sustain success elimination efforts",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Antiprotozoal Agents",
            "Retrospective Studies",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Leishmaniasis, Cutaneous"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36662825/"
    },
    {
        "pmid": "36493571",
        "title": "Assessment of pan-Leishmania detection by recombinase polymerase amplification assay.",
        "abstract": "spread vector habitat along increasing human mobility introduce atypical Leishmania specie hence challenge existing diagnostic practice rapid detection active infection specie outside narrow target range assessed panLeishmania detection ability isothermal recombinase polymerase amplification RPA assay targeting 18S rRNA gene cathepsin Llike cysteine proteinase B Cpb gene kinetoplast minicircle DNA kDNA regions lowest limit detection 18S rRNARPA CpbRPA assay estimated 12 17 standard DNA molecules respectively assay could amplify genomic DNA 7 pathogenic Leishmania species Evaluation 18S rRNARPA previously developed kDNARPA assay 70 realtime PCRpositive leishmaniasis sample varying pathology resulted sensitivity rate 3571 8857 respectively combined sensitivity 9857 Combinatorial application 18S rRNARPA kDNARPA assay recommended diagnostic assessments",
        "mesh_terms": [
            "Humans",
            "DNA, Kinetoplast",
            "Leishmania",
            "Nucleic Acid Amplification Techniques",
            "Recombinases",
            "RNA, Ribosomal, 18S",
            "Sensitivity and Specificity",
            "Leishmaniasis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36493571/"
    },
    {
        "pmid": "36302782",
        "title": "Gauging the skin resident Leishmania parasites through a loop mediated isothermal amplification (LAMP) assay in post-kala-azar dermal leishmaniasis.",
        "abstract": "Despite availability highly sensitive polymerase chain reaction PCRbased methods dearth remotely deployable diagnostic tool circumvents early accurate detection individual postkalaazar dermal leishmaniasis PKDL Here evaluate designlocked loopmediated isothermal amplification LAMP assay diagnose PKDL total 76 snipskin sample collected individual probable PKDL clinical presentation positive rK39 rapid diagnostic test RDT assessed microscopy qPCR LAMP equal number age sexmatched healthy control included determine specificity LAMP assay LAMP assay Qiagen DNA extraction QLAMP showed promising sensitivity 7237 95 CI 60918201 identifying PKDL cases LAMP assay sensitivity declined DNA extracted using boilspin method QqPCR showed 6842 56757861 sensitivity comparable LAMP excellent agreement whereas microscopy exhibited weak sensitivity 3947 28445135 microscopy andor qPCR considered gold standard QLAMP exhibited elevated sensitivity 897 95 CI 78839611 detection PKDL case Bayesian latent class modeling substantiated excellent sensitivity assay healthy control found negative Notwithstanding optimum efficiency LAMP assay towards detection PKDL cases optimization boilspin method warranted permit remote use assay",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Leishmaniasis, Visceral",
            "Leishmania donovani",
            "Parasites",
            "Leishmaniasis, Cutaneous",
            "Bayes Theorem",
            "Skin Diseases, Parasitic",
            "Real-Time Polymerase Chain Reaction"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/36302782/"
    },
    {
        "pmid": "35381827",
        "title": "First detection of voltage-gated sodium channel mutations in <i>Phlebotomus argentipes</i> collected from Bangladesh.",
        "abstract": "Phlebotomus argentipes main vector visceral leishmaniasis Bangladesh controlled using deltamethrin synthetic pyrethroid indoor residual spraying IRS mutation L1014 leucine codon 1014 voltagegated sodium channel VGSC known knockdown resistance kdr gene thought important pyrethroid resistance mechanism study detected mutation codon 1014 codon 1011 1016 1020 kdr site insects kdr relationship deltamethrin resistance P argentipes IRStargeted site Bangladesh also evaluated Sand fly collected Magurjora village Mymensingh district Bangladesh November 2012 cone bioassay test using deltamethrin conducted specimen grouped live dead morphological identification genomic DNA used genotype partial VGSC gene P argentipes kdr pyrethroid resistance relationship evaluated using Fishers exact test Targeted codon genotyped 8 live 63 dead P argentipes live specimen mutant allele L1014F L1014S codon 1014 mutant allele rate 94 live specimen 55 dead specimens mutant allele survival odds higher wildtype L1014L allele L1014F odds lower L1014S mutation codon 1011 1016 1020 L1014 mutation suggested pyrethroid resistance appeared Bangladesh research kdr mutation P argentipes important appropriate IRS",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Insecticide Resistance",
            "Insecticides",
            "Mutation",
            "Phlebotomus",
            "Pyrethrins",
            "Voltage-Gated Sodium Channels"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/35381827/"
    },
    {
        "pmid": "34983616",
        "title": "Identification of asymptomatic Leishmania infections: a scoping review.",
        "abstract": "Asymptomatic Leishmania infection may play important role transmission parasite endemic areas present consensus definition asymptomatic Leishmania infection safe accessible gold standard test identification paper present scoping review summarize definition asymptomatic Leishmania infection found literature well detail approach molecular serological cellular andor parasitological tests used researcher identify asymptomatic population scoping review published gray literature related asymptomatic Leishmania infection conducted retrieved citation screened based predefined eligibility criteria relevant data item extracted eligible articles analysis descriptive presented using tables figures thematic narrative synthesis conducted screening 3008 articles 175 selected full review articles selected 106 met inclusion criteria article published 1991 2021 last 5 years 38 article reported study conducted Brazil 26 Spain 14 India 12 Bangladesh 10 Ethiopia 7 studies 849 conducted immunocompetent population 151 conducted immunosuppressed population HIV immunosuppressive drugs organ transplantation population report 14 different technique 10 strategy employed researcher define asymptomatic Leishmania infection endemic area definition asymptomatic Leishmania infection unified across literature often includes following criteria residence or extended stay Leishmaniaendemic area reported signssymptoms compatible leishmaniasis positive combination serological molecular cellular andor parasitological tests Caution recommended comparing result different study subject asymptomatic infections reported prevalence cannot confidently compared area due wide variety test employed research groups research importance asymptomatic immunosuppressed immunocompetent Leishmaniapositive population leishmaniasis epidemiology required",
        "mesh_terms": [
            "Asymptomatic Infections",
            "Endemic Diseases",
            "Humans",
            "Leishmaniasis",
            "Neglected Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34983616/"
    },
    {
        "pmid": "34829309",
        "title": "Development of Quantitative Rapid Isothermal Amplification Assay for <i>Leishmania donovani</i>.",
        "abstract": "Quantification pathogen load although challenging paramount importance accurate diagnosis clinical management range infectious disease pointofneed testing PONT scenario resourcelimited settings formulated quantification approach test standardcurve based absolute quantification ability isothermal recombinase polymerase amplification RPA assay test principle 10fold dilution series iLeishmania donovanii LD genomic DNA prepared nucleasefreewater NFW culturespikedblood CSB tested 15 min assay performed modified algorithm formulated derive detection outcome thresholdrecord time Tr second thus obtained plotted initial load parasite genome loglinear regression analysis quantitative RPA QRPA assay evaluated LD quantitative qPCR assay DNA extracted visceral postKalaazar dermal leishmaniasis case specimen stratified different range threshold cycle Ct bestfitted regression model found linear mean rsup2suproot mean square error RMSE value residual point in seconds estimated 09968063 0992746 replicated series NFW CSB respectively series lower limit detection reached less 01 parasite genome equivalent DNA Absolute agreement QRPA LDqPCR found test positivity strong positive correlation observed Tr Ct value r  089 ipi  00001 well absolute parasite load r  087 ipi  00001 quantified respective assays finding first QRPA assay leishmaniasis suggestive potential monitoring LD load clinical specimens development rapid QRPA assay infectious diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34829309/"
    },
    {
        "pmid": "34789971",
        "title": "Efficacy and safety of single-dose liposomal amphotericin B in patients with visceral leishmaniasis in Bangladesh: a real-life experience.",
        "abstract": "Liposomal amphotericin B LAmB drug choice Bangladesh eliminate burden visceral leishmaniasis also known kalaazar fatal protozoan parasitic disease left untreated aimed assess efficacy safety singledose 10 mgkg LAmB visceral leishmaniasis VL treatment among visiting child adult tertiary care setting prospective study includes 11 child 19 adult confirmed diagnosis kalaazar total 30 cases Intravenous infusion LAmB 10 mgkg body weight given patients Clinical assessment conducted treatment hospital discharge day 30 180 treatment Efficacy estimated term initial cure at day 30 final cure at 180 days information recorded preformed case record form analysis performed SPSS 22 mean age 2713 ± 1804 year 365 male predominance 60 Significant regression spleen size found following treatment LAmB 30 day 180 day follow visit p  005 all Overall rate initial cure 90 n  27 child 909 v 8947 adult final cure 9666 n  29 child 100 v 9473 adult Fourteen adverse event recorded mostly including fever andor shivering 8571 case relapsed referred either due management Severe Adverse Event SAE reallife experience LAmB treatment visceral leishmaniasis safe effective treatment kalaazar patients online version contains supplementary material available 101007s1263902101379w",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34789971/"
    },
    {
        "pmid": "34773853",
        "title": "Immunomodulatory role of Th17 pathway in experimental visceral leishmaniasis.",
        "abstract": "Visceral leishmaniasis VL Kalaazar vector borne protozoan infection caused Leishmania donovani Indian subcontinent mainly India Nepal Bangladesh major public health problem country mostly affecting socioeconomically poor population Leishmaniasis rank third important disease malaria filariasis still considered one neglected tropical disease world development better therapeutic agent effective vaccine VL need understand host immunological change play vital role course infection Therefore investigated role Th17 pathway Balbc mouse Leishmania donovani infection treatment amphotericin B Mice divided four group ie Control Infected Uninfected treated Infected treated cytokine level estimated spleen Balbc mouse day 1 3 7 14 17 21 28 35 45 60 post infection course treatment mRNA level Th17 pathway active Leishmania donovani infection treatment determined real time polymerase chain reaction RTPCR protein level flow cytometry ELISA Results study revealed active infection associated low level Th17 cytokine IL17 IL22 IL23 elevated level IL6 IL1β TGFβ Amphotericin B treatment restored production proinflammatory cytokine IL17 IL22 level transcription factor RORγt found correlate level IL17 infection also chemotherapy whereas STAT3 level elevated infection vice versa treatment finding study suggest Th17 cytokine IL17 IL22 associated protection VL infection development intervention chemotherapeutic agent targeting Th17 pathway could important approach VL treatment",
        "mesh_terms": [
            "Animals",
            "Biomarkers",
            "Cricetinae",
            "Cytokines",
            "Disease Models, Animal",
            "Disease Susceptibility",
            "Gene Expression Regulation",
            "Host-Parasite Interactions",
            "Immunomodulation",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Lymphocyte Activation",
            "Mice",
            "Signal Transduction",
            "Spleen",
            "Th17 Cells"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34773853/"
    },
    {
        "pmid": "34699956",
        "title": "Vector-borne and zoonotic infections and their relationships with regional and socioeconomic statuses: An ID-IRI survey in 24 countries of Europe, Africa and Asia.",
        "abstract": "crosssectional international study aimed analyze vectorborne zoonotic infection VBZI significant global threats VBZIs data May 2028 2018 collected 24 Participatingcountries classified lowermiddle uppermiddle highincome 382 patient included 175458 hospitalized commonly Croatia Egypt RomaniaP  0001 significant difference distribution VBZIs according geographical regionsP  0001 Amebiasis Ancylostomiasis Blastocystosis Cryptosporidiosis Giardiasis Toxoplasmosis significantly common MiddleEast Bartonellosis Borreliosis Cat Scratch Disease Hantavirus syndrome Rickettsiosis Campylobacteriosis Salmonellosis CentralEastSouthEast Europe Brucellosis Echinococcosis CentralWest Asia Campylobacteriosis Chikungunya Tickborne encephalitis Visceral Leishmaniasis Salmonellosis Toxoplasmosis NorthMediterranean CCHF Cutaneous Leishmaniasis Dengue Malaria Taeniasis Salmonellosis Indian Subcontinent Lassa Fever West Africa significant regional difference viral hemorrhagic feversP  0001 tickborne infectionsP  0001 according economic status VBZIsP  0001 prevalence VBZIs significantly higher lowermiddle income countriesP  0001 similar region Indian Subcontinent MiddleEast Indian Subcontinent NorthMediterranean MiddleEast NorthMediterranean regions Regional socioeconomic heterogeneity still exists VBZIs Control eradication VBZIs require evidencebased surveillance data multidisciplinary efforts",
        "mesh_terms": [
            "Africa",
            "Animals",
            "Asia",
            "Cross-Sectional Studies",
            "Europe",
            "Hemorrhagic Fever Virus, Crimean-Congo",
            "Hemorrhagic Fever, Crimean",
            "Humans",
            "Socioeconomic Factors",
            "Zoonoses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34699956/"
    },
    {
        "pmid": "34695792",
        "title": "Comparison of Novel Sandfly Control Interventions: A Pilot Study in Bangladesh.",
        "abstract": "pilot comparative study investigated compared effect existing vector control tool sandfly density mortality inform support National Kalaazar Elimination Program NKEP intervention included insecticidal wall painting IWP reducedcoverage insecticidal durable wall lining DWL insecticideimpregnated bednets ITN indoor residual spraying deltamethrin IRS Sakhua union seven village study area highly endemic visceral leishmaniasis union Trishal upazila Bangladesh cluster containing different intervention included approximately 50 households Study method included random selection clusters collection sandfly CDC light trap manual aspirator determine sandfly density sandfly mortality determined cone bioassay test Trained field research assistant interviewed household head using structured questionnaire sociodemographic information well safety acceptability interventions Descriptive analytical statistical method measured interventions effect duration sandfly density reduction mortality measured relative efficacy IWP sandfly control DWL ITN IRS differenceindifference regression model found existing intervention effective safe sandfly control different duration effect acceptability relative efficacy IWP sandfly reduction varied 59 91 75 81 30 104 compared DWL ITN IRS respectively different time point 12month followup study result guide NKEP selection sandfly control tools subsequent consolidation maintenance phases",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Construction Materials",
            "Housing",
            "Insect Control",
            "Insect Vectors",
            "Insecticide-Treated Bednets",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Nitriles",
            "Phlebotomus",
            "Pilot Projects",
            "Psychodidae",
            "Pyrethrins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34695792/"
    },
    {
        "pmid": "34634528",
        "title": "Development and validation of an HPLC-MS/MS method for the quantification of the anti-leishmanial drug miltefosine in human skin tissue.",
        "abstract": "Miltefosine oral drug approved treatment various clinical presentation neglected parasitic disease leishmaniasis cutaneous leishmaniasis postkalaazar dermal leishmaniasis Leishmania parasite reside multiply dermis skin miltefosine orally administered drug currently studied treatment skinrelated type leishmaniasis urgent need accurate assay determine actual miltefosine level human skin tissue optimize treatment regimen targetsite pharmacokinetic studies describe development validation sensitive method quantify miltefosine 4mm human skin biopsy utilizing highperformance liquid chromatography coupled tandem mass spectrometry skin tissue homogenized overnight enzymatic digestion using collagenase A skin homogenate processed protein precipitation phenylbonded solid phase extraction Final extract injected onto Gemini C18 column using alkaline eluent separation elution Detection performed positive ion electrospray ionization followed quadrupole  linear ion trap mass spectrometer using deuterated miltefosine internal standard method validated linear calibration range 41000 ngmL rsup2sup ≥ 09996 using miltefosine spiked digestion solution calibration quality control samples Validation parameter within internationally accepted criteria including intra interassay accuracy precision within± 15 ≤ 15 within± 20 ≤ 20 lower limit quantitation significant matrix effect human skin tissue matrix recovery miltefosine internal standard comparable Miltefosine human skin tissue homogenate stable homogenization incubation 37 °C± 16 h minimum 10 day storage  20 °C homogenization process assay could successfully detect miltefosine skin biopsy patient postkala azar dermal leishmaniasis treated drug Bangladesh",
        "mesh_terms": [
            "Antiprotozoal Agents",
            "Chromatography, High Pressure Liquid",
            "Humans",
            "Leishmania",
            "Pharmaceutical Preparations",
            "Phosphorylcholine",
            "Reproducibility of Results",
            "Tandem Mass Spectrometry"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34634528/"
    },
    {
        "pmid": "34503557",
        "title": "Evaluation of molecular assays to detect Leishmania donovani in Phlebotomus argentipes fed on post-kala-azar dermal leishmaniasis patients.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL caused Leishmania donovani LD skin disorder often appears treatment visceral leishmaniasis VL patients PKDL patient potential reservoir LD parasites initiate new epidemic anthroponotic VL Therefore host infectiousness sand fly vector critical factor transmission accurate estimation facilitate control strategies present conventional microscopy serf reference method detect parasite vector However low sensitivity microscopy limiting factor study realtime quantitative PCR LDqPCR recombinase polymerase amplification LDRPA assay evaluated microscopy detection LD DNA extracted live sand fly five day controlled feeding PKDL cases sensitivity LDqPCR LDRPA assay found 9643 100 respectively microscopy selected fed sand fly n  28 absolute specificity molecular tool apparently unfed sand fly n  30 proportion infectious case among 47 PKDL patient estimated 4681 defined microscopic detection LD least one fed sand fly per case LDRPA assay evaluation microscopy negative sand fly fed 47 PKDL case estimated even greater proportion infectious case 5106 overall estimation infectious case retrospective manner discordance positivity rate observed p  005 LDRPA 5957 assay microscopy 4681 LDRPA slightly better positivity rate LDqPCR 5532 well Considering sensitivity cost detection time field applicability RPA assay considered promising single molecular detection tool investigation pertaining LD infection sand fly andor host infectiousness PKDL also useful confirmation microscopy negative sand fly samples",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Phlebotomus",
            "Real-Time Polymerase Chain Reaction",
            "Retrospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34503557/"
    },
    {
        "pmid": "34449767",
        "title": "Micro-CT visualization of a promastigote secretory gel (PSG) and parasite plug in the digestive tract of the sand fly Lutzomyia longipalpis infected with Leishmania mexicana.",
        "abstract": "Leishmaniasis debilitating disease tropics subtropics southern Europe caused Leishmania parasite transmitted blood feeding phlebotomine sand fly Diptera Psychodidae Using noninvasive microcomputed tomography able visualize impact laboratory model infection Lutzomyia longipalpis Leishmania mexicana response second blood meal first time able show 3D plug promastigote secretory gel PSG parasite distended midgut whole infected sand fly measure volume relation midgut also able measure degree opening stomodeal valve demonstrate extension PSG parasite pharynx Although pilot study could examine flies support hypothesis second noninfected blood meal enhances parasite transmission showed thoracic PSGparasite plug infected fly second blood meal was average twice volume plug infected fly second blood meal",
        "mesh_terms": [
            "Animals",
            "Female",
            "Gastrointestinal Tract",
            "Insect Vectors",
            "Leishmania mexicana",
            "Pilot Projects",
            "Protozoan Proteins",
            "Psychodidae",
            "X-Ray Microtomography"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34449767/"
    },
    {
        "pmid": "34370731",
        "title": "Impact of IRS: Four-years of entomological surveillance of the Indian Visceral Leishmaniases elimination programme.",
        "abstract": "2005 Bangladesh India Nepal agreed eliminate visceral leishmaniasis VL public health problem approach improved case detection treatment controlling transmission sand fly vector Phlebotomus argentipes indoor residual spraying IRS insecticide Initially India applied DDT stirrup pump IRS however reduce transmission 2015 onwards pyrethroid alphacypermethrin applied compression pumps entomological surveillance initiated 2016 Eight sentinel site established Indian state Bihar Jharkhand West Bengal IRS coverage monitored household survey quality insecticide application measured HPLC presence abundance VL vector monitored CDC light traps insecticide resistance measured diagnostic assay case incidence determined VL case register KAMIS Complete treatment house IRS increased across site 57 2016 70 house 2019 rising 80 partial house IRS coverage included except West Bengal quality insecticide application improved compared previous studies average dos insecticide filter paper ranged 152 time target dose 25mgm2 alphacypermethrin 2019 167 time 2018 Resistance DDT continued increase vector resistant carbamates organophosphate pyrethroids annual seasonal abundance P argentipes declined 2016 2019 overall infection rate 003 associated decline VL incidence block represented sentinel site 116 per 10000 population 2016 051 per 10000 2019 effective case detection management reducing infection reservoir P argentipes human population combined IRS keeping P argentipes abundance infectivity low reduced VL transmission combination effective case management vector control brought India within reach VL elimination targets",
        "mesh_terms": [
            "Animals",
            "Biological Assay",
            "Female",
            "Humans",
            "India",
            "Insect Control",
            "Insect Vectors",
            "Insecticide Resistance",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Phlebotomus",
            "Psychodidae",
            "Pyrethrins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34370731/"
    },
    {
        "pmid": "34280530",
        "title": "Early diagnosis of kala-azar in Bangladesh: Findings from a population based mixed methods research informing the post-elimination era.",
        "abstract": "Global annual report visceral leishmaniasis kalaazar black fever reduced 200000 case 2012 23804 2015 India Bangladesh Nepal reported 80 global case 2012 39 2015 sought identify major amenable barrier early diagnosis kalaazar peripheral area Mymensingh district area Bangladesh highly endemic kalaazar conducted sequential exploratory mixed method research Qualitative data first derived indepth interview focus group discussion among 29 patient diagnosed kalaazar families neighbours Preliminary result qualitative analysis used design structured questionnaire administered collect data process leading diagnosis kalaazar 102 patients Qualitative quantitative data integrated consistent chronology kalaazar patient seeking care study conducted September 2011 May 2012 Fulbaria Gaffargaon subdistricts Mymensingh median delay fever onset confirmatory diagnosis kalaazar 60 days 38 case diagnosed within 30 days Public health facility Gaffargaon subdistrict achieved high proportion early diagnosis Individual barrier early diagnosis low awareness symptom treatment facilities poverty traditional beliefs factor remoteness health care centres wet season transport difficulty misdiagnosis typhoid limited availability rK39 testing community level inclusion splenomegaly case definition Targeted community awareness campaign appropriate underprivileged community increase care seeking consequently diagnosis Improved diagnostic guideline strong referral chain kalaazar accelerate diagnosis step contribute significantly National Kalaazar Elimination Program Bangladesh especially postelimination era",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Aged",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Early Diagnosis",
            "Female",
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Patient Acceptance of Health Care",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34280530/"
    },
    {
        "pmid": "34273394",
        "title": "PpSP32-like protein as a marker of human exposure to Phlebotomus argentipes in Leishmania donovani foci in Bangladesh.",
        "abstract": "Phlebotomus argentipes predominant vector Leishmania donovani protozoan parasite causing visceral leishmaniasis Indian subcontinent host bitten P argentipes sand fly saliva elicits production specific antisalivary protein antibodies Here utilised antibody marker human exposure P argentipes visceral leishmaniasis endemic area Pabna district Bangladesh use whole salivary gland homogenate antigen detect antibody several limitations therefore superseded use specific recombinant salivary proteins identified three major P argentipes salivary antigenic protein recognised serum bitten humans expressed recombinant form rPagSP04 rPagSP05 rPagSP06 tested applicability ELISA immunoblot One them PpSP32like protein rPagSP06 identified promising antigen showing highest resemblance correlation IgG response P argentipes salivary gland homogenate Furthermore validated applicability rPagSP06 large cohort 585 individual obtained high correlation coefficient antirPagSP06 antiP argentipes saliva IgG responses antirPagSP06 antiP argentipes salivary gland homogenate IgG response followed similar rightskewed distribution first report screening human serum antiP argentipes saliva antibody using recombinant salivary protein rPagSP06 proven valid antigen screening human serum exposure P argentipes bite visceral leishmaniasis endemic area",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Bites and Stings",
            "Humans",
            "Insect Proteins",
            "Leishmania donovani",
            "Phlebotomus",
            "Saliva",
            "Salivary Proteins and Peptides"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34273394/"
    },
    {
        "pmid": "34011613",
        "title": "Answer to June 2021 Photo Quiz.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/34011613/"
    },
    {
        "pmid": "33981632",
        "title": "Evaluation of Loopamp™ <i>Leishmania</i> Detection Kit and <i>Leishmania</i> Antigen ELISA for Post-Elimination Detection and Management of Visceral Leishmaniasis in Bangladesh.",
        "abstract": "reduced prevalence visceral leishmaniasis VL Indian subcontinent ISC direct field deployable diagnostic test needed implement effective diagnostic surveillance algorithm postelimination VL control regard investigated diagnostic efficacy loopmediated isothermal amplification LAMP assay Loopamp™ iLeishmaniai Detection Kit Eiken Chemical CO Ltd Japan realtime quantitative PCR assay qPCR iLeishmaniai antigen ELISA CLINTECH UK different sampling technique evaluated prospect incorporate postelimination VL control strategies Eighty clinically rK39 rapid diagnostic test confirmed VL case 80 endemic healthy control enrolled study Peripheral blood dried blood spot DBS collected participant time diagnosis DNA extracted whole blood WB DBS iviai silica column QIAGEN boil  spin BS method tested qPCR Loopamp Urine collected participant time diagnosis directly subjected iLeishmaniai antigen ELISA 41 patient followed urine sample collected day 30 day 180 treatment ELISA performed sensitivity LoopampWBBS LoopampWBQIA 962 95 CI 89·4399·22 95 95 CI 87·6998·62 respectively sensitivity LoopampDBSQIA 85 95 CI 75·26 92·00 sensitivity qPCRWBQIA qPCRDBSQIA 938 95 CI 86·0197·94 725 95 CI 61·3881·90 respectively specificity molecular assay 100 sensitivity specificity iLeishmaniai antigen ELISA 975 95 CI 91·4799·70 9195 95 CI 84·1296·70 respectively iLeishmaniai antigen ELISA depicted clinical cure day 180 followedup cases Efficacy sustainability identify LoopampWBBS iLeishmaniai antigen ELISA promising minimally invasive VL diagnostic tool support VL diagnostic surveillance activity respectively postelimination era",
        "mesh_terms": [
            "Antigens, Protozoan",
            "Bangladesh",
            "Enzyme-Linked Immunosorbent Assay",
            "Humans",
            "Japan",
            "Leishmania",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Molecular Diagnostic Techniques",
            "Nucleic Acid Amplification Techniques",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33981632/"
    },
    {
        "pmid": "33911290",
        "title": "Post Kala-Azar Dermal Leishmaniasis: Clinical Features and Differential Diagnosis.",
        "abstract": "Post kalaazar dermal leishmaniasis PKDL mucocutaneous disease usually seen apparently cured inadequately treated untreated case visceral leishmaniasis endemic many part India Nepal Bangladesh eastern Africa Sudan Ethiopia Kenya disease usually manifest variable combination hypopigmented patches erythematous succulent papuloplaques nodular lesion face upper body sometimes extending extremities genitalia tongue Atypical morphology presentation uncommon especially endemic areas include photosensitivity verrucous hypertrophic xanthomatous ulcerative lesions Recognition spectrum mucocutaneous change help physician early initiation treatment reducing disease transmission community differential diagnosis depends pattern manifestations lepromatous leprosy closest mimicker Since PKDL cause significant morbidity least initially affected patient continue act reservoir disease active case detection required identify case early control disease transmission community",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33911290/"
    },
    {
        "pmid": "33911289",
        "title": "Epidemiology of Post-Kala-azar Dermal Leishmaniasis.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL cutaneous sequel visceral leishmaniasis VL kalaazar become entity epidemiological significance virtue ability maintain disease circulation interepidemic periods PKDL identified one epidemiological marker kalaazar elimination programme Data obtained 2018 showed PKDL distribution primarily concentrated 6 countries includes India Sudan south Sudan Bangladesh Ethiopia Nepal decreasing order caseburden India PKDL case mainly found 54 districts 33 Bihar 11 West Bengal 4 Jharkhand 6 Uttar Pradesh West Bengal district reporting case PKDL case include Darjeeling Uttar Dinajpur Dakshin Dinajpur Malda Murshidabad vulnerability young age documented various studies study also highlight male predominance disease recent active surveillance suggested macular form PKDL show femalepredominance recommended along passive case detection active survey help early identification cases thus reducing disease transmission community iAccelerated plan Kalaazar eliminationi 2017 introduced Government India goal eliminate Kalaazar public health problem target reduceing annual incidence 110000 iLeishmania donovanii established causative agent others like iL tropicai iL infantumi may occasionally lead disease especially HIVcoinfection Dermal tropism parasite attributed overexpression parasite surface receptor like gp 63 gp46 Various host factor also identified contribute development disease including high pretreatment IL 10 parasite level inadequate dose duration treatment malnutrition immunosuppression decreased interferongamma receptor 1 gene etc PKDL mostly concentrated plain altitude 600 mt attributed environment conducive vector sand fly iPhlebotumusi Risk factor also linked habitat sand fly Keeping thing mind Integrated vector control adopted iNational vector borne disease control programmei one strategy bring disease burden",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33911289/"
    },
    {
        "pmid": "33809332",
        "title": "A Multi-Country, Single-Blinded, Phase 2 Study to Evaluate a Point-of-Need System for Rapid Detection of Leishmaniasis and Its Implementation in Endemic Settings.",
        "abstract": "advancement isothermal nucleic acid amplification techniques detection pathogenic DNA clinical sample pointofneed longer dream newly developed recombinase polymerase amplification RPA assay incorporated suitcase laboratory shown promising diagnostic efficacy realtime PCR detection ileishmaniai DNA clinical samples broader application pointofneed system undertook current multicountry diagnostic evaluation study towards establishing technique different endemic setting would beneficial ongoing elimination program leishmaniasis study purpose clinical sample confirmed visceral leishmaniasis VL postkalaazar dermal leishmaniasis PKDL patient subjected realtime PCR RPA assay Bangladesh India Nepal skin sample confirmed cutaneous leishmaniasis CL patient also included Sri Lanka total 450 clinical sample VL patients 429 PKDL patients 47 CL patients 322 endemic healthyhealthy control investigation determine diagnostic efficacy RPA assay comparison realtime PCR comparative sensitivity method found realtime PCR RPA assay showed 9686 95 CI 94459842 8885 95 CI 85089196 sensitivity respectively diagnosis VL cases new isothermal method also exhibited promising diagnostic sensitivity 9350 PKDL cases skin sample used Due variation sequence target amplicons RPA assay showed comparatively lower sensitivity 5532 realtime PCR Sri Lanka diagnosis CL cases Except India assay presented absolute specificity rest sites Excellent concordance two molecular method towards detection ileishmaniai DNA clinical sample substantiates application RPA assay incorporated suitcase laboratory pointofneed diagnosis VL PKDL low resource endemic settings However improvisation method necessary diagnosis CL",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33809332/"
    },
    {
        "pmid": "33768013",
        "title": "Towards a Sustainable Vector-Control Strategy in the Post Kala-Azar Elimination Era.",
        "abstract": "Visceral leishmaniasis VL potentially deadly parasitic disease Indian subcontinent VL caused iLeishmania donovanii transmitted iviai bite infected iPhlebotomus argentipesi female sand fly competent vector specie region highest disease burden northern part Indian subcontinent especially state Bihar India Bangladesh Nepal embarked initiative coordinated World Health Organization eliminate VL public health problem year 2020 main goal reduce VL incidence one case per 10000 people early casedetection prompt diagnosis treatment reduction transmission using vector control measures Indoor residual spraying major pillar elimination program vector control strategy used government India Though India close VL elimination target important aspect vector bionomics sand fly transmission dynamic yet determined achieve sustained elimination prevent resurgence VL knowledge gap vector biology behavior constraint may pose current vector control methods need addressed Herein discus success failure previous current vectorcontrol strategy implemented combat kalaazar Bihar India identify gap understanding vector transmission towards development innovative tool ensure sustained vector control postelimination period",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Female",
            "India",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Nepal"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33768013/"
    },
    {
        "pmid": "33763264",
        "title": "Mixed Cutaneous Infection Caused by Leishmania and Dermatophytes: A Rare Coincidence or Immunological Fact.",
        "abstract": "Leishmaniasis first described 1824 Jessore district Bengal now Bangladesh prevalent Bihar Uttar Pradesh Jharkhand West Bengal disease associated depressed cellular immunity Tinea fungal infection skin become extensively pathogenic particularly patient depressed cellmediated immunity Regulatory cell Th17 cell shown responsible postkalaazar dermal leishmaniasis PKDL present rare case 52yearold house wife history recurrent itching depigmentation skin extremities loss appetite 23 month followed progressive spread lesion body apparently healthy female examination many hypopigmented scaly lesion mainly extensor aspect body Skin lesion characteristic tinea infection without PKDL diagnosis PKDL tinea made based history kalaazar skin slit smear amastigote forms irK39i test KOH mount Routine blood investigation showed negative serology HIV lower normal CD4T counts patient advised treatment systemic antifungal therapy antihistaminics later miltefosine highlighted PKDL although uncommon distinct manifestation VL case study also tried find reason coinfection probably due depressed cellular immunity skin abruptions acquired dermatophytic infection prevalent associated lower CD4 cell count",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33763264/"
    },
    {
        "pmid": "33686764",
        "title": "Domestic mammals as reservoirs for Leishmania donovani on the Indian subcontinent: Possibility and consequences on elimination.",
        "abstract": "Leishmania donovani causative agent historically anthroponotic visceral leishmaniasis VL Indian subcontinent ISC L donovani transmitted sand fly specie Phlebotomus argentipes collaborative group others shown sand fly trapped outside endemic village fed cattle dog addition people Domestic animal reservoir L donovani complex spp particularly L infantum endemic areas Multiple study using quantitative PCR serological detection method demonstrated goats cattle rat dog diagnostically positive L donovani infection exposure eastern Africa Bangladesh Nepal India limited understanding extent L donovani infection domestic animal drive transmission animal human ISC Evidence vectorborne disease elimination strategy indicated emerging infection domestic specie hindered eradication predominant lesson learned situation nonhuman reservoir must identified controlled andor prevented Massive effort underway VL elimination Indian subcontinent Despite herculean efforts residual VL incidence persists spectre animal reservoir complicating elimination effort haunt final push towards full VL control Better understanding L donovani transmission Indian subcontinent rigorous consideration nonhuman reservoir alter VL ecology critical sustain elimination goals",
        "mesh_terms": [
            "Animals",
            "Cattle",
            "Cattle Diseases",
            "Dog Diseases",
            "Dogs",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Mammals",
            "Phlebotomus",
            "Psychodidae",
            "Rats",
            "Rodent Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33686764/"
    },
    {
        "pmid": "33597000",
        "title": "Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.",
        "abstract": "Asymptomatic Leishmania infection outnumber clinical infection Indian subcontinent ISC disease reservoir anthroponotic Diagnostics detect active asymptomatic infection suitable monitoring surveillance may benefit visceral leishmaniasis VL elimination campaign ISC Quantitative polymerase chain reaction qPCR loopmediated isothermal amplification LAMP direct agglutination test DAT carried blood samples Leishmania antigen ELISA carried urine sample collected 720 household neighbouring contact 276 VL postkalaazar dermal leishmaniasis PKDL index cases symptom history VL PKDL endemic region Bangladesh September 2016 March 2018 720 contact index cases asymptomatic infection detected 69 96 participant combination qPCR 10 LAMP 21 DAT 39 Leishmania antigen ELISA 33 one 01 participant detected positive four diagnostic tests Poor agreement test calculated using Cohens kappa κ statistics however Leishmania antigen ELISA DAT combination captured participant positive one test find evidence moderately strong association index case PKDL case OR 194 p  0009 specifically macular PKDL OR 212 p  0004 positive least one four tests Leishmania antigen ELISA urine detects active asymptomatic infection requires noninvasive sample therefore may benefit monitoring transmission surveillance elimination setting combination serology Development antigen detection test rapid diagnostic test RDT format would benefit elimination campaign",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Aged",
            "Antibodies, Protozoan",
            "Antigens, Protozoan",
            "Asymptomatic Infections",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Enzyme-Linked Immunosorbent Assay",
            "Female",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Molecular Diagnostic Techniques",
            "Nucleic Acid Amplification Techniques",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33597000/"
    },
    {
        "pmid": "33572506",
        "title": "Rodent Ectoparasites in the Middle East: A Systematic Review and Meta-Analysis.",
        "abstract": "Rodents carry many ectoparasites ticks lice fleas mites potential public health importance Middle Eastern country hotspot many emerging reemerging infectious diseases plague leishmaniasis Crimean Congo hemorrhagic fever Q fever due ecological socioeconomic political diversity Rodent ectoparasite act vector many pathogens Knowledge rodent ectoparasite prime importance controlling rodent ectoparasiteborne zoonotic disease region current systematic review metaanalysis performs comprehensive synthesis available knowledge providing evidencebased overview ectoparasite detected rodent Middle Eastern countries Following systematic search Pubmed Scopus Web Science total 113 published article rodent ectoparasite studied analyzed total 87 rodent specie documented iMus musculusi iRattus norvegicusi iRattus rattusi found common Fleas reported ectoparasite 87 articles followed mite 53 tick 44 louse 25 iXenopsylla cheopisi iPolyplax spinulosai iOrnithonyssus bacotii iHyalomma rhipicephaloidesi commonly described fleas lice mites ticks respectively Based reviewed articles median flea louse mite tick index highest Israel 415 Egypt 139 Egypt 127 Saudi Arabia 117 respectively Quantitative metaanalysis using randomeffects model determined overall pooled flea prevalence Middle East 40 95 CI 2555 iIisup2sup  100 ipi  000001 ranging 13 95 CI 030 iIisup2sup  95 ipi  000001 Iran 59 95 CI 4277 iIisup2sup  75 ipi  000001 Israel overall pooled louse prevalence found 30 95 CI 1347 iIisup2sup  100 ipi  000001 ranging 25 Iran 95 CI 150 iIisup2sup  99 38 Egypt 95 CI 768 iIisup2sup  100 case mites pooled prevalence region 33 95 CI 1155 iIisup2sup  100 ipi  000001 countryspecific prevalence estimate 30 Iran 95 CI 456 iIisup2sup  99 32 Egypt 95 CI 076 iIisup2sup  100 ticks overall prevalence found 25 95 CI 247 iIisup2sup  100 ipi  000001 ranging 16 Iran 95 CI 725 iIisup2sup  74 42 Egypt 95 CI 185 iIisup2sup  100 control rodent ectoparasite considered reduce adverse effects Using One Health strategy rodent control precisely control common rodent species ie iMus musculusi iRattus norvegicusi iRattus rattusi considered control rodentborne ectoparasite region",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33572506/"
    },
    {
        "pmid": "33251349",
        "title": "Leishmaniasis in Dhaka Medical College-experience of three years.",
        "abstract": "Peoples Republic Bangladesh working eliminate visceral leishmaniasis Kalaazar case since memorandum understanding signed neighboring country 2005 part elimination activity 44 case Kalaazar diagnosed treated regional referral center Dhaka Medical College Hospital DMCH last three years reported here Confirmed leishmaniasis case included Patients attending specialized center different demographic characteristic varied presentation laboratory finding reviewed recorded structured case record form Ethical clearance obtained prior starting study total 44 patient leishmaniasis reviewed Approximately 89 n  39 New Kalaazar NKA 7 n  3 Relapse Kalaazar Relapse KA one case 2 Kalaazar Treatment Failure KATF Post Kalaazar Dermal Leishmaniasis PKDL both mean age presentation 32 years Forty percent patient house made mud 26 tin shed rest lived building semibuildings predominant clinical feature fever 909 pallor 886 splenomegaly 818 hepatomegaly 682 rK39 positive 907 cases 944 case positive LD body splenic aspirate all 9090 treated Inj Liposomal amphotericin B 910 combination Inj Liposomal Amphotericin B Inj Miltefosine Moving forward elimination leishmaniasis Bangladesh study highlight status characteristic treatment disease country",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33251349/"
    },
    {
        "pmid": "33147502",
        "title": "Evidence-based diagnostic algorithm for visceral leishmaniasis in Bangladesh.",
        "abstract": "Evidencebased diagnostic algorithm highly recommended visceral leishmaniasis VL crosssectional study performed Bangladesh evaluate VL diagnostic tool including serology buffy coat smear microscopy LD body various DNAbased technique using buffy coat 100 confirmed VL case 100 controls performance tool spleen smear gold standard evaluated using kappa coefficient Diagnostic precision inherent indicator considered index scoring IS performance tool using factor analysis diagnostic algorithm formulated based availability tool different health care facility Bangladesh high level agreement kappa ≥ 080 observed diagnostic tools highest kappa coefficient found rK39 RDT rK39 ELISA 095 followed ssuRNAPCR 094 Buffy coat smear 093 rK28 ELISA 092 rK28 RDT 089 LAMP 089 Miniexon PCR 086 ITS1 085 ITS2 PCR 080 rK39 RDT found best diagnostic test IS 17 followed rK28 RDT IS 15 buffy coat smear microscopy IS 05 rK39  rK28 ELISA IS 03 ssuRNAPCR IS 07 LAMP Miniexon ITS1  ITS2 PCR IS 09 rK39 RDT proposed best option primary health care facilities buffy coat smear microscopy found good adjunct confirmation serologypositive case proposed secondary tertiary facilities ssuRNAPCR LAMP alternate confirmation tool applicable tertiary facilities",
        "mesh_terms": [
            "Algorithms",
            "Bangladesh",
            "Case-Control Studies",
            "Cross-Sectional Studies",
            "Diagnostic Tests, Routine",
            "Enzyme-Linked Immunosorbent Assay",
            "Evidence-Based Practice",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Microscopy",
            "Polymerase Chain Reaction",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33147502/"
    },
    {
        "pmid": "33116091",
        "title": "Clinical and Hematological Features of Visceral Leishmaniasis at Mymensingh Medical College Hospital.",
        "abstract": "Visceral Leishmaniasis severe form leishmaniasis fatal absence treatment Mortality high untreated case 90 Clinical case series document 5 case fatality rate kalaazar patient hospital complication disease Nepal India Bangladesh Brazil Sudan constitute five country world 90 visceral leishmaniasis occurs Mymensingh accounted 50 total kalaazar case reported Bangladesh observational study done SKKRC Mymensingh Medical College Hospital Mymensingh Bangladesh 1st august 2013 28th February 2014 find various clinical feature hematological picture visceral leishmaniasis Total 100 diagnosed case visceral leishmaniasis taken Among total patient male female nearly equally affected kalaazar age group affected kalaazar 2 year 50 years Poor people society affected kalaazar Mymensingh highest incidence kalaazar among different district Bangladesh Pyrexia pallor weight loss main symptom visceral leishmaniasis Abdominal distension jaundice vomiting cough bleeding manifestation less frequent symptom kalaazar Hepatosplenomegaly frequent sign kalaazar Majority patient anemia leucopenia thrombocytopenia ESR frequently raised kalaazar patient among patient many high ESR 100 mm 1st hour conclusion prolong fever progressive pallor anorexia weight loss hepatosplenomegaly endemic area main clinical feature visceral leishmaniasis Anemia leucopenia thrombocytopenia bicytopenia pancytopenia high ESR frequently found hematological picture visceral leishmaniasis",
        "mesh_terms": [
            "Bangladesh",
            "Female",
            "Humans",
            "India",
            "Leishmaniasis, Visceral",
            "Male",
            "Nepal",
            "Splenomegaly"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/33116091/"
    },
    {
        "pmid": "32973088",
        "title": "Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.",
        "abstract": "Understanding spatiotemporal transmission infectious disease improved significantly recent years Advances Bayesian inference method individuallevel geolocated epidemiological data enabled reconstruction transmission tree quantification disease spread space time accounting uncertainty missing data However method rarely applied endemic disease one asymptomatic infection play role additional estimation method required Here develop method analyze longitudinal incidence data visceral leishmaniasis VL sequela postkalaazar dermal leishmaniasis PKDL highly endemic community Bangladesh Incorporating recent data VL PKDL infectiousness show VL case drive transmission incidence high contribution PKDL increase significantly VL incidence decline reaching 55 setting Transmission highly focal 85 mean distance inferred infectors secondary VL case 300 m estimated average time infector onset secondary case infection 4 mo 88 VL infectors 29 PKDL infectors Estimated number secondary case per VL PKDL case varied 0 6 strongly correlated infectors duration symptoms Counterfactual simulation suggest prevention PKDL could reduced overall VL incidence 25 result highlight need prompt detection treatment PKDL achieve VL elimination Indian subcontinent provide quantitative estimate guide spatiotemporally targeted intervention VL",
        "mesh_terms": [
            "Asymptomatic Infections",
            "Bangladesh",
            "Coinfection",
            "Contact Tracing",
            "Endemic Diseases",
            "Humans",
            "Incidence",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Longitudinal Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32973088/"
    },
    {
        "pmid": "32803128",
        "title": "Insights from mathematical modelling and quantitative analysis on the proposed WHO 2030 targets for visceral leishmaniasis on the Indian subcontinent.",
        "abstract": "Visceral leishmaniasis VL neglected tropical disease NTD caused iLeishmaniai protozoa transmitted female sand flies Indian subcontinent ISC VL targeted World Health Organization WHO elimination public health problem 2020 defined 1 VL case new relapse per 10000 population district level Nepal subdistrict level Bangladesh India currently process formulating 2030 targets asking whether maintain 2020 target modify it adding target zero mortality among detected cases NTD Modelling Consortium developed various mathematical VL transmission model gain insight transmission dynamic VL identify main knowledge gaps predict feasibility achieving sustaining target simulating impact varying intervention strategies According models current target feasible appropriate districtsubdistrict level setting medium VL endemicities up 5 reported VL case per 10000 population per year prior start interventions However setting higher precontrol endemicities additional effort may required also highlight risk postkalaazar dermal leishmaniasis PKDL may pose reaching sustaining VL targets therefore advocate adding control PKDL case new 2030 targets Spatial analysis revealed local hotspot high VL incidence remain warn current target provides perverse incentive detectreport case target approached posing risk truly achieving elimination public health problem although taken consideration procedure validation Ongoing modelling work focus risk recrudescence intervention relaxed elimination target achieved",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32803128/"
    },
    {
        "pmid": "32517156",
        "title": "Evaluation of Rapid Extraction Methods Coupled with a Recombinase Polymerase Amplification Assay for Point-of-Need Diagnosis of Post-Kala-Azar Dermal Leishmaniasis.",
        "abstract": "detect Postkalaazar leishmaniasis PKDL cases several molecular method promising diagnostic efficacy developed involve complicated expensive DNA extraction methods thus limiting application resourcepoor settings alternative evaluated two rapid DNA extraction method determined impact detection parasite DNA using newly developed recombinase polymerase amplification RPA assay Skin sample collected suspected PKDL case following diagnosis national guidelines extracted DNA three skin biopsy sample using three different extraction method subjected RPA qPCR qPCR RPA assay exhibited highest sensitivity reference DNA extraction method using Qiagen Q kit followed contrast sensitivity RPA assay dropped 767 633 respectively boil  spin BS SpeedXtract SE rapid extraction method performed Despite compromised sensitivity BSRPA technique yielded excellent agreement QqPCR k  0828 QRPA k  0831 techniques expected reference DNA extraction method found superior term diagnostic efficacy Finally apply rapid DNA extraction method resourceconstrained settings methodological refinement warranted improve DNA yield purity rigorous experiments",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32517156/"
    },
    {
        "pmid": "32491143",
        "title": "Recurrent kala-azar: report of two cured cases after total splenectomy.",
        "abstract": "Latin America causative agent kalaazar intracellular protozoan Leishmania infantum case South America reported Brazil Worldwide mainly affect Bangladesh Ethiopia India South Sudan Sudan Despite high morbidity lethality kalaazar infection asymptomatic However small portion patient evolves recurrence kalaazar becoming symptomatic even available drug treatments Kalaazar formal indication splenectomy adults Splenectomy recommended saving measure kalaazar associated symptomatic hypersplenism drugresistant cases study report two case kalaazar splenomegaly presented several hospitalization due recurrence kalaazar addition hospitalization normalizing blood count splenectomy kalaazar case effect hypersplenism cured Thus splenectomy seen surgical treatment option curative purpose patient recurrent kalaazar possibility drug therapy exhausted even progressed hypersplenism clinical repercussions",
        "mesh_terms": [
            "Adult",
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Recurrence",
            "Splenectomy",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32491143/"
    },
    {
        "pmid": "32295617",
        "title": "An immunoinformatic approach driven by experimental proteomics: in silico design of a subunit candidate vaccine targeting secretory proteins of Leishmania donovani amastigotes.",
        "abstract": "Visceral leishmaniasis VL caused dimorphic Leishmania specie parasitic disease high socioeconomic burden endemic area worldwide Sustaining control VL term proper prevailing immunity development global necessity amid unavailability prophylactic vaccine Screening experimental proteome human disease propagating form Leishmania donovani amastigote pragmatic silico mining novel vaccine candidates using immunoinformatic approach CD4 CD8 cellspecific epitope experimentally reported L donovani protein secretory potential increased abundance amastigotes screened chimera linked Tolllike receptor 4 TLR4 peptide adjuvant constructed evaluated physicochemical characteristics binding interaction TLR4 simulated physiological condition trend immune response following hypothetical immunization Selected epitope physiologically important L donovani protein found mostly conserved L infantum covering theoretically 98 global population multiepitope chimeric vaccine predicted stable antigenic nonallergenic Structural analysis vaccineTLR4 receptor docked complex molecular dynamic simulation suggest sufficiently stable binding interface along prospect noncanonical receptor activation Simulation dynamic immune response following hypothetical immunization indicate active memory B well CD4 cell generation potential likely chance Th1 polarized response methodological approach result study could facilitate informed screening selection candidate antigenic protein entry vaccine production pipeline future control human VL",
        "mesh_terms": [
            "Adjuvants, Immunologic",
            "Antigens, Protozoan",
            "CD4-Positive T-Lymphocytes",
            "CD8-Positive T-Lymphocytes",
            "Computational Biology",
            "Epitopes, T-Lymphocyte",
            "Leishmania donovani",
            "Leishmania infantum",
            "Leishmaniasis Vaccines",
            "Leishmaniasis, Visceral",
            "Molecular Docking Simulation",
            "Molecular Dynamics Simulation",
            "Proteomics",
            "Protozoan Proteins",
            "Vaccines, Subunit"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32295617/"
    },
    {
        "pmid": "32228668",
        "title": "Report of the Fifth Post-Kala-Azar Dermal Leishmaniasis Consortium Meeting, Colombo, Sri Lanka, 14-16 May 2018.",
        "abstract": "5th PostKalaAzar Dermal Leishmaniasis PKDL Consortium meeting brought together PKDL expert endemic area review discus existing new data PKDL report summarizes presentation discussion provides overall conclusion recommendations",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Kinetics",
            "Leishmaniasis Vaccines",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Sri Lanka",
            "Xenodiagnosis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32228668/"
    },
    {
        "pmid": "32209228",
        "title": "Global genome diversity of the <i>Leishmania donovani</i> complex.",
        "abstract": "Protozoan parasite iLeishmania donovanii complex  iL donovanii iL infantumi  cause fatal disease visceral leishmaniasis present first comprehensive genomewide global study 151 cultured field isolates representing geographical distribution iL donovanii isolates separated five group largely coincide geographical origin vary greatly diversity contrast majority iL infantumi sample fell one globallydistributed group little diversity picture complicated several hybrid lineages Identified genetic group vary heterozygosity level linkage suggesting different recombination histories characterise chromosomespecific pattern aneuploidy identified extensive structural variation including known suspected drug resistance loci study reveals greater genetic diversity suggested geographicallyfocused studies provides resource genomic variation future work set scene new understanding evolution genetics iLeishmania donovanii complex",
        "mesh_terms": [
            "Aneuploidy",
            "Animals",
            "DNA Copy Number Variations",
            "Drug Resistance",
            "Evolution, Molecular",
            "Genetic Variation",
            "Genome, Protozoan",
            "Heterozygote",
            "Leishmania donovani",
            "Polymorphism, Single Nucleotide",
            "Selection, Genetic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/32209228/"
    },
    {
        "pmid": "31995564",
        "title": "Male predominance in reported Visceral Leishmaniasis cases: Nature or nurture? A comparison of population-based with health facility-reported data.",
        "abstract": "Bangladesh India Nepal aim elimination Visceral Leishmaniasis VL systemic parasitic infectious disease public health problem 2020 decades male patient comprised majority reported VL case region comparing reported VL sex ratio one observed populationbased study conducted Indian subcontinent tested working hypothesis mainly sociocultural gender difference healthcareseeking behavior explain gender imbalance compared observed sex ratio male versus female among VL case reported health system Nepal two endemic state India observed populationbased cohort study India Nepal Also assessed male sex potential risk factor seroprevalence baseline seroconversion VL incidence populationbased data malefemale ratio among VL case reported health system 140 95 CI 137143 population cohort data age study siteadjusted male female risk ratio 127 95 CI 108151 Also male 19 higher chance seropositive baseline population survey RR 119 95 CI 111127 observed significant difference seroconversion rate sex DAT cutoff titer defined primary endpoint populationbased data show male sex risk factor VL sociocultural determinant Biological sexrelated difference likely play important role pathogenesis disease",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Child",
            "Child, Preschool",
            "Disease Notification",
            "Health Facilities",
            "Humans",
            "Incidence",
            "Infant",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Seroepidemiologic Studies",
            "Sex Ratio",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31995564/"
    },
    {
        "pmid": "31699125",
        "title": "Imported cutaneous leishmaniasis: molecular investigation unveils Leishmania major in Bangladesh.",
        "abstract": "main clinical form leishmaniasis Bangladesh visceral leishmaniasis postkalaazar dermal leishmaniasis caused Leishmania donovani Imported cutaneous leishmaniasis CL emerging globally due mainly increased human mobility recent years several imported CL case also reported Bangladesh Sporadic atypical case CL challenging diagnosis clinical management occurrence infection frequent basis alarming report case Bangladeshi temporarymigrant worker who upon return presented development skin lesion characteristic CL serum sample collected tested rK39 immunochromatographic test Nucleic acid skin biopsy derived culture sample extracted screened realtime PCR assay target conserved REPL repeat region L donovani complex internal transcribed spacer 2 region ribosomal RNA gene cluster amplified sequenced suspect history travel CL VL endemic area positive rK39 test result Based clinical presentation travel history demonstration parasite skin biopsy CL diagnosed patient underwent combination therapy Miltefosine liposomal amphotericin B typical endemic specie detected identified Leishmania major specie that knowledge never reported Bangladesh Proper monitoring reporting imported case given careful consideration clinical epidemiological reasons Molecular test performed diagnosis avoid dilemma identification causative specie prioritized",
        "mesh_terms": [
            "Adult",
            "Antibodies, Protozoan",
            "Bangladesh",
            "Biopsy",
            "Communicable Diseases, Imported",
            "Humans",
            "Immunoassay",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Male",
            "Real-Time Polymerase Chain Reaction",
            "Sequence Analysis, DNA",
            "Skin",
            "Travel"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31699125/"
    },
    {
        "pmid": "31649631",
        "title": "Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse.",
        "abstract": "sustain achievement kalaazar elimination program KEP early detection treatment visceral leishmaniasis VL case associated modality treatment failure TF relapse VL RVL Postkalaazar dermal leishmaniasis PKDL cornerstone predictive biomarker VL development related complication could also play crucial role curtailing disease incidence transmission Investigations find biomarker prospective capability are however scarce Using sample known clinical outcome generated within two previous longitudinal cohort studies aimed determine fluctuation serum antirK39 antibody level could provide predictive value Serum sample collected four different time point Baseline 12 18 24 months 16 patient developed VL within monitoring period 15 asymptomatic healthy control counterpart investigated investigate potential prediction VL related complications serum sample 32 PKDL 10 RVL 07 TF 38 cured VL single dose AmBisome trial analyzed second panel patient monitored 5 year serum collected four time point Baseline 1 6 12 month treatment level antirK39 antibody archived sample measured semiquantitative ELISA mean antibody level significantly higher VL patient compared asymptomatic healthy counterpart time point Likewise observed trend toward elevation antibody level PKDL RVL TF relative reducing level observed cured VL Receiver operating characteristic ROC analysis found promising predictive power rK39 antibody level reveal progression asymptomatic iLeishmania donovanii infection stage VL defined 875 sensitive 95 specific Following treatment rk39 antibody notably showed 100 sensitivity 95 specificity predicting TF data indicate relative quantity serum antirK39 antibody promise within either predictive prognostic algorithm VL VLrelated modalities could enable VL control program implement effective measure eliminate disease research is however imperative standardize rK39 antibody ELISA site prior broader use",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31649631/"
    },
    {
        "pmid": "31589291",
        "title": "Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani.",
        "abstract": "Visceral leishmaniasis VL Old World caused infection Leishmania donovani Although number new reported case VL Africa relatively stable several years low number currently reported Indian subcontinent suggest positive impact new treatment intervention strategies regions however VL relapse postkalaazar dermal leishmaniasis PKDL maintain infectious reservoir therefore present threat control programs review outline evolving appreciation PKDL impactful disease right discus various diagnostic method applied detection characterization PKDL cases also highlight data indicate potential likely contribution PKDL case ongoing transmission L donovani",
        "mesh_terms": [
            "Disease Reservoirs",
            "Disease Transmission, Infectious",
            "Global Health",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Recurrence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31589291/"
    },
    {
        "pmid": "31525195",
        "title": "Effect of insecticide-treated bed nets on visceral leishmaniasis incidence in Bangladesh. A retrospective cohort analysis.",
        "abstract": "Visceral leishmaniasis VL parasitic disease transmitted sand fly specie Phlebotomus argentipes Indian subcontinent Effective vector control highly desirable reduce vector density human vector contact endemic community aim curtail disease transmission evaluated effect long lasting insecticide treated bed net LLIN bed net impregnated slowrelease insecticide tablet KO TAB 123 jointly insecticidetreated net ITN VL incidence highly endemic subdistrict upazila Bangladesh Several distribution LLIN KO TAB 123 selfimpregnation bed net home took place Fulbaria upazila Mymensigh district 2004 2008 three research projects respectively funded CDC Atlanta USA 2004 WHOTDR Geneva Switzerland 2006  2008 included household n  8142 20 village benefited past one intervention 1295 donated LLIN 11918 local bed net impregnated KO TAB 123 exposed cohort recruited nonexposed cohort village contemporaneously similar incidence rate received vector control intervention 7729 HHs nine villages cohorts visited family house house ascertained VL case 3 year period intervention evaluated incidence rate IR VL cohort primary endpoint applying differenceindifferences method study identified 1011 VL case IR 1404710000 per year py intervention 534 477 case intervention control area respectively IR 1441310000 py 53437050 1365910000 py 47734923 intervention control area respectively significant difference p  03901 intervention intervention total 555 case IR 771110000 py identified 178 IR 480410000 py intervention 377 1079510000 py control area intervention area significant lower IR control area follow up rate difference  5991 p00001 IR follow significantly reduced 960910000 py intervention area p00001 286310000 py control area p00001 compared baseline strong significant overall effect ITN intervention δ  6745 p 00001 Sex OR  136 p00001 age OR  099 p00001 also significant effect VL incidence Male higher risk VL female one year increase age decreased likelihood VL 092 Two third VL incidence occurred age range 2 30 year median age VL patient 17 years VL incidence rate significantly lower ITN intervention cohort compared control Bangladesh bias due intense screenandtreat activity intervention intervention area cannot ruled out Nonetheless given feasibility sustainability ITNs considered integrated vector control maintenance phase VL elimination programme",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Animals",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Cohort Studies",
            "Female",
            "Humans",
            "Incidence",
            "Infant",
            "Insect Control",
            "Insect Vectors",
            "Insecticide-Treated Bednets",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Nitriles",
            "Phlebotomus",
            "Pyrethrins",
            "Retrospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31525195/"
    },
    {
        "pmid": "31415565",
        "title": "Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from Bangladesh.",
        "abstract": "investigated relationship treatment regimen visceral leishmaniasis VL postkalaazar dermal leishmaniasis PKDL visceral leishmaniasis relapse VLR development Study subject included cohort patient cured VL since treatment monotherapy sodium stibogluconate SSG miltefosine MF paromomycin intramuscular injection PMIM liposomal amphotericin B AmBisome AMB single dose SDAMB multidose MDAMB combination therapy AMBPMIM AMBMF PMIMMF Follow period 4 year treatment Cohorts prospective except SSG retrospective MF partially retrospective compared incidence proportion rate 100person4year PKDL VLR treatment regimen using univariate multivariate analysis 974 984 enrolled participant completed study Overall incidence proportion PKDL VLR 123 95 CI 104145 70 95 CI 5688 respectively incidence rate 95 CI PKDL VLR 140 86227 76 41147 accordingly SSG cohort lowest incidence rate PKDL 30 1373 VLR 18 0656 followed MDAMB 82 43157 PKDL 27 0984 VLR Development PKDL VLR related treatment regimen VL SSG MDAMB resulted less incidence PKDL VLR compared treatment regimens MDAMB considered VL first step prevention PKDL VLR since SSG highly toxic recommended VL",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Aged",
            "Aged, 80 and over",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Drug Therapy",
            "Drug Therapy, Combination",
            "Female",
            "Humans",
            "Incidence",
            "Injections, Intramuscular",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Prospective Studies",
            "Recurrence",
            "Retrospective Studies",
            "Treatment Outcome",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31415565/"
    },
    {
        "pmid": "31318906",
        "title": "Awareness of residents about kala-azar and its related practices in two endemic areas of Bangladesh.",
        "abstract": "",
        "mesh_terms": [
            "Adult",
            "Animals",
            "Bangladesh",
            "Family Characteristics",
            "Female",
            "Geography",
            "Health Knowledge, Attitudes, Practice",
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Psychodidae"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31318906/"
    },
    {
        "pmid": "31108098",
        "title": "A novel multilocus sequence typing scheme identifying genetic diversity amongst Leishmania donovani isolates from a genetically homogeneous population in the Indian subcontinent.",
        "abstract": "Indian subcontinent infection Leishmania donovani cause fatal visceral leishmaniasis Genetic variation L donovani believed occur rapidly environmental change selective drug pressures thereby allowing continued disease occurrence region previous molecular marker commonly use multilocus microsatellite typing multilocus sequence typing monomorphic L donovani originating Indian subcontinent with exceptions hence suitable region multilocus sequence typing scheme consisting new set seven housekeeping gene developed study based recent finding whole genome sequencing data new scheme used assess genetic diversity amongst 22 autochthonous L donovani isolates Bangladesh Nineteen additional isolates L donovani complex including sequence L donovani reference strain BPK282A1 country included comparison using restriction fragment length polymorphism internal transcribed spacer 1 region ITS1RFLP ITS1 sequencing Bangladeshi isolates confirmed L donovani Population genetic analysis 41 isolates using seven new MLST locus clearly separated L donovani Leishmania infantum multilocus sequence typing scheme seven genotype identified amongst Bangladeshi L donovani isolates isolates found phylogenetically different compared India Nepal Iraq Africa novel multilocus sequence typing approach detect intra interspecies variation within L donovani complex importantly molecular marker applied resolve phylogenetically homogeneous L donovani strain Indian subcontinent Four marker found suitable differentiate strain originating Bangladesh marker A2P discriminative one",
        "mesh_terms": [
            "Bangladesh",
            "DNA, Ribosomal Spacer",
            "Genetic Variation",
            "Genotype",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Multilocus Sequence Typing",
            "Phylogeny",
            "Polymorphism, Restriction Fragment Length",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31108098/"
    },
    {
        "pmid": "31086147",
        "title": "Miltefosine Induced Reduced Male Fertility Capacity after Treatment of Post Kala-azar Dermal Leishmaniasis, Bangladesh.",
        "abstract": "Post Kalaazar Dermal Leishmaniasis PKDL sequel visceral leishmaniasis Indian subcontinent may appear among patient without previous history visceral leishmaniasis VL aim study understand male reproductive safety profile miltefosine used treatment Post Kalaazar Dermal Leishmaniasis PKDL Bangladesh January 2017 March 2017 exploratory study carried male fertility capacity Bangladesh among male patient 14 year old PKDL treated miltefosine Twenty nine male patient included observe effect miltefosine reproductive health PKDL patient history visceral leishmaniasis VL different time periods Among three 103 patient unable ejaculate semen semen analysis 3 patient 103 found azoospermia sperm count  motility 0 viscosity good pH 7 8 microscopically presence RBC 515HPF WBC 815HPF Another 3 patient 103 found oligospermia sperm count 42 153 millionml motility 20 50 viscosity good pH 6 9 RBC 4 15HPF WBC 4 15HPF study documented important finding evaluating male infertility selection drug regimen treating PKDL patient miltefosine 12 weeks",
        "mesh_terms": [
            "Adolescent",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Fertility",
            "Humans",
            "Infertility, Male",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Phosphorylcholine",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/31086147/"
    },
    {
        "pmid": "30941668",
        "title": "Characterization of Transplasma Membrane Electron Transport Chain in Wild and Drug-Resistant Leishmania donovani Promastigote and Amastigote.",
        "abstract": "Leishmania donovani L donovani one parasite cause leishmaniasis mechanism L donovani fight adverse environment becomes resistant drug well understood yet present study designed evaluate effect different regulator modulation Transplasma Membrane Electron Transport transPMET system susceptible resistant L donovani cells Effects UV different buffers electron transport inhibitor stimulators reduction αlipoic acid ALA 12naphthoquinone4sulphonic acid NQSA ferricyanide determined ALA reduction inhibited susceptible sodium antimony gluconate SAGresistant paromomycin PMMresistant AG83 amastigote cells stimulated susceptible SAGresistant AG83 promastigote cell upon UV exposure result indicate UV irradiation almost oppositely affect ALA reduction amastigotes promastigotes ALA reduction stimulated sensitive inhibited resistant GE1 amastigotes upon UV exposure Susceptible amastigotes promastigotes inhibited resistant amastigotes promastigotes stimulated NQSA reduction UV irradiation Thus susceptible drugresistant amastigotes promastigotes different reduction ALA Susceptible resistant AG83 amastigotes promastigotes inhibited ferricyanide reduction upon UV exposure indicates difference ferricyanide reduction among susceptible well resistant AG83 amastigotes promastigotes reduction extracellular electron excerptors susceptible promastigotes requires availability Nasupsup Clsupsup ion maximal activity susceptible amastigotes mostly dependent availability Nasupsup Clsupsup ions promastigotes amastigotes reduction electron acceptor strongly inhibited carbonyl cyanide ptrifluoromethoxyphenylhydrazone Furthermore antimycin A rotenone capsaicin markedly inhibited reduction electron acceptor promastigotes amastigotes Results study suggest transPMET system functionally different wild resistant strain L donovani",
        "mesh_terms": [
            "Drug Resistance",
            "Electron Transport",
            "Ferricyanides",
            "Leishmania donovani",
            "Life Cycle Stages",
            "Naphthoquinones",
            "Oxidation-Reduction",
            "Paromomycin",
            "Sulfonic Acids",
            "Thioctic Acid",
            "Ultraviolet Rays"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30941668/"
    },
    {
        "pmid": "30670453",
        "title": "Eliminating visceral leishmaniasis in South Asia: the road ahead.",
        "abstract": "bSuman Rijal colleaguesb highlight lesson regional collaboration eliminate visceral leishmaniasis identify priority postelimination plan",
        "mesh_terms": [
            "Amphotericin B",
            "Animals",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Disease Vectors",
            "Drug Therapy, Combination",
            "Epidemiological Monitoring",
            "Humans",
            "India",
            "International Cooperation",
            "Leishmaniasis, Visceral",
            "Neglected Diseases",
            "Nepal",
            "Paromomycin",
            "Phosphorylcholine",
            "Program Development",
            "Program Evaluation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30670453/"
    },
    {
        "pmid": "30618453",
        "title": "An investigation about the possible role of cattle and goats as reservoir hosts for <i>Leishmania donovani</i> in Bangladesh.",
        "abstract": "",
        "mesh_terms": [
            "Animals",
            "Animals, Domestic",
            "Antibodies, Protozoan",
            "Bangladesh",
            "Cattle",
            "DNA, Protozoan",
            "Disease Reservoirs",
            "Goats",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Polymerase Chain Reaction"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30618453/"
    },
    {
        "pmid": "30577877",
        "title": "Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study.",
        "abstract": "Based study India as study outside India amphotericin B deoxycholate considered backup drug treatment visceral leishmaniasis However treatment response adverse effect antileishmanial drug may vary across different population Bangladesh effect amphotericin B deoxycholate treatment visceral leishmaniasis still unknown Therefore need explore cure rate adverse effect amphotericin B deoxycholate justify use visceral leishmaniasis patient Bangladesh report 34 visceral leishmaniasis patient received treatment amphotericin B deoxycholate Surya Kanta Kalaazar Research Centre December 2011 June 2015 dose treatment 1 mgkg body weight 15 day followed 12 month treatment Response amphotericin B deoxycholate treatment excellent 34 patient achieved final cure Hypokalaemia 47 shivering 47 vomiting 35 acidity 15 common adverse events However observe serious adverse events Amphotericin B deoxycholate relapse visceral leishmaniasis found highly effective safe study justified include amphotericin B deoxycholate second line drug visceral leishmaniasis Bangladesh",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Amphotericin B",
            "Anti-Infective Agents",
            "Bangladesh",
            "Child",
            "Cross-Sectional Studies",
            "Deoxycholic Acid",
            "Drug Combinations",
            "Female",
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Recurrence",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30577877/"
    },
    {
        "pmid": "30577826",
        "title": "Evaluation of rapid extraction and isothermal amplification techniques for the detection of Leishmania donovani DNA from skin lesions of suspected cases at the point of need in Sri Lanka.",
        "abstract": "Leishmaniasis disease caused vectorborne protozoans Sri Lanka cutaneous form disease predominant usually diagnosed using Giemsastained slit skin smear examination histology However sensitivity slit skin smear histology reportedly low Moreover facility highly sensitive polymerase chain reaction PCR available highlyequipped parasitology laboratories Therefore need low cost sensitive specific screening test diagnosis leishmaniasis point need study mobile suitcase laboratory applying novel extraction SpeedXtract isothermal amplification detection recombinase polymerase amplification assay RPA method evaluated diagnosis cutaneous leishmaniasis Sri Lanka First developed assay applied three different sample type punch biopsy slit skin smear fine needle aspirates local hospital result showed 2 mm punch biopsy sample produced best exponential amplification curve early fluorescence signal RPA assay Secondly punch biopsy collected 150 suspected cutaneous leishmaniasis case screened SpeedXtractRPA RNAlaterPCR ATL bufferPCR addition Giemsastained slit skin smears Fiftyseven sample negative detection methods total 93 sample positive assay sensitivity 655 SpeedXtractRPA 634 RNAlaterPCR 924 ATL bufferPCR Giemsastained slit skin smear delivered worst clinical sensitivity 322 SpeedXtractRPA method field condition took 35 min almost 8 h needed finalize extraction detection PCR laboratory SpeedXtractRPA method produced similar sensitivity sample preserved RNAlater subjected PCR amplification less sensitive ATLpreserved sample subjected PCR amplification need standardization sample collection nucleic acid extraction methods",
        "mesh_terms": [
            "Adult",
            "Aged",
            "Chemical Fractionation",
            "DNA, Protozoan",
            "Female",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Male",
            "Middle Aged",
            "Nucleic Acid Amplification Techniques",
            "Point-of-Care Systems",
            "Skin",
            "Sri Lanka",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30577826/"
    },
    {
        "pmid": "30561583",
        "title": "Reply to Shamim Islam.",
        "abstract": "",
        "mesh_terms": [
            "Amphotericin B",
            "Bangladesh",
            "Humans",
            "Leishmaniasis, Visceral",
            "Prospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30561583/"
    },
    {
        "pmid": "30561535",
        "title": "AmBisome for Kala-azar and Post-kala-azar Dermal Leishmaniasis: An Essential Option but Not a Universal Solution.",
        "abstract": "",
        "mesh_terms": [
            "Amphotericin B",
            "Bangladesh",
            "Humans",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Prospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30561535/"
    },
    {
        "pmid": "30541022",
        "title": "Detection of Immunoglobulin G1 Against rK39 Improves Monitoring of Treatment Outcomes in Visceral Leishmaniasis.",
        "abstract": "Visceral leishmaniasis VL caused Leishmania donovani complex fatal neglected tropical disease targeted elimination India Nepal Bangladesh Improved diagnostic test required early case detection monitoring outcome treatments Previous investigation using Leishmania lysate antigen demonstrated immunoglobulin Ig G1 response potential indicator patients clinical status chemotherapy IgG1 IgG enzymelinked immunosorbent assay ELISAs rK39 lysate antigen novel IgG1 rK39 rapid diagnostic test RDTs assessed Indian VL serum sample following clinical groups paired pre postchemotherapy deemed cured relapsed infectious diseases endemic healthy controls paired pre posttreatment sample n  37 pairs ELISAs rK39 IgG1specific conjugate gave far discriminative decrease posttreatment antibody response compared IgG P  0001 Novel IgG1 rK39 RDTs provided strong evidence decreased IgG1 response patient successful treatment P  0001 Furthermore IgG1 rK39 RDTs n  38 ELISAs showed highly significant difference test outcome cured patient relapsed n  23 P  0001 RDTs sensitive corresponding ELISAs present strong evidence use IgG1 monitoring treatment outcome VL first use IgG1based RDT using rK39 antigen discrimination posttreatment cure versus relapse VL RDT may significant role monitoring patient targeted control elimination devastating disease",
        "mesh_terms": [
            "Antibodies, Protozoan",
            "Antigens, Protozoan",
            "Antiprotozoal Agents",
            "Diagnostic Tests, Routine",
            "Enzyme-Linked Immunosorbent Assay",
            "Humans",
            "Immunoglobulin G",
            "Leishmania",
            "Leishmaniasis, Visceral",
            "Recurrence",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30541022/"
    },
    {
        "pmid": "30487514",
        "title": "Role of Immune Cells and Cytokines for Immune Response in Kala-Azar.",
        "abstract": "Resolution leishmanial infection dependent coordinated interaction component cell mediated immune response central activation targeted Tcell population appropriate cytokine production activation infected cells correlation clinical outcome Leishmania infection cytokine response profile protective immune response Leishmania clearly identified related influence typel response IFNγ production precise role helper TH 2 cytokine nonhealing infection requires exploration Experimental evidence clinical study indicate multifaceted role various factor leading parasite survival multiplication early stage infection generation reactive oxygen nitrogen intermediate play significant role curtailing parasite multiplication later phase hepatic resistance expressed dominant role played nitric oxide synthase NOS2 gene regulation hand production inhibitor NOS2 gene expression interleukin 10 IL10 transforming growth factorβ TGFβ correlate well reduced parasite killing hepatic infection usually selflimiting due production multiple cytokine response including moderate level tumour necrosis factor TNF spleen excess TNF mediates destructive pathology CD8 cell appear play multiple role comprising cytotoxic activity secretion cytokine chemokines better understanding innate acquired immune functioning host could aid rational control better therapeutic intervention disease",
        "mesh_terms": [
            "Cytokines",
            "Humans",
            "Leishmaniasis, Visceral",
            "Spleen"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30487514/"
    },
    {
        "pmid": "30457088",
        "title": "Intervention Packages for Early Visceral Leishmaniasis Case Detection and Sandfly Control in Bangladesh: A Comparative Analysis.",
        "abstract": "compared efficacy three intervention package active case detection ACD visceral leishmaniasis VLpostkalaazar dermal leishmaniasis PKDL combined sandfly control around index case package 1 kalaazar transmission activity involving indoor residual spraying IRS deltamethrin peridomestic deployment larvicide temephos housetohouse search cases 2 fever camp FC plus durable wall lining DWL deltamethrin 3 FC plus insecticide deltamethrin impregnated bednets ITN around index case Fever camp includes 1day campaign village level screen diagnose VL PKDL leprosy malaria tuberculosis among resident chronic fever skin disease Efficacy measured yield new cases vector density reduction mortality 1 3 6 9 12 month following intervention Fever camp  DWL efficacious intervention package 05 case detected per intervention 79 reduction vector density incidence rate ratio IRR  021 iPi  0010 951 95 confidence interval 934 968 sandfly mortality 12 months kalaazar transmission activity efficacious vector control 74 vector reduction IRR  026 iPi  00001 9 months 84 sandfly mortality 3 months case detection 0 case per intervention Fever camp  ITN efficacious detection VLPKDL case 043 case per intervention efficacy vector control inconsistent recommend index casebased FC ACD combined DWL IRS plus larvicide sandfly control consolidation maintenance phase VL elimination program Indian subcontinent",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Animals",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Cluster Analysis",
            "Disease Vectors",
            "Female",
            "Fever",
            "Humans",
            "Insect Control",
            "Insecticide-Treated Bednets",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Leprosy",
            "Malaria",
            "Male",
            "Phlebotomus",
            "Tuberculosis",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30457088/"
    },
    {
        "pmid": "30357373",
        "title": "Quantifying the Infectiousness of Post-Kala-Azar Dermal Leishmaniasis Toward Sand Flies.",
        "abstract": "Indian subcontinent visceral leishmaniasis VL incidence track reach elimination goal 2020 nearly endemic districts Although included official targets previous data suggest postkalaazar dermal leishmaniasis PKDL patient act infection reservoir conducted xenodiagnosis 47 PKDL patient 15 VL patient using laboratoryreared Phlebotomus argentipes direct xenodiagnosis fly allowed feed patients skin 15 minutes indirect xenodiagnosis fly fed membrane patients blood Five day later bloodfed fly dissected examined microscopy andor polymerase chain reaction PCR 3mm skin snip biopsy PKDL venous blood VL processed quantitative PCR Twentyseven PKDL patient 574 positive result direct andor indirect xenodiagnosis Direct significantly sensitive indirect xenodiagnosis 553 v 64 P  0001 positive xenodiagnosis median skin parasite load 1 log10 unit higher negative result 288 v 166 P  0001 multivariable model parasite load nodular lesions positive skin microscopy significantly associated positive xenodiagnosis Blood parasite load strongest predictor VL Compared VL nodular PKDL likely macular PKDL less likely result positive xenodiagnosis neither difference reached statistical significance Nodular macular PKDL VL infectious sand flies Active PKDL case detection prompt treatment instituted maintained integral part VL control elimination programs",
        "mesh_terms": [
            "Adult",
            "Animals",
            "Disease Reservoirs",
            "Disease Transmission, Infectious",
            "Female",
            "Humans",
            "Insect Vectors",
            "Leishmania donovani",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Psychodidae"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30357373/"
    },
    {
        "pmid": "30320150",
        "title": "Evaluation of Real-time PCR for Diagnosis of Post-Kala-azar Dermal Leishmaniasis in Endemic Foci of Bangladesh.",
        "abstract": "Postkalaazar dermal leishmaniasis PKDL sequel visceral leishmaniasis VL found VLendemic country including Bangladesh enigmatic cases success National Kalaazar Elimination Program threat date diagnostic method PKDL case endemic region limited clinical examination rK39 test microscopy suitable accurate alternative method needed study investigated application realtime polymerase chain reaction PCR potential method diagnosis PKDL comparison microscopy Ninetyone suspected macular PKDL case Mymensingh district Bangladesh enrolled study diagnosis clinical examination rK39 strip test responded completion treatment miltefosine enrollment skin biopsy done patient microscopy realtime PCR performed detection quantification iLeishmania donovani body LDB LD DNA respectively Realtime PCR detected 83 case among suspected PKDL patients encouraging sensitivity 912 834961 whereas microscopy showed 506 399612 sensitivity Among suspected PKDL cases 42 case positive microscopy qPCR whereas 41 case detected positive qPCR only study provides evidence realtime PCR promising tool diagnosis PKDL endemic regions addition diagnosis quantitative ability method could exploited aftertreatment prognosis cure assessment PKDL cases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30320150/"
    },
    {
        "pmid": "30296295",
        "title": "The role of case proximity in transmission of visceral leishmaniasis in a highly endemic village in Bangladesh.",
        "abstract": "Visceral leishmaniasis VL characterised high degree spatial clustering scales feature remains even successful control measures VL targeted elimination public health problem Indian subcontinent 2020 incidence falling rapidly since 2011 Current control based early diagnosis treatment clinical cases blanket indoor residual spraying insecticide IRS endemic village kill sandfly vectors Spatially targeting active case detection andor IRS higher risk area would greatly reduce cost control effectiveness control strategy unknown effectiveness depends two key unknowns quickly transmission risk decrease distance VL case much asymptomatically infected individual contribute transmission estimate key parameters spatiotemporal transmission model VL developed fitted geolocated epidemiological data 2494 individual highly endemic village Mymensingh Bangladesh Bayesian inference framework could account unknown infection time VL cases missing symptom onset recovery times developed perform parameter estimation parameter estimate obtained suggest that highly endemic setting VL risk decrease relatively quickly distance casehalving within 90mand VL case contribute significantly transmission asymptomatic individuals result suggest spatiallytargeted intervention may effective limiting transmission However extent spatial transmission pattern asymptomatic contribution vary VL endemicity time uncertain event intervention would need performed promptly large radius ≥300m around new case reduce transmission risk",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Aged",
            "Aged, 80 and over",
            "Bangladesh",
            "Child",
            "Child, Preschool",
            "Disease Transmission, Infectious",
            "Endemic Diseases",
            "Epidemiologic Studies",
            "Female",
            "Geography",
            "Humans",
            "Infant",
            "Infant, Newborn",
            "Leishmaniasis, Visceral",
            "Longitudinal Studies",
            "Male",
            "Middle Aged",
            "Models, Statistical",
            "Rural Population",
            "Spatio-Temporal Analysis",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30296295/"
    },
    {
        "pmid": "30273402",
        "title": "Indoor residual spraying for kala-azar vector control in Bangladesh: A continuing challenge.",
        "abstract": "Visceral leishmaniasis VL Indian subcontinent fatal disease left untreated 1994 2013 Ministry Health Bangladesh reported 109266 case VL 329 VL related death 37 endemic districts Indoor residual spraying IRS using dichlorodiphenyltrichloroethane DDT used national programme 1960s control malaria Despite finding research trial demonstrating synthetic pyrethroid deltamethrin 5 WP effective reducing vector densities national VL vector control operation took place Bangladesh 1999 early 2012 2012 IRS using deltamethrin 5 WP reintroduced national programme consisted premonsoon spraying eight highly endemic subdistricts upazilas present study aim evaluate effectiveness IRS VL vectors well process performance spraying activity national programme staff Five highly endemic upazilas Mymensingh district purposively selected Fulbaria Trishal Mukthagacha Gaforgaon Bhaluka conduct present study using WHOTDR monitoring evaluation tool kit IRS operations conducted 136 squadsteams 544 spraymen observed using check list questionnaire included WHOTDR monitoring evaluation tool kit household HH acceptability survey IRS conducted study area using structured questionnaire 600 HHs measure efficacy IRS preIRS two week prior postIRS at one five month after vector density measured using CDC light trap two consecutive nights Bioassays using conemethod carried 80 HHs 40 sprayed 40 unsprayed measure effectiveness insecticide sprayed surfaces 544 spraymen interviewed preIRS 60 3 37 received training one two three day respectively spraying activities 64 spraying squad supervisor 4 upazilas one upazila Mukthagacha achieved 100 supervision squads Overall 728 spraying squad study upazilas informed HHs member prepare house prior spraying required personal protective equipment provided national programme observation spraying technique used sprayer substandard compared standard procedure mentioned ME toolkit HH interviews 948 600 respondent said living room cattle shed sprayed Regarding effectiveness measurement ie reduction vector densities total 4132 sand fly trapped three intervals 3310 801 P argentipes 465 1540 male 535 1770 females one month postIRS P argentipes density reduced 225 5 month postIRS reduction 64 male female bioassay test showed mean corrected mortality P argentipes sand fly one month postIRS 873 dropped 745 4 month postIRS three upazilas threshold level 80 national programme conduct monitoring evaluation activity ensure high quality IRS operation precondition achieving fast sustained reduction vector densities continue important maintenance phase VL elimination Indian subcontinent research needed determine suitable vector control options case number low",
        "mesh_terms": [
            "Aerosols",
            "Animals",
            "Bangladesh",
            "Biological Assay",
            "Family Characteristics",
            "Health Services Research",
            "Humans",
            "Insect Control",
            "Insecticides",
            "Leishmaniasis, Visceral",
            "Nitriles",
            "Patient Acceptance of Health Care",
            "Population Density",
            "Psychodidae",
            "Pyrethrins",
            "Surveys and Questionnaires",
            "Survival Analysis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30273402/"
    },
    {
        "pmid": "30222747",
        "title": "Corneal complications following Post Kala-azar Dermal Leishmaniasis treatment.",
        "abstract": "Post Kalaazar Dermal Leishmaniasis PKDL sequel Visceral Leishmaniasis VL patient act reservoir causative parasite ie Leishmania donovani thus diagnosed treated utmost urgency prevent transmission disease study tried report first instance corneal complication supposedly associated Miltefosine MF PKDL patient probable pathophysiology events recently rejuvenated National Kalaazar Elimination Program Bangladesh put great emphasis monitoring leishmaniasis patient investigate possible adverse drug reaction ADR total 194 patient received Miltefosine treatment Post Kalaazar Dermal Leishmaniasis far five patient found developed unilateral ophthalmic complication period May 2016 October 2017 treated MF PKDL Unfortunately one go complete evisceration affected eyeball Despite fact MF oral formulation choice treat PKDL occurrence unexpected ADRs MF administration urge exploration pathogenesis incident determine measure avert occurrence happening future",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Humans",
            "Keratitis",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Phosphorylcholine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30222747/"
    },
    {
        "pmid": "30141437",
        "title": "Clinical Characteristics and Haematological Parameters Associated With Visceral Leishmaniasis in Bangladeshi Individuals.",
        "abstract": "Visceral leishmaniasis VL also known kalaazar KA severe form leishmaniasis fatal absence treatment KA highly endemic Mymensingh region Bangladesh Although estimating true incidence VL may difficult objective study evaluate clinicohaematological parameter different group leishmaniasis cases crosssectional descriptive type study conducted research centre Mymensingh Bangladesh February 2016 January 2017 total 90 case rk39 strip test positive five division Bangladesh admitted Research Centre included clinical haematological parameters case categorized five different group depending clinical case definition Real Time PCR RTPCR performed using buffy coat preparation age study subject ranged 3 80 years Mymensingh highest affected division 60 primary kala azar PKA case half study subjects Fever common feature 100 PKA relapse kala azar RKA treatment failure kala azar TFKA followed splenomegaly 702 PKA loss appetite 629 RKA skin pigmentation observed 100 PKDL cases Anaemia present 627 leucopenia 576 thrombocytopenia 617 PKA cases Pancytopenia observed total 33 case groups significant change serum bilirubin SGPT serum creatinine level RTPCR performed case found positive 30 638 PKA 16 593 RKA 2 100 TFKA 2 50 RKA associated PKDL cases Overall VL case positive 625 5080 PKDL case detected buffycoat RTPCR endemic areas magnitude problem limited resource developing country like ours clinical characteristic hematological parameter may also play important role diagnosis clinical cases",
        "mesh_terms": [
            "Bangladesh",
            "Cross-Sectional Studies",
            "Fever",
            "Humans",
            "Leishmaniasis, Visceral"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30141437/"
    },
    {
        "pmid": "30099967",
        "title": "Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.",
        "abstract": "Adverse effect antileishmanial drug affect patients quality life adherence therapy visceral leishmaniasis VL postkalaazar dermal leishmaniasis PKDL Bangladesh 26 treatment center manage leishmaniasis case coming 100 endemic upazilas subdistricts 26 district these include VL PKDL treatment failure relapse VL cutaneous leishmaniasis cases study aimed investigate feasibility using focused pharmacovigilance VL VLPV Bangladeshs National Kalaazar Elimination Programme early detection prevention expected unexpected adverse drug reaction ADRs activity going since December 2014 Activity area includes secondary public hospital Upazila health complex UHC hundred sub district Surya Kanta Kalaazar Research Center SKKRC Mymensingh District specialized center management complicated VL PKDL cases Communicable Disease Control CDC Directorate General Health Services DGHS assigned twenty five hundred UHCs SKKRC total 26 treatment center depending suitable geographical location implemented better management VL case Liposomal Amphotericin B AmBisome® ensure patient convenience proper utilization expensive donated drug VLPV expert committee UHC VLPV team established operational manual pharmacovigilance report form developed training refresher training health personnel took place UHCs central level collected information patient data including demographics treatment history response adverse event analyzed report includes information period December 2014 December 2016 December 2014 December 2016 1327 leishmaniasis patient treated 1066 80 available VLPV these 57 33 9 1 new VL PKDL VL relapse cases respectively Liposomal amphotericin B mostly used 82 case management followed miltefosine 20 paromomycin 3 1066 patients 26 experienced ADRs frequent ADR fever 17 1761066 followed vomiting 5 511066 Thirteen serious adverse event SAEs eight death five unexpected SAEs observed expert committee assessed three death unexpected SAEs possibly related treatment five unexpected SAEs four miltefosineinduced ophthalmic complication AmBisome®induced avascular necrosis nasal alae Directorate General Drug Administration entered ADRs World Health Organization Uppsala Monitoring Centre WHOUMC VigiFlow database study found VLPV NKEP feasible continued routine activity public health system Bangladesh ensure patient safety antileishmanial drugs",
        "mesh_terms": [
            "Acute Kidney Injury",
            "Adolescent",
            "Adult",
            "Aged",
            "Amphotericin B",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Female",
            "Humans",
            "Leishmania donovani",
            "Leishmania tropica",
            "Leishmaniasis, Cutaneous",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Myocardial Infarction",
            "Paromomycin",
            "Patient Safety",
            "Pharmacovigilance",
            "Phosphorylcholine",
            "Quality of Life",
            "Recurrence",
            "Survival Analysis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/30099967/"
    },
    {
        "pmid": "29866195",
        "title": "Susceptibility of field-collected Phlebotomus argentipes (Diptera: Psychodidae) sand flies from Bangladesh and Nepal to different insecticides.",
        "abstract": "sand fly Phlebotomus argentipes vector visceral leishmaniasis VL Indian subcontinent Bangladesh since 2012 indoor residual spraying IRS applied VL endemic area using deltamethrin Nepal IRS initiated 1992 VL vector control using lambdacyhalothrin Irrational use insecticide may lead vector resistance little information subject available countries objective study generate information susceptibility vector sand fly P argentipes insecticide support VL elimination initiative Indian subcontinent Susceptibility test performed using test kit following standard procedure regarding alpha cypermethrin 005 deltamethrin 005 lambdacyhalothrin 005 permethrin 075 malathion 5 bendiocarb 01 six upazilas subdistricts Bangladesh Nepal test performed two insecticides alpha cypermethrin 005 deltamethrin 005 Adult P argentipes sand fly collected Bangladesh six VL endemic upazilas subdistricts Nepal three endemic district using manual aspirators result show VL vector highly susceptible insecticide 60 minute exposure countries Bangladesh corrected mortality 100 15 minute well 30 minute exposure study site Nepal however showed diverse results mortality rate less 90 15 minute exposure alpha cypermethrin deltamethrin two district 95 30 minute exposure result suggest insecticide tested still used national programme Bangladesh Nepal However insecticide rotation performed mitigate possible development insecticide resistance Periodic susceptibility test performed country get timely alert regarding insecticide resistance",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Female",
            "Humans",
            "Insect Control",
            "Insect Vectors",
            "Insecticides",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Male",
            "Nepal",
            "Nitriles",
            "Phlebotomus",
            "Pyrethrins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/29866195/"
    },
    {
        "pmid": "29860031",
        "title": "Potential of cell-free DNA as a screening marker for parasite infections in dog.",
        "abstract": "Parasitic infection common stray dog accurate knowledge parasite community dog would provide insight epidemiology parasitic diseases study used Illumina sequencing technology evaluate cellfree DNA cfDNA marker screening parasitic infection dogs Plasma sample 14 stray dog captured Bangladesh used experiments average 23 million read obtained sample BLASTn analysis identified 150 read high similarity parasite 19 different genera particular detected sequence Babesia spp five dogs consistent this previous study using conventional PCR showed four dog positive B gibsoni Several read similarity Leishmania filarial nematode also identified finding indicate cfDNA blood potential screening marker identifying parasite diversity dogs",
        "mesh_terms": [
            "Animals",
            "Babesia",
            "Babesiosis",
            "Cell-Free Nucleic Acids",
            "DNA, Protozoan",
            "Dog Diseases",
            "Dogs",
            "Leishmania",
            "Leishmaniasis",
            "Molecular Diagnostic Techniques"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/29860031/"
    },
    {
        "pmid": "29775824",
        "title": "Is urine a reliable clinical sample for the diagnosis of human visceral leishmaniasis? A systematic review and meta-analysis.",
        "abstract": "Visualization amastigotes lymph nodes bone marrow tissue sample remains gold standard method diagnosis visceral leishmaniasis VL humans gold standard diagnostic method us technically challenging microscopy procedure often accessible many place world VL endemic Here report current systematic review metaanalysis evaluate whether urine reliable clinical sample diagnosis human VL Data extracted ten available database period 2002 2017 Overall 29 article fulfilled inclusion criterion used data extraction systematic review study 724 using urine specimen reported five countries India 6 207 Iran 5 172 Bangladesh 4 138 Japan 3 103 Spain 3 103 respectively common diagnostic test performed urine Katex 621 ELISA 241 rK39 172 assays metaanalysis sensitivity specificity three commonly used diagnostic assay rK39 97 CI 9199 9876100 ELISA 91 8295 99 CI 94100 Katex 83 7390 98 98100 suggesting rK39 assay provided highest sensitivity ELISA assay provided highest specificity diagnosis VL urine samples finding suggest urine valuable clinical sample diagnosis human VL particularly area gold standard test VL available",
        "mesh_terms": [
            "Antigens, Protozoan",
            "Enzyme-Linked Immunosorbent Assay",
            "Humans",
            "Latex Fixation Tests",
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Molecular Diagnostic Techniques",
            "Polymerase Chain Reaction",
            "Protozoan Proteins",
            "Reagent Kits, Diagnostic",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/29775824/"
    },
    {
        "pmid": "29642962",
        "title": "Leishmaniasis: current challenges and prospects for elimination with special focus on the South Asian region.",
        "abstract": "Leishmania donovani virulent specie Leishmania found South Asian region harbour majority visceral leishmaniasis VL case world traditionally accepted relationship causative specie Leishmania resultant disease phenotype challenged recent year underscored importance revisiting previously established taxonomy revision classification weak voice afflicted decade neglect scientist policy maker led miserably inadequate slow advancement product development field diagnostics chemotherapeutics vector control continue hinder effective management control infection Limitations notwithstanding regional drive elimination VL initiated decade ago focused India Nepal Bangladesh three main afflicted country Indian subcontinent therefore commendable subsequent status review restructuring strategy possibly even so However renewed effort would need combined plan combat new challenge SouthAsian region includes emergence atypical parasite variants order realistically achieve set goal regional elimination VL",
        "mesh_terms": [
            "Animals",
            "Bangladesh",
            "Disease Eradication",
            "Humans",
            "India",
            "Leishmania donovani",
            "Leishmaniasis",
            "Leishmaniasis, Visceral",
            "Neglected Diseases",
            "Nepal",
            "Psychodidae"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/29642962/"
    },
    {
        "pmid": "29554244",
        "title": "Safety and Effectiveness of Short-Course AmBisome in the Treatment of Post-Kala-Azar Dermal Leishmaniasis: A Prospective Cohort Study in Bangladesh.",
        "abstract": "safe effective shortcourse treatment regimen postkalaazar dermal leishmaniasis PKDL considered essential achieving sustaining elimination visceral leishmaniasis VL Indian subcontinent 1 2 Here singledose liposomal amphotericin B AmBisome adopted firstline regimen VL however effectiveness safety AmBisome PKDL formally evaluated safety effectiveness AmBisome 15 mgkg given 15 day 5 biweekly infusion 3 mgkg outpatient basis evaluated April November 2014 patient clinically diagnosed PKDL aged ≥12 year residing highly VLendemic area Bangladesh prospective cohort observational study objective assess final cure 12 month treatment Clinical response monitored 1 3 6 12 months safety treatment 1 month treatment 280 patient meeting inclusion criteria 273 assessed 12 months complete major improvement lesion seen 245 patient 897 213 780 considered completely cured Lesions improve 28 103 new lesion appeared 13 48 patient completed treatment without severe serious adverse events shortcourse 15mgkg AmBisome regimen proved safe effective treatment clinically diagnosed PKDL Bangladesh considered treatment option routine programmatic use VL elimination effort Indian subcontinent",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Amphotericin B",
            "Antiprotozoal Agents",
            "Bangladesh",
            "Female",
            "Humans",
            "Leishmaniasis, Visceral",
            "Male",
            "Middle Aged",
            "Prospective Studies",
            "Recurrence",
            "Treatment Outcome",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/29554244/"
    },
    {
        "pmid": "40818547",
        "title": "Biophysical analysis of an oligomerization-attenuated variant of the Leishmania donovani dynamin-1-like protein.",
        "abstract": "Chemotherapy cornerstone battle leishmaniasis neglected tropical disease caused Leishmania parasite affect million worldwide alarming number report describing treatment failure currently available drugs thereby explaining dire need discovery novel compounds preferably yet unexplored mode action respect L donovani dynamin1 like protein LdoDLP1 interest mutation LdoDLP1 recently shown confer resistance new antileishmanial compound suggesting potential drug target combination biochemical structural biophysical methods able show wildtype LdoDLP1 strong inherent propensity selfassemble higherorder oligomers Guided structural modeling selection nine point mutation including resistance markers screened oligomerization behavior generate selfassembly impaired LdoDLP1 mutant would occur solution dimer andor tetramers led identification double mutant G354DR357S exhibit significantly altered reduced yet completely abolished oligomerization behavior characterization LdoDLP1 G354DR357S double mutant using smallangle Xray scattering SAXS revealed fraction protein population occurs dimer solution Additionally SAXS analysis experimentally confirmed LdoDLP1 like dynaminlike proteins lack structurally defined pleckstrin homology PH domain classical dynamins instead possesses intrinsically disordered B insert grouping among dynaminlike protein play key role process mitochondrial fission",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40818547/"
    },
    {
        "pmid": "40808943",
        "title": "Protein dysregulation during <i>Leishmania infantum</i> infection in anti-TNF immunosuppressed mice revealed through quantitative proteomics analysis of extracellular vesicles.",
        "abstract": "Visceral leishmaniasis VL occurs frequently immunosuppressed individuals especially undergoing immunosuppressive drug therapy autoimmune disease receiving TNF antagonist therapy antiTNF course VL severe response traditional leishmanicidal treatments antimonials Sb often reduced effect antiTNF treatment observed immunosuppressedmouse model VL model compared antiTNF immunosuppression immunosuppression VL treatment Sb Serumderived extracellular vesicle EVs analyzed labelfree quantitative proteomics identify protein involved VL severity impact antiTNF immunosuppression treatment outcome total 223 dysregulated protein found pretreatment groups majority which vitronectin haemopexin caveolin1 downregulated antiTNF samples contrast 173 protein identified Sbtreatment groups found enriched antiTNF plus treatment sample antiTNFSb including fibronectin transferrin vitronectin dipeptidyl peptidase4 differentiallyexpressed protein associated pathway related immune system liver regeneration ion transport finding useful implication clinical management VL patient antiTNF immunosuppression",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808943/"
    },
    {
        "pmid": "40799923",
        "title": "Rare detection of dermal <i>Leishmania infantum</i> in two pediatric patients with cutaneous leishmaniasis (CL) in southern Iran.",
        "abstract": "study highlight rare detection dermal iLeishmania infantumi two pediatric patient cutaneous leishmaniasis CL southern Iran patient history visceral leishmaniasis VL presented atypical facial lesions Molecular assay confirmed presence L iinfantumi specie PCR targeting cysteine protease B cpb gene revealing 702741bp amplicons Phylogenetic analysis describes two pediatric CL case southern Iran caused strain L iinfantumi closely related LIPA59 genotype detection immunocompetent child challenge traditional association L iinfantumi solely VL highlight capacity atypical dermal manifestations finding underscore necessity molecular diagnostics differentiate iLeishmaniai species misidentification risk ineffective treatment potential disease progression Enhanced surveillance integrating PCRbased method critical track dermal strain region VL CL overlap particularly given potential ecological genetic driver atypical tropism Addressing emerging threat requires integrated strategy mitigate dual burden cutaneous visceral disease vulnerable populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799923/"
    },
    {
        "pmid": "40797335",
        "title": "Microbial diversity in cutaneous leishmaniasis lesions and potential implications for disease progression and treatment outcomes.",
        "abstract": "Beyond parasitic infection Cutaneous leishmaniasis CL secondary bacterial colonization influence disease chronicity delay healing reduce treatment efficacy study investigated bacterial diversity CL lesions association lesion duration potential impact treatment outcome among Sri Lankan patients Fifteen bacterial specie identified including Grampositive Gramnegative organisms Staphylococcus aureus associated longest lesion duration up 12 months extended treatment 15 cycle intralesional sodium stibogluconate cryotherapy contrast specie Kocuria palustris Acinetobacter baylyi linked shorter treatment durations Multivariate analysis revealed lesion type significantly influenced treatment duration P  005 larger lesion size diabetes showed marginal association prolonged therapy presence opportunistic antibioticresistant species particularly S aureus suggests potential contributory role bacterial coinfections CL progression highlight need consider presence treatment planning Integrating microbial profiling clinical protocol may enhance treatment efficacy inform personalized care strategies However limited sample size conveniencebased recruitment may affect generalizability findings potential influence bacterial colonization treatment response warrant investigation larger cohorts",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797335/"
    },
    {
        "pmid": "40796014",
        "title": "Lymphatic-targeted amphotericin B nanocrystals delivered using microarray patches applied to cutaneous leishmaniasis.",
        "abstract": "Leishmaniasis parasitic disease transmitted female sandflies primarily affect impoverished population tropical subtropical regions Cutaneous leishmaniasis CL prevalent form 600000 new case annually Leishmania parasite spread via lymphatic system leading disease progression Amphotericin B AmB shown efficacy Leishmania spp yet cause renal toxicity requires intravenous administration posing challenge resourcelimited settings study explores intradermal delivery AmB nanocrystals NCs via dissolving microarray patch MAPs enhance lymphatic uptake AmBNCs formulated using medium milling achieving mean particle size 108 ± 4 nm vitro study showed faster dissolution potent antileishmanial activity lower host cell toxicity Ex vivo study demonstrated MAPmediated intradermal drug deposition 247 ± 25 μg049 cmsup2sup vivo rat study revealed MAPs achieved 32fold 28fold higher AmB accumulation axillary lumbar lymph nodes respectively compared commercial formulation IV AmBisome® p  005 Reduced liver spleen kidney accumulation suggests lower organ toxicity AmBNCs MAPs present promising minimally invasive alternative CL treatment enhancing lymphatic targeting reducing healthcare burdens addressing key barrier effective treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796014/"
    },
    {
        "pmid": "40794782",
        "title": "Transcriptome profiling of L. infantum-infected human macrophages reveals sex-specific type I interferon induction.",
        "abstract": "Sexbased difference immune system influence clinical course infectious diseases including many parasitic infections Field study human infection controlled experimental rodent model shown certain clinical form leishmaniasis occur frequently males Leishmania parasite infect proliferate innate immune cells particularly macrophages modulate early immune response constrain survival replication study used highthroughput vitro system assess sex difference human macrophagespecific immunity Leishmania L infantum infection Quantification infection showed significantly higher infection rate parasite load macrophage derived men compared woman 76 hour postinfection hpi Evaluation macrophage phenotype L infantum infection revealed minor change proportion primarily proinflammatory M1like macrophages whereas reduction antiinflammatory M2like phenotype observed sexes Cytokine profiling revealed elevated level TNF IL8 IL10 reduced level IL18 CCL2 culture supernatant time infection Transcriptomic analysis showed highest adaptation gene expression 6 hpi pronounced femalederived macrophage 1428 downregulated2145 upregulated genes compared malederived macrophage 972 downregulated1637 upregulated genes gradually decreased time sexes Genes associated type interferon response eg IFIT2 IFIT3 IFIT5 OASL JAK1 specific cytokine response IL15 IL1R1 matrix metalloproteinase MMP9 upregulated female macrophages gene encoding proinflammatory chemokines involved immune cell recruitment CXCL1 CXCL3 CCL20 CCL7 upregulated male macrophages Treatment infected macrophage estradiol conferred marginal resistance infection femalederived macrophages whereas testosterone treatment effect summary finding reveal immune mediator underscore biological sex difference may explain females superior ability combat Leishmania infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794782/"
    },
    {
        "pmid": "40794727",
        "title": "Putting behaviors into context for vector-borne diseases: Examining behaviors that may reduce exposure to disease vectors.",
        "abstract": "Understanding people adopt ignore vectorborne disease VBD preventive measure key better risk assessment control However little known household adopt preventive practice others not particularly striking era One Healths attention human environmental animal health examined household factor linked practice may reduce exposure disease vectors focus Chagas disease CD American Cutaneous Leishmaniasis ACL vectors surveyed 204 household 12 rural community Coclé Province Republic Panama March 2022 December 2023 used logistic regression model explore association household contextual elements respondents sex wealth consumer good agricultural knowledge ACL CD feeling insects perception control health outcomes personal use repellents hand protection touching CD vector propertybased behavior use insecticide house use windowsdoors screens cleaning peridomestic debris may reduce exposure disease vectors found mixed association protective behavior contextual household elements Participants reported feeling bothered insect likely use repellent Odds Ratio OR 297 95 Confidence Interval 95CI 147620 whereas reported control health less likely use protection touching CD vector OR  08 CI 067095 Windowdoor screen associated household consumer good wealth OR 144 CI 123171 household history ACL case likely peridomestic debris accumulation OR 233 CI 117475 Additionally householder bothered insect less likely peridomestic debris OR 042 CI 020084 well believe health outcome happen chance OR 089 CI 082098 finding emphasize importance considering comprehensive household background attention cultural value foster contextsensitive strategy vectorborne pathogen prevention control",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Animals",
            "Vector Borne Diseases",
            "Chagas Disease",
            "Adult",
            "Middle Aged",
            "Panama",
            "Rural Population",
            "Leishmaniasis, Cutaneous",
            "Young Adult",
            "Health Knowledge, Attitudes, Practice",
            "Family Characteristics",
            "Surveys and Questionnaires",
            "Adolescent",
            "Aged",
            "Insect Vectors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794727/"
    },
    {
        "pmid": "40786644",
        "title": "Cutaneous leishmaniasis in a renal transplant patient: Diagnostic challenges in a non-endemic setting.",
        "abstract": "Leishmanial infections though uncommon Southeast Central Asia remain clinically significant due potential cause substantial morbidity mortality case report present young Nepalese male four year postrenal transplant chronic allograft dysfunction secondary noncompliance presented right chest skin lesion fever Initially suspected cutaneous tuberculosis malignancy investigations including skin biopsy revealed cutaneous leishmaniasis patient responded well treatment liposomal amphotericin B highlighting importance considering leishmaniasis differential diagnoses especially immunocompromised individual from travelling to endemic regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786644/"
    },
    {
        "pmid": "40781989",
        "title": "Pediatric Cutaneous Leishmaniasis: A Case Series in a Montreal Tertiary Care Hospital.",
        "abstract": "diagnosis management cutaneous leishmaniasis CL pose important challenge pediatric population determined CL clinical characteristic infected child Montreal Canada Demographic clinical data medical record child CL retrieved retrospectively 20042023 SainteJustine University Medical Center Fourteen child 9 boy 5 girls CL first 9 second 5 generation immigrant immigrated travelled country origin CL developed post arrivalreturn Canada mean 66 months mean age onset 84 year range 316 years Lesions multiple 10 cases face leg frequently involved mean diagnostic delay 3 months largely due limited access healthcare initial misdiagnoses range 17 months Histopathology 12 polymerase chain reaction 8 7 confirmed diagnosis Two patient cleared CL without treatment 2 others showed clinical improvement antileishmanial agent treatment alone Patients treated fluconazole 7 liposomal amphotericin B 6 either alone association intralesional meglumine antimoniate 2 mean time CL onset resolution 5 month range 110 months resulting atrophic scar 10 patient known outcome Awareness occurrence CL child living nonendemic country result earlier diagnosis treatment better outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781989/"
    },
    {
        "pmid": "40768926",
        "title": "Mechanistic, in-silico and in vitro studies with nitrofurans reveal potent leishmanicidal activity and inhibition of trypanothione reductase.",
        "abstract": "Visceral leishmaniasis caused Leishmania infantum Leishmania donovani one neglected tropical disease NTDs caused trypanosomatids treatment option limited outdated drug often causing adverse effect promoting drug resistance Previous antileishmanial drug discovery campaign identified nitroheterocyclic molecule high efficacy high selectivity index Therefore evaluated screening platform fluorescent L donovani amastigotes antileishmanial activity seven nitrofuran derivatives furazolidone nitrofurazone nitrofurantoin nifurtimox 5nitro2furaldehyde diacetate PYZD4409 5nitro2furonitrile compound showed good efficacy axenic intramacrophage amastigotes showing low cytotoxicity mammalian cell lines nitrofuran derivative induced reactive oxygen specie production axenic amastigotes inhibited trypanothione reductase TryR either uncompetitive competitive manner thus suggesting mechanism action involves increased oxidative stress caused imbalance redox metabolism Furazolidone exhibited promising antileishmanial profile molecular docking analysis revealed consistency strongest TryR uncompetitive inhibitory effect demonstrating high affinity alternative binding site near substrate oxidized trypanothione pocket Docking result also highlighted PYZD4409 compound highest binding affinity showed consistency competitive inhibition mechanism Furthermore similar binding mode identified across L donovani TryR homologous protein suggest potential broadspectrum activity nitrofuran derivatives thus underscoring importance promising candidate development novel antileishmanial therapy broadspectrum applications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768926/"
    },
    {
        "pmid": "40764931",
        "title": "Systematic suppression of Leishmania (Leishmania) amazonensis-mediated delayed-type hypersensitivity response in American cutaneous leishmaniasis.",
        "abstract": "American cutaneous leishmaniasis ACL protozoan parasitic disease caused different Leishmania spp L Leishmania L Viannia subgenera Brazil seven Leishmania spp act ACL agents Infection L L amazonensis present wide clinicalimmunopathological spectrum ranging localized cutaneous leishmaniasis LCL usually responds well antimony therapy borderline disseminated cutaneous leishmaniasis BDCL may require twice much LCLantimony therapy cure and finally anergic diffuse cutaneous leishmaniasis ADCL highly resistant chemotherapy clinical variability driven different degree Tcell immunosuppression negatively impact delayedtype hypersensitivity DTH assessed Montenegro skin test MST Given MSTs role Tcellmediated resistance marker used diagnosing monitoring patient LCL n  8 BDCL n  3 due L L amazonensis assess Tcell immunosuppression patients MST assessed diagnosis treatment although one patient LCL refused treatment study took place Evandro Chagas Institute Pará Brazil diagnosis confirmed parasitological assays MST using L V braziliensis antigen indirect fluorescent antibody test IFATimmunoglobulin IgG serology histopathology PCR Phenotypic genotypic analysis used identify primary agent MST negative patients successful treatment Notably one patient LCL declined treatment also showed MST reactivity spontaneous healing absence MST reactivity persisted 1 year postcure LCL 2 year BDCL indicating sustained lack MST reactivity regardless treatment outcome spontaneous healing lack MST reactivity pre posttreatment LCL BDCL challenge role DTH marker Tcellmediated resistance L L amazonensis infection Moreover first case spontaneous LCL cure L L amazonensis showed MST reactivity pre postresolution raising doubt role DTH process",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Cutaneous",
            "Hypersensitivity, Delayed",
            "Female",
            "Male",
            "Adult",
            "Middle Aged",
            "Leishmania",
            "Skin Tests",
            "Antiprotozoal Agents",
            "Leishmania mexicana",
            "T-Lymphocytes",
            "Brazil",
            "Antimony"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764931/"
    },
    {
        "pmid": "40755873",
        "title": "Efficacy and safety of microneedling with topical insulin compared with placebo in the treatment of atrophic scars: a prospective study and literature review.",
        "abstract": "Atrophic scars affect many individual arise various causes currently lack standardized treatment protocol Recent study suggest combining microneedling topical insulin TI may offer promising new approach improving appearance scars evaluate efficacy safety microneedling combined TI treating atrophic scar caused acne cutaneous leishmaniasis stria alba postoperative wounds Additionally aimed assess impact treatment improving quality life total 158 patient various type atrophic scar divided two groups one received microneedling TI received microneedling placebo participant underwent 12 monthly sessions followed 1year followup assess longterm outcomes Primary outcome measured via Goodman Baron qualitative grading system acne scarring grading system along patient satisfaction Dermatology Life Quality Index scores statistically significant improvement observed TI group reported patient clinicians especially regarding postacne postleishmaniasis scar iPi  0001 improvement quality life pronounced postacne group iPi  0002 study suggests microneedling combined TI safe effective standalone treatment atrophic scar resulting various causes Additionally approach may enhance quality life patient condition However research larger sample size needed validate findings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755873/"
    },
    {
        "pmid": "40753261",
        "title": "Establishment of THTT derivatives as potential antileishmanial and anti-inflammatory agents through in vitro and in silico investigations.",
        "abstract": "Cutaneous leishmaniasis neglected tropical disease NTD caused Leishmania tropica Leishmania major member species pose significant challenge public health sector especially developing countries limitation current treatments including toxicity resistance availability cost effectiveness necessitate development novel therapeutics study investigated leishmanicidal potential five Thiadiazine thione derivative THTT L tropica dose range 25426 µM using MTT assay Compounds T9 T24 T25 trisTHTT PG monoTHTT exhibited notable ICsub50sub value 2001 2694 2771 8279 µM respectively Moreover compound demonstrated promising docking score critical leishmanial enzymes Trypanothione reductase Trypanothione synthetase Leishmanolysin C24sterol methyl transferase Hemolytic assay revealed compound nontoxic lower concentrations MonoTHTTs PG BG showed higher CCsub50sub value ie 40165 37568 compared trisTHTTs T9 T24 T25 10461 10451 8973 µM respectively derivative showed high selectivity index SI compared standard drug AmphotericinB Furthermore insilico investigation targeting COX1 COX2 enzyme unveiled high affinity tested compound towards enzymes indicating potential involvement antiinflammatory agents Subsequent invitro HRBC membrane stabilization egg albumin denaturation assay confirmed antiinflammatory potential compounds finding validate THTT derivative effective novel class antileishmanial agent L tropica favorable safety profile potential antiinflammatory properties research recommended elucidate mechanism action invivo efficacy",
        "mesh_terms": [
            "Antiprotozoal Agents",
            "Anti-Inflammatory Agents",
            "Leishmania tropica",
            "Molecular Docking Simulation",
            "Animals",
            "Computer Simulation",
            "Humans",
            "Thiones",
            "Mice"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40753261/"
    },
    {
        "pmid": "40752712",
        "title": "Polymeric micelles loaded with a 1,2,3-triazolium derivative: a promising strategy against tegumentary leishmaniasis.",
        "abstract": "Current drug used treat tegumentary leishmaniasis TL toxic present high cost andor emergence resistant strains Thus requirement identify new antileishmanial candidate and present study 123triazolium derivative called Nic incorporated polymeric micelle used treat Leishmania amazonensisinfected BALBc mice Animals infected and 60 day postinfection received saline empty micelle MIC Nic NicMIC amphotericin B AmpB drug control one 30 day therapy animal euthanized blood samples infected tissue organ collected perform biochemical parasitological immunological assays Results showed time points mouse treated NicMIC generated antileishmanial Th1type cellular humoral response characterized significantly higher level P  005 IFNγ IL12 IFNγ mRNA expression nitrite IgG2a antibodies Significant reduction parasite load found evaluating livers spleens draining lymph node infected footpad animals addition low level urea creatinine alanine transaminase aspartate transaminase found sera conclusion data suggest NicMIC could considered future study therapeutic candidate TL",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40752712/"
    },
    {
        "pmid": "40752711",
        "title": "Metal-organic frameworks (MOFs): Redefining antiparasitic drug delivery.",
        "abstract": "Metalorganic framework MOFs represent highly promising platform biomedical field particularly advanced drug delivery customizable design permit precise adjustment porosity pore size chemical composition render ideal vehicle efficient transport controlled release therapeutic agents capability crucial addressing parasitic diseases review focus use MOFs drug delivery system used parasitic diseases MOFs highly effective drug delivery systems capacity encapsulate precisely release antiparasitic compound enhances therapeutic potency enabling lower dos reduce toxicity improve patient safety eg Chagas disease Additionally MOFs augment drug activity bioavailability facilitating targeted delivery infection sites also protect vital tissue modulate hosts immune response Certain MOFs exhibit antiinflammatory antioxidant cytoprotective properties application demonstrated various parasitic diseases including cutaneous leishmaniasis Chagas disease chronic toxoplasmosis trichinosis challenge persist optimizing synthesis achieving precise controlled release ensuring longterm biocompatibility promising result obtained date unequivocally warrant sustained investment research development Ultimately MOFs could provide effective safer highly targeted treatments thereby transforming life million affected diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40752711/"
    },
    {
        "pmid": "40751264",
        "title": "Seasonal variation of anti-Leishmania infantum antibodies and laboratory abnormalities in dogs with leishmaniosis.",
        "abstract": "dog affected leishmaniosis laboratory abnormality antiLeishmania antibody titer crucial initial relapse diagnosis well informing therapeutic decisions study aimed evaluate laboratory finding L infantum seropositive dog transmission season basis evidence antiL infantum antibody titer vary sand fly nonsand fly transmission period dog area leishmaniosis endemic September 2021 transmission season T1 January 2022 nontransmission season T2 L infantum seropositive dog physically examined blood sampling performed laboratory tests time points dog underwent routine hematology complete biochemical panel including acute phase protein ie Creactive protein CRP ferritin erythrocyte sedimentation rate ESR measurement serum capillary electrophoresis serology L infantum Potential coinfections arthropodborne Anaplasma phagocythophilum Ehrlichia canis Dirofilaria spp snailborne Angiostrongylus vasorum pathogen also excluded Total protein CRP level slightly reduced T2 compared T1 although difference statistically significant Antibody titer also decreased 10 18 dog 555 two 20 becoming seronegative remained constant eight 18 dog 444 Furthermore statistically significant reduction observed globulin percentage ferritin ESR whereas albumin percentage total iron level significantly increased AntiL infantum antibody titer laboratory abnormality seropositive dog living endemic area leishmaniosis may vary variation may related vector seasonality and consequently dogs exposure sand fly saliva potential reinfections result reinforce importance considering sampling season clinical evaluation management dog affected leishmaniosis avoid misdiagnosis unnecessary antileishmanial treatments",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Leishmania infantum",
            "Dog Diseases",
            "Seasons",
            "Antibodies, Protozoan",
            "Leishmaniasis, Visceral",
            "Male",
            "Psychodidae",
            "Female",
            "Leishmaniasis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751264/"
    },
    {
        "pmid": "40747852",
        "title": "Cutaneous Leishmaniasis Treatment and Care in Neglected Settings with Poor Access to Medicines.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40747852/"
    },
    {
        "pmid": "40747508",
        "title": "Seroprevalence of Canine Leishmaniasis in Sheltered Dogs in Bushehr Province, Southwest of Iran during 2022-2023.",
        "abstract": "Mediterranean form visceral leishmaniasis VL endemic region Iran often seen child 10 year old 90 mortality patients diagnosis treatment done time Canids reservoirs play important role spread disease Bushehr Province southern Iran always mentioned one endemic area VL purpose first study region 112 sheltered dog Bushehr City evaluated canine leishmaniasis CanL using serological Direct Agglutination Test DAT well detailed clinical examinations 112 sample collected 714 case antiiL infantumi IgG antibody titer 180 higher therefore considered seropositive Furthermore 70 seropositive dog antibody titer 1320 higher 47 42 least one clinical symptom associated VL considered case CanL current seroprevalence situation dog region noticeable important alarm policymakers health system practitioners comprehensive complementary parasitological study carried number reservoir region diagnosis treatment accurately determine statistic disease compared obtained seroprevalence status",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40747508/"
    },
    {
        "pmid": "40747503",
        "title": "Spatial Epidemiology of Clinical Forms of Cutaneous Leishmaniasis and Treatment Practice: Evidence from Leishmaniasis Research and Treatment Center, Northwest Ethiopia.",
        "abstract": "aimed conduct comprehensive analysis cutaneous leishmaniasiss CL clinical polymorphism examining relationship clinical forms duration illness spatiotemporal distribution retrospective study University Gondar Hospital analyzed cutaneous leishmaniasis patient treated 2022 2024 Demographic epidemiologic data collected parasite detection via microscopic clinical examination Overall 454 CL case 49 district diagnosed predominantly affecting male aged ≤30 mean age 2531 yr SD ±183 Significant difference noted age sex iPi005 Approximately 70 lesion ≥4 cm CL case 2 parasite loads Sodium stibogluconate SSG remained primary treatment choice patients spatial distribution CL case covered larger geographical area although case 20 concentrated Central Gondar mucosal CL shared similar geographical pattern recurrent CL type Notably 48 chronic presentation lived disease ≥12 months diffuse CL DCL longer delay seen clinical presentation associated longitudinal time series Acute patient exhibited higher parasitic load chronic one 38 vs 24 respectively CL significantly affected schoolaged children symmetrical distribution case district studied could increase attention clinician enhance management strategies Extended disease duration necessitated specialized treatment clinical transitions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40747503/"
    },
    {
        "pmid": "40747498",
        "title": "Evaluating the Effects of Imiquimod on Paths of TLRs and Inflammatory Cytokines Signaling in Infected Macrophages with <i>Leishmania major</i> in Vitro and in Vivo.",
        "abstract": "iLeishmania majori obligate intracellular pathogen macrophage cell host iL majori Imiquimod stimulates macrophage secrete different cytokine via expression TLRs study carried Department Parasitology Faculty Medical Sciences Tarbiat Modares University 2018 effect imiquimod investigated noninfected infected macrophage iL majori expression Tolllike receptor TLRs inflammatory cytokines TLRs play important role enhancing proceeding phagocytosis killing parasites Moreover cytokine TNFα IL6 IL1 often identified inflammatory condition interfering target treatment Healthy macrophage macrophage infected iLeishmania majori parasite affected different concentration imiquimod expression TLR gene TLR1 TLR2 TLR3 TLR4 TLR7 TLR9 cytokine evaluated real time RTPCR experiment laboratory animals infected BALBc mouse exposed imiquimod isolated peritoneal macrophages expression TLR2 decreased noninfected macrophage affected imiquimod expression level TLR7 healthy macrophages decreased difference control group significant Imiquimod increase expression inflammatory cytokine IL12 mouse macrophage also decrease expression IL10 suggests imiquimod may improve therapeutic effect infected mouse iLeishmania majori Imiquimod cause TLR2 decreased expression TLR7 TLR9 increased expression Imiquimod TLR7 agonist enhance recovery leishmaniasis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40747498/"
    },
    {
        "pmid": "40745935",
        "title": "Oral Treatment With Heat Shock Protein 65-Producing Lactococcus lactis Induces Regulatory T Cells, Modulating Inflammatory Response in Leishmania braziliensis Infection.",
        "abstract": "Cutaneous leishmaniasis CL neglected tropical disease prevalent Brazil caused Leishmania braziliensis L braziliensis marked ulcerative skin lesion exacerbated Th1driven inflammatory response study investigates therapeutic potential oral tolerance OT induced genetically modified strain Lactococcus lactis L lactis producing heat shock protein 65 HSP65 Mycobacterium leprae murine model CL BALBc mouse infected L braziliensis treated orally HSP65producing L lactis control L lactis empty vector four consecutive days starting 4 week postinfection Mice receiving HSP65producing L lactis showed reduced lesion size parasite burden Cytokine analysis draining lymph node revealed shift proinflammatory IFNγ response increased IL10 production correlating milder inflammation less tissue damage Additionally treatment promoted increase regulatory cell Tregs including CD4supsupCD25supsupFOXP3supsup CD4supsupLAPsupsup membraneassociated TGFβ cell draining lymph nodes therapeutic effect observed severe model CL using Leishmania major study underscore potential oral tolerance induction using HSP65producing L lactis promising immunoregulatory therapeutic approach chronic inflammatory infections mainly display primed balance immune response",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40745935/"
    },
    {
        "pmid": "40739813",
        "title": "Localized Cutaneous Nodule in an Elderly Patient.",
        "abstract": "Localized cutaneous nodule common elderly may indicate benign malignant conditions case highlight diagnostic challenge cutaneous leishmaniasis CL mimicked malignancy elderly woman minimal travel history CL due L donovani rare Europe confirmed via histopathology staining Given patients renal comorbidities prior cancer local treatment preferred systemic therapy CL included differential diagnosis chronic nodules especially patient past travel endemic areas Biopsy remains crucial accurate diagnosis appropriate individualized management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40739813/"
    },
    {
        "pmid": "40737310",
        "title": "LeishTec vaccination disrupts vertical transmission of Leishmania infantum.",
        "abstract": "Zoonotic canine leishmaniosis caused Leishmania infantum fatal disease worldwide human reservoir host dogs primary route transmission via sand fly bite Vertical transplacental transmission L infantum offspring shown critical maintenance infection endemic nonendemic areas United States canine leishmaniosis CanL enzootic within hunting dog populations Previous work US hunting dog found transplacental transmission L infantum occurs frequently high infectivity Dogs born CanL infected mother almost fourteen time likely become positive L infantum lifetime Globally public health agency control CanL canine human case detection treatment case dog culling reducing vector populations specific strategy control vertical transmission CanL previous randomized field trial US hunting dog found Leishmania A2 protein saponinadjuvanted vaccine LeishTec used immunotherapy significantly reduced risk progression clinically overt leishmaniasis 30 asymptomatic dogs unknown whether maternal vaccination could inhibit infection risk offspring hypothesized dog born infected vaccinated dam would less likely test diagnostically positive via L infantum specific kqPCR serology compared dog born infected unvaccinated mothers population dog born L infantum infected dam evaluated assess LeishTec vaccination prevent transmission offspring Dogs born unvaccinated L infantum infected dam higher mortality 1250 v 000 higher likelihood clinical disease 9412 v 5900 likely diagnostically positive CanL 2222 v 455 Vaccination dam already infected prior pregnancy greatly reduced risk transplacental transmission L infantum Incorporating vertical transmission prevention public health intervention country Leishmania endemic could aid infection control",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Leishmania infantum",
            "Infectious Disease Transmission, Vertical",
            "Dog Diseases",
            "Leishmaniasis, Visceral",
            "Female",
            "Vaccination",
            "Leishmaniasis Vaccines",
            "Pregnancy",
            "Humans"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40737310/"
    },
    {
        "pmid": "40732717",
        "title": "Investigation of <i>Leishmania infantum</i> Infection and Feeding Preferences of <i>Lutzomyia longipalpis</i> During Deltamethrin (4%) Dog Collar Intervention.",
        "abstract": "Leishmaniasis zoonotic disease caused protozoa genus iLeishmaniai transmitted phlebotomine sand flies Understanding feeding behavior infection rate vector crucial disease surveillance control aimed investigate natural infection rate iLeishmaniai spp phlebotomines analyze bloodfeeding pattern one priority area state São Paulo implementation insecticideimpregnated dog collars Sand fly collected urban periurban area 2022 2024 using CDC light traps manual aspiration Shannon traps PCR used detect iLeishmaniai DNA SSU rDNA gene blood meal source COI gene total 414 sand fly collected 222 engorged female analyzed blood meal 192 specimen tested iLeishmaniai spp infection predominant blood source human 67 followed chicken 641 dog 189 considering 451 sample presented mixed blood meals iLeishmania infantumi found 1 samples finding highlight feeding plasticity sand fly potential role disease transmission reinforcing need continuous epidemiological surveillance vector control strategies particularly implementation insecticideimpregnated dog collars",
        "mesh_terms": [
            "Animals",
            "Psychodidae",
            "Leishmania infantum",
            "Dogs",
            "Pyrethrins",
            "Feeding Behavior",
            "Female",
            "Leishmaniasis, Visceral",
            "Insect Vectors",
            "Nitriles",
            "Insecticides",
            "Humans",
            "Brazil",
            "Dog Diseases",
            "Chickens"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40732717/"
    },
    {
        "pmid": "40732071",
        "title": "Design, Synthesis, and Biological Evaluation of <i>N</i>-Acylhydrazones and Their Activity Against <i>Leishmania amazonensis</i> Promastigotes.",
        "abstract": "Leishmaniasis significant public health concern affecting million causing substantial mortality thus urgently requiring effective safer treatments study explored potential 33 novel iNiacylhydrazonederived compound iLeishmania amazonensisi parasites focusing inhibition iLeishmaniai arginase enzyme promastigote growth Compounds b8b b18b showed 90 inhibitory activity promastigote culture 72 h treatment Compound b8b showed ICsub50sub 105 µM 94118 µM compound b18b exhibited ICsub50sub 428 µM 413444 µM antipromastigote effect compound highlight potential new drug design finding offer promising starting point addressing pressing need new therapeutic option leishmaniasis addition used webbased tool predict compounds toxicity pharmacokinetic parameters Despite lack inhibition iL amazonensisi arginase enzyme investigation mechanism action compound vivo efficacy could contribute development safer effective treatment neglected tropical disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40732071/"
    },
    {
        "pmid": "40730118",
        "title": "Exploring the phytomedicine properties of azadiradione against leishmaniasis: in silico and in vitro insights.",
        "abstract": "Leishmaniasis continues pose significant global health challenge exacerbated increasing resistance current therapeutic agent miltefosine amphotericin B growing resistance highlight urgent need alternative treatment strategies context phytomedicine emerged promising avenue novel antileishmanial therapies previous study crude extract derived neem Azadirachta indica leaf exhibited notable antileishmanial activity Subsequent analysis using LCMSMS enabled identification bioactive constituent within active fraction including azadiradione AZD drug potential therapeutic effect unexplored leishmaniasis AZD exhibited dosedependent growth inhibition along structural disruption DNA fragmentation promastigotes ICsub50sub 1709 μM silico docking simulation AZD identified Leishmania peroxidase eg ascorbate peroxidase tryparedoxin peroxidase probable molecular targets subsequent downregulation expression confirmed vitro CCsub50sub human macrophage MФs ECsub50sub intracellular amastigotes determined 5632 μM 1167 μM AZD respectively dosedependent reduction MФs infectivity demonstrates drug potential AZD pathogenic stage Leishmania However selectivity index SI AZD calculated 483 indicating moderate Leishmaniaspecific drug potential AZD decrease IL10 IL1β arginase expression increase IL12 iNOS expression reinforce immunoregulatory potential AZD favour host investigation required optimize dosage improve selectivity AZD proposing treatment Leishmania infection study demonstrated novel finding related drug potential AZD defined Leishmania target host protective cytokine response Studies animal model may deliver insight therapeutic potential",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40730118/"
    },
    {
        "pmid": "40726640",
        "title": "Atypical presentations of cutaneous leishmaniasis in Morocco: Emerging clinical and epidemiological trends.",
        "abstract": "Cutaneous leishmaniasis CL endemic parasitic disease Morocco exhibit increasing diversity clinical manifestations clinical polymorphism often lead misdiagnosis delay treatment aim study illustrate atypical presentation CL series six case diagnosed department highlighting diagnostic challenge public health implications report six atypical case CL Case 1 33yearold male ulcerative crusty lesion lower lip mucosa mimicking epidermoid carcinoma Case 2 44yearold male chondritislike erythematosquamous plaque left ear Case 3 25yearold male welllimited erosive plaque right arm developed leishmaniasis recidivans Case 4 53yearold female ulceroverrucous facial lesion concomitant cutaneous lupus Case 5 69yearold female sarcoidosislike papulonodular facial lesion infiltrated nasal plaque mimicking lupus pernio Case 6 75yearold female crateriform lesion nose suggestive keratoacanthoma case illustrate changing clinical epidemiological profile CL Morocco highlighting importance early recognition precise diagnosis detailed anamnesis parasitological examinations underline necessity enhanced epidemiological surveillance awarenessraising among practitioner improve management control disease",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40726640/"
    },
    {
        "pmid": "40722720",
        "title": "Sialic Acid and Colchicine Functionalized Silica Nanoparticles: A Novel Approach to Leishmanicidal Selective Treatments.",
        "abstract": "bBackgroundObjectivesb Leishmaniasis remains neglected tropical disease nearly one million new case annually limited investment research Current treatments primarily based pentavalent antimonials associated severe side effect increasing resistance study aim develop novel therapeutic strategy using nanomaterial functionalized sialic acid SA colchicine COL selectively target iLeishmania braziliensisi parasites bMethodsb nanostructured system engineered functionalizing surface SA COL SA chosen mimic host cell surfaces enhancing parasite attraction COL selected known leishmanicidal properties nanomaterial designed concentrate extracellular parasite surface via SAmediated interactions thereby increasing local COL efficacy bResultsb functionalized nanomaterial demonstrated dual mechanism SA facilitated selective accumulation iLeishmania braziliensisi parasite nanostructure surface COL exerted cytotoxic effect synergistic interaction resulted enhanced parasite mortality vitro suggesting improved selectivity potency compared conventional treatments bConclusionsb proposed nanomaterial offer promising alternative leishmaniasis treatment combining targeted parasite attraction localized drug delivery strategy may reduce systemic toxicity improve therapeutic outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40722720/"
    },
    {
        "pmid": "40722705",
        "title": "Persistence of <i>L. V. braziliensis</i> in the Nasal Mucosa of Treated Patients.",
        "abstract": "bBackgroundObjectivesb Cutaneous leishmaniasis infectious disease frequently affect neglected populations Besides incidence high disease burden associated possibility mucosal sequelae Clinical followup patient difficult due limited access affected population healthcare long lapse development cutaneous mucosal diseases study evaluated positivity iL V braziliensisi DNA nasal mucosa patient treated leishmaniasis attempt estimate possible longterm risk developing mucosal leishmaniasis association important clinical characteristics bMethodsb Samples collected immediately treatment completion using nasal swab specific DNA amplified detected using realtime PCR Clinical laboratorial data systematically collected bResultsb positivity iL V braziliensisi 7 treatment 60 mucosal lesion treatment compared 134 patient negative iL V braziliensisi treatment ipi  0031 bConclusionsb Molecular detection iL V braziliensisi DNA nasal mucosa promising strategy improve followup treatment patient American Tegumentary Leishmaniasis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40722705/"
    },
    {
        "pmid": "40717070",
        "title": "Nicolau syndrome in a pediatric patient after corticosteroid injection: a case report and review of the literature.",
        "abstract": "Nicolau syndrome rare serious complication occur following various form drug administration particularly intramuscular injections characterized onset painful edema affected area shortly injection often accompanied notable livedoid discoloration skin lead ischemic necrosis surrounding skin soft tissue muscular tissue Here report 4yearold Iranian girl developed significant swelling discoloration buttock area accompanied severe pain receiving intramuscular injection triamcinolone acetonide progressive vitiligo basis patients clinical presentation medical history imaging findings definitive diagnosis NS established managed effectively prophylactic antibiotics analgesics antithrombotic therapy Healthcare provider must aware potential complication associated intramuscular injections Recognizing sign distress significant pain discoloration crucial timely intervention significantly improve patient outcomes",
        "mesh_terms": [
            "Humans",
            "Female",
            "Injections, Intramuscular",
            "Nicolau Syndrome",
            "Child, Preschool",
            "Triamcinolone Acetonide",
            "Glucocorticoids",
            "Buttocks",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40717070/"
    },
    {
        "pmid": "40720469",
        "title": "Application of the SARIMA-LSTM model to evaluate the effectiveness of interventions for Visceral Leishmaniasis.",
        "abstract": "study proposes combined Seasonal Autoregressive Integrated Moving Average Long ShortTerm Memory SARIMALSTM model enhance accuracy evaluating effectiveness visceral leishmaniasis prevention control effort Yangquan China Data obtained Yangquan Centre Disease Control Prevention hybrid model integrates SARIMA component residualbased LSTM neural network SARIMALSTM model LSTM component included seven hidden layer nodes learning rate 0001 500 training epochs batch size 256 utilized Adam optimization algorithm SARIMALSTM model demonstrated superior performance MSE  2824 MAE  1279 RMSE  1681 paired sample ttest revealed statistically significant difference predicted actual case count t  4058 p  0001 indicating actual number case lower predicted combined SARIMALSTM model outperformed individual SARIMA LSTM models suggesting implemented intervention generally effective",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Humans",
            "China",
            "Neural Networks, Computer",
            "Seasons",
            "Models, Statistical"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40720469/"
    },
    {
        "pmid": "40712662",
        "title": "A Rare Periorbital Ulceronecrotic Wound: A Case of Anthrax Cellulitis.",
        "abstract": "Cutaneous anthrax zoonotic bacterial infection mostly involves head neck upper extremities Periorbital involvement cutaneous anthrax rare presentation lead severe irreversible complications Herein describe 25yearold girl periorbital anthrax cellulitis presented severe swelling right side face ulceronecrotic lesion right eyebrow receiving appropriate antibiotic regimen condition improved discharged without intraocular complications",
        "mesh_terms": [
            "Humans",
            "Female",
            "Anthrax",
            "Child, Preschool",
            "Anti-Bacterial Agents",
            "Skin Diseases, Bacterial",
            "Cellulitis",
            "Necrosis",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40712662/"
    },
    {
        "pmid": "40709372",
        "title": "Unveiling potent anti-leishmanial agents: a QSAR exploration of diverse chemical scaffolds targeting <i>Leishmania donovani</i> amastigotes.",
        "abstract": "Leishmaniasis caused iLeishmaniai spp remains major global health concern due drug resistance toxicity nonspecificity prolonged treatments Addressing need new therapeutics investigated range bioactive compounds including chalcones pyrimidines quinolines azoles sulphonamides flavonoids quinazoline derivatives targeting iLeishmania donovanii amastigotes Key molecular descriptor influencing antileishmanial activity identified using LASSO multiple linear regression MLR yielding robust QSAR model irisup2sup  084 validated rigorous statistical analysis Virtual screening scaffoldhopping strategy led design 12 novel compounds among six mainly benzothiazole benzoxazole derivative exhibited clear predicted pIC₅₀ value promising ADMET profiles Quinolinebased compound showed moderate activity consistent prior experimental data Structural analysis revealed significance quinoline ring linked thiazole benzoxazole moieties modification like alkyl halide methyl group enhancing bioactivity molecular docking iLeishmania donovanii Nmyristoyltransferase LdNMT sterol 14α demethylase CYP51 demonstrated strong binding affinity compound N8 N9 N11 Structurebased similarity search using ChEMBL confirmed selective bioactivity low predicted cytotoxicity supporting minimal offtarget interactions finding present computationally guided framework developing effective targeted antileishmanial agents",
        "mesh_terms": [
            "Leishmania donovani",
            "Quantitative Structure-Activity Relationship",
            "Antiprotozoal Agents",
            "Molecular Docking Simulation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40709372/"
    },
    {
        "pmid": "40708344",
        "title": "Geospatial technologies for targeting priority areas on surveillance and response of visceral leishmaniasis in São Paulo state, Brazil: embracing a One Health integrative approach.",
        "abstract": "2023 Brazil accounted 935 reported case visceral leishmaniasis VL Latin America study employing One Health approach aims i analyse spatial distribution VL using integrated geospatial methods ii temporal trend VL assess impact COVID19 pandemic occurrence cases iii identify spatial cluster municipality heightened environmental vulnerability prioritise surveillance control effort VL São Paulo state Brazil Archival database 1999 2022 analysed Highrisk cluster human VL HVL identified using Local Moran Index Incidence mortality rate modelled Generalized Additive Model Data distribution Lutzomyia longipalpis vector obtained São Paulos Supervision Control Endemics spatial distribution canine visceral leishmaniasis CVL based survey data Adolfo Lutz Institute Environmental factors including normalized difference vegetation index NDVI land surface temperature LST geomorphology derived Moderate Resolution Imaging Spectroradiometer MODIS data Environmental Information Database BDiA platform Lutzomyia longipalpis detected 324 municipalities CVL 290 HVL 180 western region characterised plateau geomorphology elevated deforestation higher temperatures accounted 306 highrisk clusters underscoring priority status control surveillance VL case remain stable COVID19 pandemic lethality rate increased Addressing VL reducing lethality rate pose significant challenge public health authority São Paulo coming years",
        "mesh_terms": [
            "Brazil",
            "Leishmaniasis, Visceral",
            "Humans",
            "Animals",
            "COVID-19",
            "Psychodidae",
            "One Health",
            "Dogs",
            "Dog Diseases",
            "Spatial Analysis",
            "Insect Vectors",
            "Incidence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40708344/"
    },
    {
        "pmid": "40700721",
        "title": "Optic Neuritis Associated with Herpes Zoster Ophthalmicus: A Systematic Review and Analysis.",
        "abstract": "systematically review analyze reported case herpes zoster ophthalmicus HZOrelated optic neuritis ON without retinal involvement potentially sightthreatening complication varicellazoster virus VZV PRISMAguided search online database inception January 31 2025 identified case report series describing HZOrelated without retinal involvement Study quality assessed using Joanna Briggs Institute checklists Data demographics clinical features diagnostics treatments outcome analyzed using SPSS Thirtytwo study 19192025 comprising 38 patient included mean patient age 526 year ranging 6 82 nearequal gender distribution Comorbid condition human immunodeficiency virus HIV infection diabetes autoimmune disorder noted onethird cases commonly presented unilaterally ipsilateral dermatome HZO mean interval HZO onset approximately 22 day ranging 10 day prior 150 day afterward Blurred vision eye pain frequent symptoms Common sign include visual field defect congestion mydriasis ophthalmoplegia Keratitis common observation slitlamp examination 628 22 35 cases Corticosteroid therapy including highdose pulse regimens administered thirdfourth 28 38 patients outcome assessment 528 19 36 achieved mild impairment 363 12 36 experienced clinical blindness HZOrelated uncommon significant sightthreatening complication HZO Timely diagnosis appropriate antiviral treatment along corticosteroid therapy may improve visual prognosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40700721/"
    },
    {
        "pmid": "40694583",
        "title": "Outbreak of cutaneous leishmaniasis amongst militia members in a non-endemic district under conflict in the lowlands of Somali Region caused by Leishmania tropica, Eastern Ethiopia.",
        "abstract": "Cutaneous leishmaniasis CL Ethiopia typically linked highaltitude region recently emerged unusually low altitude 500 meter Somali Region raising public health concerns Cutaneous leishmaniasis previously identified region conflict starting area militia infected serious lesions Routine clinical sociodemographic information extracted patient chart using case report form Additionally clinical laboratory data obtained 30 patient suspected CL Skin scraping fine needle aspirate collected raised edges nodular centre lesion followed DNA extraction using DNeasy Blood Tissue kit total 1050 CL patient recruited male militia members immunologically naïve displaced conflict area likely sylvatic transmission cycle identified Leishmania tropica causative species challenging previous assumption L aethiopica primary agent CL Ethiopia Notably 77 patient 10 lesions presentation atypical L tropica elsewhere Phlebotomus orientalis P sergenti vector visceral leishmaniasis CL North Africa respectively found outbreak area research needed explore ecoepidemiology outbreak patients treatment responses Insights help develop management strategy control newly emerging form CL prevent spread region hybridization Leishmania strain causing VL endemic area",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Cutaneous",
            "Ethiopia",
            "Male",
            "Leishmania tropica",
            "Disease Outbreaks",
            "Adult",
            "Middle Aged",
            "Young Adult",
            "Adolescent",
            "Child",
            "Female",
            "Somalia",
            "Aged",
            "Animals",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40694583/"
    },
    {
        "pmid": "40689741",
        "title": "Exploring the <i>in vitro</i> and <i>in vivo</i> antileishmanial potential of Marizomib against <i>Leishmania amazonensis</i> and <i>Leishmania infantum</i>.",
        "abstract": "Current treatment available leishmaniasis fraught numerous problems search new treatment alternative leishmaniasis urgent necessary proteasome selected promising target Marizomib proteasome inhibitor shown antitumor effects ongoing clinical tests work aimed evaluate iin vitroi iin vivoi effect Marizomib iLeishmania amazonensisi iLeishmania infantumi Interestingly Marizomib effective promastigote form iL amazonensisi iL infantum vitroi showed significant effect intracellular amastigotes iL amazonensisi iL infantumi showing selectivity parasite compared host cell Furthermore transmission electron microscopy possible show Marizomib induces extensive ultrastructural change amastigotes iL amazonensisi iL infantumi appearance many vacuole parasite cytoplasm mitochondrial swelling Marizomib also shown effective murine model cutaneous leishmaniasis reduction size lesion parasite load footpad draining lymph node animal infected iL amazonensisi also effective model visceral leishmaniasis reduction parasite load spleen liver animal infected iL infantumi Importantly Marizomib treatment regimen used cause renal hepatic acute toxicity infected animals result highlight antileishmanial potential Marizomib encouraging u conduct preclinical test animal models well clinical trials",
        "mesh_terms": [
            "Animals",
            "Leishmania infantum",
            "Antiprotozoal Agents",
            "Mice",
            "Leishmaniasis, Visceral",
            "Leishmania mexicana",
            "Mice, Inbred BALB C",
            "Leishmaniasis, Cutaneous",
            "Female",
            "Microscopy, Electron, Transmission"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40689741/"
    },
    {
        "pmid": "40686227",
        "title": "Synergistic Effect of Copper Nanoparticles and Paromomycin in the Treatment of Cutaneous Leishmaniasis.",
        "abstract": "interest nanotechnology application medicine particularly combating microbial infections surged recent years study investigated vitro vivo antileishmanial effect copper nanoparticles CuNPs green synthesised using Capparis spinosa fruit extract conjunction paromomycin PM CuNPs synthesised methanolic extract C spinosa assessed vitro antileishmanial activity CuNPs 10200 μgmL well concentration CuNPs 10200 μgmL combined PM 10200 μgmL targeting promastigote amastigote form Leishmania major Additionally evaluated cytotoxic effect CuNPs THP1 cells Subsequently tested formulation female BALBc mouse infected L major study measured footpad swelling quantified parasite load realtime PCR assessed level cytokine interleukin4 IL4 gamma interferon IFNɤ nitric oxide NO arginase ARG result demonstrated CuNPs particularly combined PM significantly inhibited p  0001 growth L major promastigotes amastigotes stimulated IFNɤ production reduced IL4 ARG level p  005 Importantly CuNPs exhibited minimal cytotoxicity towards THP1 cells infected mice treatment CuNPs notably combination PM resulted significant p  005 reduction mean number parasites Treatment CuNPs concentration 100 200 mgmL led decrease lesion diameter result study highlight potent antileishmanial activity synergistic effect CuNPs alone combination PM L major promastigotes amastigote forms well potential treating cutaneous leishmaniasis CL BALBc mice",
        "mesh_terms": [
            "Animals",
            "Paromomycin",
            "Copper",
            "Leishmaniasis, Cutaneous",
            "Mice, Inbred BALB C",
            "Female",
            "Metal Nanoparticles",
            "Leishmania major",
            "Antiprotozoal Agents",
            "Humans",
            "Mice",
            "Drug Synergism",
            "THP-1 Cells",
            "Plant Extracts",
            "Parasite Load",
            "Disease Models, Animal",
            "Cytokines"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40686227/"
    },
    {
        "pmid": "40685763",
        "title": "Combating Drug-Resistant Protozoal Infections: A Review of Emerging Therapeutics.",
        "abstract": "Protozoal infection remain significant global health burden despite significant progress understanding infection recent year due continuing emergence multidrug resistance among protozoal parasites review focus recent innovation protozoal disease treatment aimed combating growing challenge drug resistance escalating prevalence multidrug resistance among protozoal parasites especially responsible widespread disease malaria leishmaniasis trypanosomiasis rapidly emerging grave threat human health worldwide resistance undermines efficacy existing treatments making imperative develop explore novel therapeutic approaches Diverse strategies including concept hybrid drugs development advanced analog existing drugs drug repurposing employed counter drug resistance outmaneuvering evolution resistant parasite restoring effectiveness treatments review delve significant finding reported 2020 2024 aim providing overview state protozoal disease treatment highlighting progress made exploring promising avenue tackling devastating diseases offering insight future direction overcoming persistent challenge drug resistance Given emergence drug resistance call multifaceted approach address protozoal infections longterm success depends interdisciplinary research collaborations equitable access treatment appropriate drug resistance surveillance addition advancement research development therapeutic strategy described review",
        "mesh_terms": [
            "Humans",
            "Antiprotozoal Agents",
            "Protozoan Infections",
            "Animals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40685763/"
    },
    {
        "pmid": "40677299",
        "title": "A Case Report of Venous Ulcer Mimicking Cutaneous Leishmaniasis.",
        "abstract": "Venous ulcer sometimes difficult diagnose accurately resemble skin lesion cutaneous leishmaniasis Here present patient venous ulcer mimic cutaneous leishmaniasis mycetoma lesions 50yearold female patient presented nonhealing venous ulcer right lower leg suspected cutaneous leishmaniasis ulcerated mycetoma lesions misdiagnosed cutaneous leishmaniasis referred Rufaa teaching hospital AlGezira State Sudan color Doppler sonography result revealed several finding consistent chronic venous insufficiency including incompetent superficial femoral junction SFJ short reflux among great saphenous vein GSV incompetent saphenopopliteal junction SPJ short reflux along small saphenous vein SSV Additionally examination showed patency compressibility GSV SSV well presence superficial varicose veins Surgical closure fistula done case report highlight challenge distinguishing venous ulcer mycetoma cutaneous leishmaniasis current case emphasizes importance considering comprehensive assessment patients medical history physical examination potentially diagnostic tests Collaborating experienced healthcare providers dermatologist wound care specialists may also beneficial confirming diagnosis developing appropriate treatment plan",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40677299/"
    },
    {
        "pmid": "40670989",
        "title": "Prunus amygdalus var. amara seed extract enhances the antileishmanial activity of miltefosine.",
        "abstract": "Leishmaniasis infectious disease transmitted via sand fly caused protozoan parasite Leishmania spp treatment disease quite challenging due high cost resistance toxicity conventional drugs Various research study demonstrated plant based drug possess least toxicity antiinflammatory antioxidant properties Here evaluation antileishmanial activity methanolic Prunus amygdalus var amara seed extract conducted found inhibited L donovani proliferation cause apoptosis Moreover combination miltefosine enhanced antileishmanial effects GCMS analysis confirmed presence various phytochemical extract contributed pharmacological efficacy finding highlighted potential herbal product valuable source new treatment leishmaniasis antileishmanial effect determined promastigote amastigote assays Parasite load evaluated staining L donovaniinfected macrophage modified Giemsa stain Cytotoxicity seed extract estimated MTT 34 5 dimethylthiazol2yl2 5diphenyl tetrazolium bromide assay addition Proapoptotic event inferred using RTPCR qRTPCR characterization phytoconstituents evaluated gas chromatography mass spectrometry extract promoted dosedependent reduction growth promastigotes IC50  4312 ± 303 μgml amastigotes IC50  4965 ± 334 μgml Further extract combination miltefosine showed enhanced antileishmanial activity form L donovani promastigotes IC50  4547 ± 12 μgml well amastigotes IC50  1954 ± 24 μgml Earlystage apoptotic event also observed promastigote form determining increased expression LdMetacaspase PARP1 cytotoxic potential THP1 differentiated macrophage assessed indicated insignificant cytotoxicity different dos extract CC50  79919 ± 13459 μgml combination miltefosine CC50  38416 ± 17747 μgml Furthermore presence phytocompounds like chaulmoogric acid hydnocarpic acid described first time Prunus amygdalus var amara seed extract finding indicated EPA play significant role combating leishmaniasis hold promise potential treatment disease Moreover combined miltefosine EPA demonstrated increased effectiveness leishmaniasis Therefore combination EPA miltefosine present promising outlook potential therapy leishmaniasis",
        "mesh_terms": [
            "Plant Extracts",
            "Phosphorylcholine",
            "Antiprotozoal Agents",
            "Seeds",
            "Animals",
            "Leishmania donovani",
            "Apoptosis",
            "Mice",
            "Humans"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40670989/"
    },
    {
        "pmid": "40670370",
        "title": "IL-12 mRNA-LNP promotes dermal resident memory CD4<sup>+</sup> T cell development.",
        "abstract": "Dermal resident memory CD4supsup cell dTrm provide protection vectorborne infections However factor promote development remain unclear tested mRNA vaccine encoding protective leishmanial antigen induced dTrm cells mRNA vaccine induced robust systemic Tcell responses Trm cell found skin Since IL12 promotes Th1 responses tested whether IL12 mRNA combined mRNA vaccine could enhance dTrm cell development combination significantly expanded Leishmaniaspecific Th1 cell expressing skinhoming molecule memory cell marker draining lymph node Additionally higher number dTrm cell maintained skin mouse exhibited functional immunity indicated delayed hypersensitivity response protection upon challenge Leishmania finding highlight IL12 key driver CD4supsup dTrm development enabling global seeding across skin underscore potential IL12enhanced mRNA vaccine generate durable immunity cutaneous leishmaniasis skintargeted infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40670370/"
    },
    {
        "pmid": "40666521",
        "title": "The F1F3 recombinant chimera induced higher vaccine efficacy than its independent F1 and F3 components against <i>Leishmania</i> (<i>L.</i>) <i>infantum chagasi</i> mice infection.",
        "abstract": "Visceral leishmaniasis VL severe human vectorborne CD4immunosuppressive disease lethal untreated soon symptom arise vaccine available human VL chemotherapy highly toxic requires hospitalization VL patient show substantially decreased CD4subsub total iLeishmaniaispecific CD4 cell counts iLeishmania L donovanii nucleoside hydrolase NH36 DNA metabolism enzyme conserved marker iLeishmaniai genus considered among iLeishmaniai antigens vaccine candidate mouse vaccinated NH36 protection VL mediated CD4subsub cell response NH36 Cterminal domain F3 cutaneous leishmaniasis CL CD4 response F3 CD8 response NH36 Nterminal F1 Vaccination recombinant chimera containing F1 F3 domain expressed tandem F1F3 protected mouse heterologous CL infection iL L amazonensisi iL V braziliensisi investigation BALBc mouse immunized either F1 F3 mixture both F1F3 chimera plus saponin challenged amastigotes iL L infantum chagasii agent VL America infection F1F3 chimera F3 vaccine promoted highest IgA IgM IgG IgG1 IgG2a IgG2b IgG3 antibody responses F1F3 chimera promoted strongest intradermal response leishmanial antigen highest body weight gain potent reduction spleen liver relative weights addition F1F3 chimera vaccine increased secretion IFNγ and together F3 vaccine secretion TNFα splenocytes F1F3 chimera F1 vaccine also promoted strongest secretion IL10 low mouse immunized F3 Thus IFNγIL10 TNFαIL10 ratios characteristic Th1 response increased mouse vaccinated F3 F1F3 chimera F3 vaccine reduced parasite load liver F1F3 chimera described heterologous CL infections also optimizes protection homologous visceral leishmaniasis infection iL L infantum chagasii Th1 contribution F3 peptide regulatory response F1 peptide Expression F1 F3 domain iin tandemi induced higher efficacy simple mixture F1 F3 domains",
        "mesh_terms": [
            "Animals",
            "Mice",
            "Leishmania infantum",
            "Leishmaniasis Vaccines",
            "Leishmaniasis, Visceral",
            "Mice, Inbred BALB C",
            "Antigens, Protozoan",
            "Female",
            "Antibodies, Protozoan",
            "Vaccine Efficacy",
            "Protozoan Proteins",
            "N-Glycosyl Hydrolases",
            "Disease Models, Animal",
            "CD4-Positive T-Lymphocytes",
            "Leishmaniasis, Cutaneous",
            "Recombinant Fusion Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40666521/"
    },
    {
        "pmid": "40664709",
        "title": "Molecular epidemiology, distribution, and determinants of cutaneous leishmaniasis in Northeast Ethiopia.",
        "abstract": "Cutaneous leishmaniasis CL common vectorborne neglected tropical disease caused protozoan parasite endemic Ethiopia Evidence molecular epidemiology CL community endemic area Ethiopia scarce study aimed investigate molecular epidemiology distribution determinant CL communitybased crosssectional study conducted March 2022 2023 356 suspected CL cases DNA extracted skinscraped samples Leishmania parasite detection specie identification performed via polymerase chain reaction PCR Variable multivariate binary logistic regression AORs p value ≤ 005 used identify determinant determine strength associations Among 384 suspected cases 356 included study resulting response rate 927 Among 356 suspected cases 253 711 positive Leishmania parasite according PCR Leishmania aethiopica causative agent CL study area confirmed CL case recorded among living poor housing conditions presence animal house AOR 206 95 CI 123343 age group  9 year AOR 294 95 CI 121714 age group 9 19 year AOR 323 95 CI 189551 size household five year AOR 278 95 CI 160484 statistically significant association CL study revealed CL major public health problem Northeast Ethiopia targeted tailored control strategy needed mitigate burden area",
        "mesh_terms": [
            "Ethiopia",
            "Humans",
            "Leishmaniasis, Cutaneous",
            "Female",
            "Male",
            "Child",
            "Adult",
            "Adolescent",
            "Leishmania",
            "Cross-Sectional Studies",
            "Young Adult",
            "Child, Preschool",
            "Middle Aged",
            "Molecular Epidemiology",
            "Animals",
            "Infant",
            "Risk Factors",
            "Aged",
            "DNA, Protozoan"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40664709/"
    },
    {
        "pmid": "40661166",
        "title": "Efficacy of meglumine antimoniate treatment on boxer <i>Leishmania infantum</i> skin lesions: case report.",
        "abstract": "clinical report describes beneficial effect local subcutaneous injection meglumine antimoniate Glucantime® iLeishmaniai cutaneous lesion dog Calabria region Southern Italy Leishmaniasis endemic zoonotic disease European Union particularly Mediterranean countries well part north east Africa India China Central South America caused protozoa genus iLeishmaniai spp infect several reservoirs including human domestic animals southern Europe main etiological agent iLeishmania infantumi transmitted sandfly subfamily Phlebotominae common cause cutaneous leishmaniasis CL regions dog considered primary domestic reservoir parasite 7yearold male nonsterilized Boxer named Ettore underwent prevaccination blood test Leishmania indirect immunofluorescence IFI test confirmed presence antibody protozoan iLeishmania infantumi antibody titer 11280 supporting diagnosis CL dog underwent therapeutic protocol consisting miltefosine Milteforan™  Virbac® 2 mgKg bw per os 28 day allopurinol 300 mg 10 mgKg bw po 6 months However end treatment period appearance suspicious skin lesion left tarsus reported appeared inflamed infected subsequent antibiotic antiinflammatory therapy based amoxicillinclavulanic acid 125 mgkg bw po 15 days metronidazole 75000UI  125 mg po 15 days prednisone 05 mgkg bw po 10 days failed effective thus lesion worsened also spread dorsal femoral surface hind limbs presenting blackish swollen painful alopecic oozing bloody purulent material Mild renal microlithiasis splenopathy reported abdominal ultrasound associated possible leishmania pattern Finally skin lesion experimentally treated subcutaneous injection Glucantime® 200 mglesion  05 mLlesion month 5 months followed complete healing Interestingly experimental localized treatment Glucantime® proved crucial counteracting Leishmania skin lesions result obtained suggest that appropriate diagnosis possible define targeted effective therapeutic protocol useful management canine leishmaniasis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40661166/"
    },
    {
        "pmid": "40660056",
        "title": "Diagnostic Accuracy of Various Genetic Markers (tpi, gdh, and bg) for Prevalence and Genotyping of Giardia duodenalis in Human Samples: A Comparative Global Systematic Review and Meta-Analysis.",
        "abstract": "Giardia duodenalis widespread intestinal protozoan causing giardiasis human animals Precise detection genotyping parasite vital understanding epidemiology implementing appropriate treatments mitigating transmission Molecular techniques particularly multilocus genotyping MLG targeting betagiardin bg triose phosphate isomerase tpi glutamate dehydrogenase gdh genes improved diagnostic precision However variation sensitivity diagnostic performance among gene influence prevalence rate genotyping results particularly assemblage B common humans study evaluated pooled prevalence G duodenalis human sample confirmed positive microscopy andor small subunit ribosomal RNA SSU rRNA using bg tpi gdh genes comprehensive literature search identified 32 study MLG design published January 13 2025 encompassing 96 datasets 21 country four continents Data extraction quality assessment conducted independently two reviewers Metaanalyses employed randomeffects model using CMA software heterogeneity assessed via I² statistic Pooled prevalence diagnostic accuracy highest using tpi gene 643 95 CI 561718 followed gdh 597 95 CI 518671 bg 583 95 CI 498663 Nonetheless notable fraction microscopy andor SSU rRNAconfirmed sample undetected loci Assemblage B prevalent across genetic markers gdh gene showed superior sensitivity assemblage B 595 whereas bg slightly higher detection rate assemblage 416 finding underscore importance using multiple genetic marker precise detection genotyping tpi gene offer highest sensitivity overall prevalence among Giardiapositive samples gdh bg contribute critical assemblagespecific insights higher prevalence assemblage B underline need targeted public health strategies especially given association severe recurrent infections Overall integrating MLG SSU rRNA analysis essential improving diagnostics surveillance control strategy giardiasis globally",
        "mesh_terms": [
            "Humans",
            "Cytoskeletal Proteins",
            "Genetic Markers",
            "Genotype",
            "Genotyping Techniques",
            "Giardia lamblia",
            "Giardiasis",
            "Glutamate Dehydrogenase",
            "Prevalence",
            "Protozoan Proteins",
            "Sensitivity and Specificity",
            "Triose-Phosphate Isomerase"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40660056/"
    },
    {
        "pmid": "40658390",
        "title": "Barbituric Acid Derivatives as Covalent Inhibitors of <i>Leishmania braziliensis</i> Dihydroorotate Dehydrogenase.",
        "abstract": "Covalent drug design applied parasite protein enables selective therapy targeting nucleophilic residue macromolecules present first covalent inhibitor iiLeishmania braziliensisii dihydroorotate dehydrogenase iLbiDHODH key enzyme pyrimidine biosynthesis reactive cysteine Cyssup131sup active site barbituric acid derivatives discovered b2ib iLbiDHODH inhibitor leishmanicidal activity exhibiting ICsub5subsub0sub 05 ± 01 μM KsubinactsubKiIi 767 Msup1supssup1sup inhibition human ortholog ECsub5subsub0sub 11 ± 5 μM iiL braziliensisii promastigotes cytotoxicity THP1 cell good passive permeability Xray crystallography confirms covalent bond formation Cyssup131sup reveals activesite rearrangements finding support proposed covalent inhibition mechanism provide structural insight optimization study validates iLbiDHODH promising target leishmaniasis therapy highlight potential covalent inhibition antiparasitic drug discovery",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40658390/"
    },
    {
        "pmid": "40658170",
        "title": "Knowledge, Attitudes, and Practices toward Cutaneous Leishmaniasis as a Neglected Tropical Disease among the General Population: A Systematic Review and Meta-Analysis.",
        "abstract": "Cutaneous Leishmaniasis CL tropical disease public health concern resulting infection Leishmania parasite transmitted bite infected female sandflies Community awareness essential component disease control prevention study aimed synthesize evidence knowledge attitudes practice CL among general population comprehensive literature search performed across multiple databases including PubMed Scopus Web Science EMBASE ScienceDirect Google Scholar Springer ProQuest study published English January 2025 Search term included MeSH freetext keywords related KAP toward CL quality included study assessed using NewcastleOttawa Scale NOS Data extracted randomeffects metaanalysis proportion applied pooling studies Heterogeneity explored subgroup sensitivity analyses certainty evidence evaluated using GRADE approach Knowledge assessed 47 study n  21930 attitude assessed 32 study n  13171 practice evaluated 30 study n  13729 CL Overall general population estimated 54595 CI 478 611 good knowledge CL positive attitude 562 95 CI 485 638 practically 495 95 CI 403538 substantial heterogeneity observed study I2  98 cases European region highest level knowledge 753 Southeast Asia region positive attitude 656 good practice Eastern Mediterranean region 459 Metaregression analysis indicated year publication significantly associated heterogeneity knowledge attitude outcomes contrast region significantly associated heterogeneity practice outcome p  005 According GRADE approach overall certainty evidence moderate knowledge attitude outcomes high practice outcomes level knowledge attitude practice general population regarding CL desired level many regions especially endemic countries result emphasize need design implement educational intervention targeted awareness program promote public KAP CL especially area high prevalence low practice",
        "mesh_terms": [
            "Humans",
            "Health Knowledge, Attitudes, Practice",
            "Leishmaniasis, Cutaneous",
            "Neglected Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40658170/"
    },
    {
        "pmid": "40657022",
        "title": "Diagnostically Challenging Case: Coexistence of Two Zoonoses.",
        "abstract": "male patient presented fever cytopenia hepatosplenomegaly patients iBrucellai tube agglutination test positive titer 1640 Due lack response brucellosis treatment additional test performed iLeishmaniai amastigotes seen second bone marrow biopsy preparations iLeishmaniai PCR positive visceral leishmaniasis VL diagnosed Here present case VL brucellosis coinfection presented B symptom fever night sweats weight loss cytopenia difficult diagnose",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40657022/"
    },
    {
        "pmid": "40656817",
        "title": "Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous <i>Leishmania Braziliensis</i> in a Recent Traveler in Belize and Guatemala.",
        "abstract": "report case 53yearold male recent travel Guatemala Belize diagnosed cutaneous leishmaniasis CL treated empirically miltefosine improvement switched amphotericin B upon specie identification iL braziliensisi resulting resolution lesions case demonstrates clinician recognize importance systemic therapy treating complex CL well importance identification specie type tailoring treatments Furthermore miltefosine proven efficacious CL many New World locales demonstrated lower cure rate CL Guatemala thus identification region origin CL infection imperative guiding treatment may vary according difference drug potency regionspecific resistance rates",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40656817/"
    },
    {
        "pmid": "40655011",
        "title": "Dysregulated lymphatic remodeling promotes immunopathology during non-healing cutaneous leishmaniasis.",
        "abstract": "Cutaneous leishmaniasis CL vector borne disease endemic tropical subtropical region world disproportionately affecting low socioeconomic status combined role parasite hosts immune response determining disease severity made challenging discover new antileishmanial treatments Previous work lab established dermal lymphatic network necessary wound resolution model healing CL iLeishmania majori parasites CL lymphatic remodeling allows accumulated fluid drain lesional site thereby reducing disease severity report present new mechanism immunopathology nonhealing CL brought iL amazonensisi infection show nonhealing CL develops alongside accumulation cell fluid skin resulting chronic inflammation Lymphatic remodeling attenuated chronic phase iL amazonensisi infection Moreover percentage proliferating lymphatic endothelial cell LECs decrease 6 12 week post infection wpi leading decrease time lymphatic vessel LV density induce lymphangiogenesis exogenous vascular endothelial growth factorC VEGFC administered adenoviral delivery VEGFC increased LV dilation leading reduced lesion size without altering parasite burdens arguing targeting lymphatics alleviate immunopathology Taken together result show impaired lymphatic function contributes nonhealing disease due iL amazonensisi infection lymphatics targeted decrease inflammation skin infection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40655011/"
    },
    {
        "pmid": "40655006",
        "title": "An oviposition pheromone, hexadecanoic acid, found on the eggs of <i>Phlebotomus papatasi</i> from Central Tunisia, attracts gravid females and stimulates oviposition.",
        "abstract": "iPhlebotomus papatasii vector iLeishmania majori etiologic agent zoonotic cutaneous leishmaniasis disfiguring debilitating disease study identified fatty acid found exterior egg laid female iP papatasii could potential oviposition pheromones tested effect different treatment 1 number egg laid 2 spatial distribution egg laid treatment included three quantity egg 80 160 320 hexane extract 160 eggs 160 egg washed hexane remove pheromones three concentration 1ng 10ng 100ng synthetic version three fatty acid identified present egg exteriors saturated fatty acid dodecanoic C12 tetradecanoic C14 acid identified GCMS analysis abundant hexane extract egg gravid female present trace amount males Hexadecanoic hexadecenoic C16 acid abundant eggs gravid female males negative binomial GLM found significantly egg oviposited gravid female response 80 egg iPi00255 160 egg iPi0001 320 egg iPi0001 hexane extract 160 egg iPi0001 Eggs washed hexane attractive control iPi0591 number egg laid increased three concentration hexadecanoic acid iPi0001 10ng 100ng tetradecanoic acid iPi0001 1ng 10ng dodecanoic acid iPi0001 spatial response oviposition the proportion egg laid test vs control side oviposition pot weaker response total egg laid beta GLM found gravid female laid significantly higher proportion egg near 160 egg iPi0004 significantly lower proportion egg near 100ng dodecanoic acid iPi0016 Bootstrapping permutation test also suggested significant attractive effect 320 eggs egg extract 1ng 10 ng hexadecenoic acid result suggest hexadecanoic acid oviposition pheromone iP papatasii Tunisia presence increase number egg laid attracts oviposition small spatial scale assay Studies others shown dodecanoic acid oviposition pheromone iP papatasii Turkey study dodecanoic acid increased number egg laid either change spatial distribution repulsive highest concentration observed difference may related different geographical origin sand fly used study",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40655006/"
    },
    {
        "pmid": "40654248",
        "title": "In Vitro Leishmanicidal Efficacy of Synthesized Arylidene Analogues of Glitazone.",
        "abstract": "Diabetes fastgrowing health issue low middleincome countries 80 diabetic living tropic subtropics deadly condition claiming life million individual annually therapeutic treatment available date management diabetes thus limited symptomatic relief glycemic control Furthermore geographical overlap diabetes neglected tropical disease NTDs concern diabetes known increase infection susceptibility severity contrast diabetesinfection comorbidity negatively affect treatment responses Leishmaniasis rank among top 10 NTDs current therapeutic treatment relies handful drug marred two main shortcomings toxicity reduced efficacy due pathogenic resistance Hence pressing need new effective antileishmanial therapeutics evidence rising case leishmaniasisdiabetes coinfection may require use dualactive therapeutic curb them search new effective antileishmanial agent potential dual use evaluated vitro antileishmanial antidiabetic activity series arylidenes derived hydantoin glitazone rhodanine scaffold using phenotypic assays previously investigated antidiabetic potential Additionally antitrypanosomal potential compound also considered due taxonomic relation Leishmania Trypanosoma spp reported concern Chagas disease human African trypanosomiasisdiabetes comorbidities Three leishmanicidal early lead submicromolar activity uncovered antitrypanosomal dual leishmaniasisdiabetes active hit identified",
        "mesh_terms": [
            "Antiprotozoal Agents",
            "Animals",
            "Humans",
            "Hypoglycemic Agents",
            "Thiazolidinediones",
            "Leishmaniasis",
            "Leishmania",
            "Parasitic Sensitivity Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40654248/"
    },
    {
        "pmid": "40650542",
        "title": "Designing drugs against leishmaniasis: is targeting the sterol biosynthesis pathway the answer?",
        "abstract": "Leishmaniasis devastating complex parasitic disease caused different specie protozoan member genus iLeishmaniai Unfortunately available drug far ideal vaccine available circumstances new effective antileishmanial drug reduced host toxicity improved dosing protocol urgently needed sterol biosynthesis pathway SBP promising focus combating iLeishmaniai infections Thus various strategy documented drug repurposing combined therapy rational drug design use synergistic effect develop metallodrugs act essential parasite targets article review critical enzyme participating ergostanebased sterol biosynthesis pathway SBP iLeishmaniai species well recent progress rational drug design repurposing drugs combined therapies development metallodrugs use antileishmanial agents review based literature searcher using SciFinder Lensorg Google Scholar Web Science Pub Med DrugBank limited focus human leishmaniasis resulted shortfall effective treatment parasitic disease postsqualene segment sterol biosynthetic pathway promising target treating iLeishmaniai infections particularly effective drug metallodrugs inhibit CYP51 24SMT enzymes",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis",
            "Leishmania",
            "Antiprotozoal Agents",
            "Sterols",
            "Drug Design",
            "Animals",
            "Drug Repositioning",
            "Biosynthetic Pathways",
            "Drug Development"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40650542/"
    },
    {
        "pmid": "40645246",
        "title": "Antibody functionalized thiolated chitosan stabilized silver nanoparticles as theranostics toward visceral leishmaniasis.",
        "abstract": "Leishmaniasis VL neglected disease caused Leishmania protozoa transmitted insect vectors fatal without adequate treatment Current therapy hindered issue drug resistance side effects making rapid diagnosis essential Biosensors explored enhance detection silver nanoparticles AgNPs emerged promising tool diagnosis treatment improve stability functionality AgNPs coated thiolated chitosan TCh synthesized introducing thiol group chitosan using 3mercaptopropionic acid confirmed sup1supH NMR FTIR analysis TChstabilized AgNPs TChAgNPs created using chemical reduction method resulting nanoparticles mean diameter 66 ± 1 nm maximum absorbance peak 418 ± 2 nm AntirK39 antibody anchored nanoparticles TChAgNPsAb showed enhanced interaction kinetics rK39 protein compared free antibodies indicated 23 time stronger signal Additionally TChAgNPs demonstrated greater antileishmanial activity cell culture compared control groups result suggest TChAgNPs could serve valuable platform developing sensitive diagnostics effective treatment VL",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40645246/"
    },
    {
        "pmid": "40642881",
        "title": "Evaluation of itraconazole monotherapy versus its combination with a single dose of pentamidine for treating cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis in Amazonas state, western Brazilian Amazon.",
        "abstract": "Cutaneous leishmaniasis long neglected tropical disease mainly due therapy limitations search safe effective alternative treatments particularly oral medications led development secondline treatments azole antifungals including itraconazole study aimed evaluate compare therapeutic effectiveness itraconazole alone combination pentamidine patient cutaneous leishmaniasis caused Leishmania Viannia guyanensis randomised clinical trial conducted leishmaniasis outpatient clinic Fundação de Medicina Tropical Doutor Heitor Vieira Dourado Manaus Amazonas Ninety eligible patient diagnosed cutaneous leishmaniasis selected randomly assigned three treatment groups Control groupGroup 1 G1 received pentamidine isethionate experimental groupGroup 2 G2 received itraconazole monotherapy experimental groupGroup 3 G3 received combination itraconazole one dose pentamidine isethionate standardised doses Patients monitored 30 60 90 180 day completion treatment Leishmania specie identified using biomolecular methods patient predominantly male 844 mean age 405 ± 129 years 93 case originated peripheral area Manaus Amazonas average duration skin lesion evolution 30 days 84 presenting ulcerated lesions single lesion observed 57 cases 41 measured 2 3 cmsup2sup predominantly lower limbs Four specie Leishmania identified L guyanensis causing 90 cases L brasiliensis causing 6 cases L amazonensis causing 25 case L naiffi causing 12 cases Among 72 case L V guyanensis cure rate 96 itraconazole  pentamidine 83 itraconazole alone 58 pentamidine alone serious adverse event observed term toxicity tolerability Injection site pain induration common adverse effect G1 term efficacy patient G2 G3 experienced favourable outcomes 90day cure rate 56 G1 73 G2 90 G3 90 days itraconazolepentamidine combination therapy effective 90 either itraconazole pentamidine alone cutaneous leishmaniasis Amazonas state caused L guyanensis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40642881/"
    },
    {
        "pmid": "40642251",
        "title": "Telemedicine in the clinical care of Chagas disease and American cutaneous leishmaniasis: pilot study in a public referral hospital in Brazil.",
        "abstract": "Neglected tropical disease NTDs remain major public health challenge low middleincome country LMICs especially rural underserved regions Although telemedicine expanded globally evidence implementation individual clinical care NTDs remains scarce pilot implementation study aimed assess feasibility acceptability synchronous telemedicine consultation patient Chagas disease CD American Cutaneous Leishmaniasis ACL national reference hospital Brazil conducted mixedmethods implementation study using Design Science Research Methodology DSRM context analysis involved structured survey 31 health professional semistructured interview two local managers Patients diagnosed CD ACL recruited August October 2024 Teleconsultations performed via WhatsApp video call four specialists Patient satisfaction evaluated using structured questionnaires 46 patient recruited 38 826 completed teleconsultations older adult prior telehealth experience Despite low digital literacy education levels 632 2438 completed teleconsultation without assistance High level satisfaction reported 974 3738 satisfied would attend future virtual visits Participants reported reduced travel burden improved access care major technical issue observed Synchronous telemedicine via lowcost widely available platform feasible wellaccepted clinical followup CD ACL Brazilian public hospital approach may help reduce access barrier specialized care NTDs research evaluate clinical outcome costeffectiveness LMIC settings",
        "mesh_terms": [
            "Humans",
            "Brazil",
            "Pilot Projects",
            "Telemedicine",
            "Female",
            "Male",
            "Adult",
            "Chagas Disease",
            "Middle Aged",
            "Leishmaniasis, Cutaneous",
            "Patient Satisfaction",
            "Hospitals, Public",
            "Surveys and Questionnaires",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40642251/"
    },
    {
        "pmid": "40637365",
        "title": "Relationship Between Hepcidin, Iron Metabolism, Inflammation and Hypersplenism in Anaemia of Kala-Azar.",
        "abstract": "Kalaazar visceral leishmaniasis VL parasitic disease caused Leishmania spp characterised fever weight loss splenomegaly hepatomegaly anaemia study evaluated relationship hepcidin inflammation iron metabolism hypersplenism VLassociated anaemia crosssectional study confirmed VL patient without recent transfusion assessed Haematological inflammatory parameter analysed using correlation multivariate regression tests Anaemia present 952 sample predominantly normocytic 595 normochromic 762 microcytic 405 hypochromic 238 Inflammatory marker markedly elevated patients particularly hepcidin increased 976 case median 35146 ngmL suggesting persistent inflammation impaired iron bioavailability However IL6 CRP ferritin showed weak moderate negative correlation hepcidin ρ  033 ρ  066 ρ  030 respectively finding highlight complex interplay anaemia inflammation kalaazar elevated hepcidin level paradoxical correlation inflammatory markers underscore central role splenomegaly VLrelated anaemia suggest potential contribution factor affecting iron metabolism erythropoietin erythroferrone Understanding dynamic marker throughout disease progression treatment may elucidate pathophysiology VL support development targeted therapies",
        "mesh_terms": [
            "Humans",
            "Hepcidins",
            "Leishmaniasis, Visceral",
            "Female",
            "Cross-Sectional Studies",
            "Male",
            "Adult",
            "Anemia",
            "Iron",
            "Inflammation",
            "Middle Aged",
            "Hypersplenism",
            "Young Adult",
            "Adolescent",
            "Biomarkers"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40637365/"
    },
    {
        "pmid": "40632305",
        "title": "Investigating the impact of HIS-1 and HSP-70 genes on drug response and pathology of Leishmania major using antisense oligonucleotides.",
        "abstract": "Leishmaniasis protozoan disease caused protozoan Leishmania spp present wide spectrum manifestations Researchers currently unable control treat different form leishmaniasis effective vaccine treatment yet available study aimed assess pathological aspect drug susceptibility L major treated antisense oligonucleotides ASO targeting HSP70 HIS1 genes study investigates antileishmanial property antisense oligonucleotides ASO directed HSP70 HIS1 genes play critical role stage differentiation resistance antileishmanial drugs experiment conducted using L major promastigotes amastigotes vitro mouse model cutaneous leishmaniasis CL result indicated expression HSP70 HIS1 gene significantly reduced group receiving antisense oligonucleotides ASO group treated HSP70 ASO amastigote count macrophage significantly reduced compared groups finding vivo experiment revealed group receiving HIS1 ASO size CL lesion significantly reduced susceptibility glucantime significantly increased compared groups result current study demonstrated HIS1 HSP70 ASOs successfully inhibit pathogenicity L major decrease lesion size CL ASO novel technique genetic manipulation also revealed aid control prevention various diseases",
        "mesh_terms": [
            "Animals",
            "Oligonucleotides, Antisense",
            "HSP70 Heat-Shock Proteins",
            "Leishmania major",
            "Mice",
            "Leishmaniasis, Cutaneous",
            "Antiprotozoal Agents",
            "Mice, Inbred BALB C",
            "Protozoan Proteins",
            "Disease Models, Animal",
            "Female",
            "Macrophages"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40632305/"
    },
    {
        "pmid": "40631203",
        "title": "Guanylate-Binding Proteins Promote Host Defense Against <i>Leishmania major</i> by Balancing iNOS/Arg-1 in Myeloid Cells.",
        "abstract": "Cutaneous leishmaniasis CL debilitating neglected tropical disease characterized lesion range selfhealing permanent disfigurations predominant Th1 response stimulates IFNγ production crucial parasite control selfhealing CL IFNγ primarily activates macrophage produce nitric oxide via inducible nitric oxide synthase iNOS leading parasite control IFNγ also activates downstream pathway involved cell autonomous immunity One pathway activation guanylate binding protein GBPs class interferon inducible GTPases However role GBPs CL minimally explored Utilizing RNASeq found iLeishmania majori infection lead upregulation several GBPs C57Bl6 mice vitro study using GBPChr3 knockout KO C57Bl6 control mouse reveal bone marrowderived macrophage BMDMs KO mouse exhibit higher parasite burden following IFNγ treatment independent GBP localization parasite Singlecell RNASeq identifies macrophage primary expressers GBPs iL majori infection iin vivoi iIn vivoi GBPChr3 KO mouse display increased disease severity parasite load GBPChr3 KO macrophage monocyte show elevated ARG1 reduced iNOS expression indicating shift toward parasitepermissive environment support parasite growth finding highlight critical role GBPs immunemediated control CL",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40631203/"
    },
    {
        "pmid": "40628941",
        "title": "Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasis.",
        "abstract": "drug discovery pipeline neglected kinetoplastid disease remains sparse particular field leishmaniasis drug discovery limited success translating potential drug candidate viable therapies Here describe development two lead compounds BZ1 BZ1I potent vitro antileishmanial activity Leishmania donovani DD8 intracellular amastigotes 059 ± 013 µM 040 ± 038 µM corresponding selectivity   3389  4912 differentiated THP1 cell Human monocytic cell line respectively characterization biological profiling identified addition activity L donovani DD8 Old World  Indian strain compound active intracellular parasite specie strain Old New World namely L donovani Old World  Sudanese strain L infantum chagasi New WorldSouth American strain vivo evaluation using hamster model illustrated activity observed vitro translated vivo outstanding results data suggests compound represent promising starting point developing novel lead series future antileishmanial therapeutics",
        "mesh_terms": [
            "Leishmania donovani",
            "Leishmaniasis, Visceral",
            "Leishmania infantum",
            "Animals",
            "Humans",
            "Antiprotozoal Agents",
            "Cricetinae",
            "THP-1 Cells",
            "Drug Discovery"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40628941/"
    },
    {
        "pmid": "40627779",
        "title": "Prevalence of Leishmania infection in refugee camps: A serological and molecular study in Gambella and Benishangul-Gumuz, Ethiopia.",
        "abstract": "Leishmaniasis transmitted sandflies cause severe health threat East African refugee camps High mobility poor condition limited healthcare access heighten risk visceral leishmaniasis VL among refugees Though data infection prevalence remains limited study aim determine prevalence Leishmania infection refugee camp Benishangul Gumuz Gambella region improve VL detection guide effective control strategy humanitarian settings crosssectional study conducted May August 2023 four refugee camp determine Leishmania infection using DAT rtPCR blood samples Sociodemographic clinical data collected using structured questionnaires Ethical approval granted informed consent obtained Data analyzed using SPSS v23 association assessed using logistic regression Chisquare test 005 significance level Continuous variable summarized median interquartile range IQR study included 1223 participant 440 Tsore camp 220 Sherkole Benishangul Gumuz Region 288 Kule camp 275 Terkidi Gambella Region South Sudan 667 majority female 565 178 participant reported fever spleen liver enlargement 02 lymph node swelling Realtime PCR positivity significantly higher Tsore 146 χ²  214 p  0001 significant difference DAT positivity observed across refugee camp χ²  66 p  0084 Leishmania DAT positivity rate 60 46 47 fever chill headache respectively Leishmania kDNA based rtPCR positivity rate 117 88 73 62 fever chills headache weakness respectively Participants Benishangul Gumuz region AOR 367 95CI 157859 p  0003 South Sudanese AOR 287 95CI 126650 p  0012 fever AOR 208 95CI 101428 p  0047 higher odds DAT positivity hand lower rtPCR positivity rate seen Sherkole refugee camp compared Tsore camp Benishangul Gumuz region AOR 019 95CI 008045 p  00001 Leishmania infection prevalent refugee camp Gambella Benishangul Gumuz regions Asymptomatic case low parasite load common highlighting need active case detection intervention including treatment vector control manage VL transmission effectively",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Cross-Sectional Studies",
            "Refugee Camps",
            "Adult",
            "Prevalence",
            "Adolescent",
            "Young Adult",
            "Child",
            "Ethiopia",
            "Middle Aged",
            "Child, Preschool",
            "Refugees",
            "Leishmania",
            "Seroepidemiologic Studies",
            "Leishmaniasis, Visceral",
            "Leishmaniasis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40627779/"
    },
    {
        "pmid": "40622619",
        "title": "In Vitro Anti-Leishmanial Activity and Molecular Docking of Eugenol as a Potential Agent Against Leishmania Major.",
        "abstract": "Eugenol aromatic compound belongs phenol group found various natural sources clove oil study aimed investigate eugenols leishmanicidal activity mechanism action using molecular docking predict potential biochemical target eugenol Leishmania major interaction eugenol TNFαIL12p40 evaluated using docking methods leishmanicidal activity eugenol Glucantimesup®sup MA combination assessed promastigote amastigote stage Leishmania major Additionally realtime PCR used measure cytokine gene expression level murine macrophage treated studied drugs ICsub50sub value eugenol MA combination L major promastigotes determined 23522 µgmL 29893 µgmL 15902 µgmL respectively Regarding antiamastigote activity combination eugenol exhibited lowest ICsub50sub value 417 µgmL compared 731 µgmL eugenol alone combination ICsub50sub located line showed additivity role Docking study suggest residue within active site eugenol capable interacting TNFα IL12p40 Specifically Leu57 Leu120 Gly120 Gly122 identified common amino acid involved binding eugenol TNFα whereas Glu12 Asn200 His83 associated eugenols interaction IL12p40 Gene expression analysis revealed upregulation Th1 cytokine IL12P40 iNOS IFNγ downregulation Th2 cytokine IL4 IL10 combined treatment relative individual treatments superior efficacy combined treatment eugenol L major necessitates research clinical potential combination treatment leishmaniasis",
        "mesh_terms": [
            "Eugenol",
            "Molecular Docking Simulation",
            "Animals",
            "Mice",
            "Leishmania major",
            "Antiprotozoal Agents",
            "Tumor Necrosis Factor-alpha",
            "Macrophages",
            "Cytokines",
            "Interleukin-12 Subunit p40",
            "Inhibitory Concentration 50"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40622619/"
    },
    {
        "pmid": "40620982",
        "title": "Amine-Functionalized Graphene Quantum Dots Conjugated with Amphotericin B: Synthesis, Characterization, and In Vitro Evaluation for Visceral Leishmaniasis Treatment.",
        "abstract": "Visceral Leishmaniasis VL lifethreatening parasitic disease primarily affecting population resourcelimited endemic regions Existing treatment VL face limitation toxicity high costs suboptimal efficacy specific patient groups Given lack vaccine chemotherapy remains option emphasizing urgent need safer effective treatments Nanotechnology offer promising avenue overcome challenges study introduces novel approach involving aminefunctionalized graphene quantum dot fGQDs conjugated Amphotericin B fGQDAmB enhance targeted drug delivery infected macrophages novel approach could lead safer effective treatment VL significant contribution field Structural characterization XRD FTIR confirmed successful GQD synthesis functionalization cellular assay demonstrated significantly higher macrophage uptake enhanced antileishmanial efficacy fGQDAmB demonstrated approximately 42fold greater potency intracellular amastigotes 2fold higher efficacy promastigotes also exhibiting reduced cytotoxicity compared conventional AmB safety effectiveness fGQDAmB validated hemolysis assay providing reassurance confidence potential use instilling confidence potential Quantum Dotbased Nanomedicine formulations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40620982/"
    },
    {
        "pmid": "40618369",
        "title": "Potent antileishmanial and synergic effects of phellandrene through its immunomodulation, modulating oxidant/antioxidant, and apoptotic induction.",
        "abstract": "primary pharmaceutical treatment cutaneous leishmaniasis CL linked range negative complications development innovative pharmacological agent aimed enhancing cellular immune response could denote promising therapeutic approach CL therapy Here present study investigated impact phellandrene PR cyclic monoterpene found various plant species Leishmania tropica focusing antileishmanial properties immunomodulatory effects antioxidant activity capacity induce apoptosis antileishmaial synergistic property effect PR alone conjunction glucantime GCT L tropica promastigote amastigote form investigated well influence PR immunomodulatoryassociated genes antioxidantassociated genes plasma membrane integrity ROS generation apoptosis induction nitric oxide NO production assessed found PR principally conjunction GCT notably reduced number promastigote amastigote form within macrophage dosedependent reduction plt0001 found significant upregulation expression iNOS interferon gamma IFNg tumor necrosis factor TNFa gene infected macrophage subsequent treatment RP particularly conjunction GCT Conversely notable downregulation expression interleukin 10 IL10 superoxide dismutase SOD catalase CAT genes whereas result substantial rise release macrophage cell p0001 PR GCT PRGCT resulted dosedependent enhancement caspase3 activity increase plasma membrane integrity reactive oxygen specie ROS production p0001 finding indicate PR mainly along GCT substantial effect inhibition elimination Leishmania parasite controlled laboratory environments Although certain cellular mechanism action recognized including immune modulation cellular immunity response induction apoptosis ROS production reducing antioxidant activity affecting membrane integrity response Leishmania additional research required interpret effectiveness animal model human participants",
        "mesh_terms": [
            "Apoptosis",
            "Antioxidants",
            "Animals",
            "Antiprotozoal Agents",
            "Monoterpenes",
            "Leishmania tropica",
            "Mice",
            "Drug Synergism",
            "Nitric Oxide",
            "Macrophages",
            "Meglumine Antimoniate",
            "Immunomodulation",
            "Reactive Oxygen Species",
            "Oxidants"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40618369/"
    },
    {
        "pmid": "40615842",
        "title": "Retrospective study of canine leishmaniosis in Israel.",
        "abstract": "Canine human leishmaniasis prevalent around Mediterranean Basin dog considered main peridomestic reservoir human disease Canine leishmaniosis initially diagnosed central Israel 1994 Since then routinely detected canine population Israel small number human case reported annually retrospective analysis dog diagnosed Leishmania infection Hebrew University 1994 December 2023 included 658 dogs Although infected dog reported 16 subdistricts Israel geographic distribution location infected dog focused mainly central northern Israel 2020 isolated case also detected southern Israel suggesting southward spread disease majority infected dog n  341 518 resident rural localities remainder n  267 406 present urban areas highest number case found Jerusalem Subdistrict highest density infected dogs case per square km present Tel Aviv Subdistrict incidence rate clinical leishmaniosis year 20072023 based Israeli dog registry ranged 003 009 per 1000 registered dogs 353 dog diagnosed 2013 onward age ranged 3 month 145 year median 45 years 38 dog also tested polymerase chain reaction PCR Leishmania spp since 2010 32 84 infected L infantum 4 11 L tropica 2 5 L major epidemiology canine leishmaniosis caused mostly L infantum present contrary picture human leishmaniasis Israel 99 patient reported cutaneous leishmaniasis caused mostly L major L tropica less 1 visceral disease due L infantum widespread presence canine L infantum infection central northern Israel constitutes zoonotic reservoir disease humans wildlife cats dogs",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Israel",
            "Dog Diseases",
            "Retrospective Studies",
            "Leishmaniasis",
            "Male",
            "Female",
            "Humans",
            "Incidence",
            "Leishmania infantum",
            "Leishmania",
            "Leishmaniasis, Visceral"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40615842/"
    },
    {
        "pmid": "40613607",
        "title": "Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy.",
        "abstract": "Cutaneous leishmaniasis present significant challenge public health due diverse clinical manifestations resistance development treatmentrelated adverse effects Here examined efficacy ivermectin moxidectin MOX afoxolaner permethrin stage Leishmania tropica THP1 cells also assessed potential resistance acquisition 15 round artificial selection elucidate mode action MOX employed RNA sequencing molecular dynamic simulation chloride flux assays Additionally evaluated therapeutic index MOX using Galleria mellonella infection model MOX demonstrated highest selectivity index leishmaniasis promastigotes 058 μM amastigotes 096 μM host cells 6029 μM Moreover MOX exhibited lowest resistance acquisition promastigotes intracellular amastigotes 15 round artificial selection resistance ratio 1723 459 respectively Postexposure MOX differential gene expression profile showed stagespecific stageunspecific enrichment gene family involved crucial biological processes Moreover molecular dynamic simulation revealed potential neutralizing effect MOX chloride channel L tropica Specifically MOX bind selectivity filter potentially disrupting osmotic equilibrium thereby killing parasite vivo introduction MOX significantly inhibited growth L tropica G mellonella larvae resulting decreased rate mortality melanization finding indicate MOX promising candidate treatment L tropica infections warranting investigation potential consideration clinical use",
        "mesh_terms": [
            "Animals",
            "Leishmaniasis, Cutaneous",
            "Humans",
            "Macrolides",
            "Leishmania tropica",
            "Drug Repositioning",
            "Molecular Dynamics Simulation",
            "Antiprotozoal Agents",
            "Drug Resistance",
            "Moths",
            "Ivermectin",
            "Cell Line",
            "Permethrin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40613607/"
    },
    {
        "pmid": "40611204",
        "title": "Enhancing protection against vector-borne diseases in forcibly displaced communities: evaluating the efficacy of spatial repellents for cutaneous leishmaniasis control in North-East Syria.",
        "abstract": "Syria 14 year outbreak civil war 167 million people forced flee homes 72 million remain internally displaced 2025 Breakdown waste management caused aerial bombardment created ideal condition cutaneous leishmaniasis CL transmission vectored phlebotomine sandflies Displaced population reside flimsy shelter conventional vector control tool operationally unfeasible small lightweight portable transfluthrinbased spatial repellent Mosquito Shield™ developed may circumvent logistical issue provide improved protection vectorborne disease harsh environments twoarm nonrandomised cluster trial undertaken ArRaqqa governorate NorthEast Syria evaluate efficacy Mosquito Shield™ reducing CL case incidence sandfly density shelters Weekly epidemiological monitoring performed MENTOR Initiative mobile clinic supported health facilities Entomological monitoring performed fortnightly using indoor US Centers Disease Control Prevention light trap 40 randomly selected household per study arm Phlebotomine sandfly morphologically identified subset analysed molecular specie confirmation bloodmeal preference pyrethroid resistance Household survey focus group discussion used assess intervention feasibility acceptability uptake Assuming 2month diagnosis cutoff CL incidence rate 99 52 per 1000 control intervention arms respectively Mosquito Shield™ demonstrated significant impact rate CL infection age incidence rate ratio IRR 052 95 CI 037074 p  00001 Mosquito Shield™ demonstrated significant impact female sandfly density IRR 022 95 CI 014033 p  00001 bloodfed female sandfly density IRR 021 95 CI 011040 p  00001 Mosquito Shield™ received positively perceived easy use protect CL sandfly insect bite required minimal behaviour change Trial finding provide first demonstrable impact spatial repellent CL transmission strengthening growing evidence basis effectiveness intervention multiple vector specie associated pathogens Study result strongly support deployment spatial repellent control CL humanitarian crises ClinicalTrialsgov NCT06917040",
        "mesh_terms": [
            "Adolescent",
            "Adult",
            "Animals",
            "Child",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "Young Adult",
            "Insect Repellents",
            "Leishmaniasis, Cutaneous",
            "Psychodidae",
            "Syria",
            "Vector Borne Diseases",
            "Cyclopropanes",
            "Fluorobenzenes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40611204/"
    },
    {
        "pmid": "40610818",
        "title": "High-throughput screening identifies novel chemical scaffolds targeting Leishmania donovani parasites.",
        "abstract": "Highthroughput screening HTS one critical strategy accelerate process drug discovery exploring small druglike molecule libraries HTS noticeably contributes identification potential hit using various automation tool biological assays Leishmaniasis neglected tropical disease one deadly protozoan parasitic infection causing significant global burden certain povertystricken countries Given paucity effective chemotherapeutic agent available treatment lifethreatening infection discovery novel leishmanicidal scaffold innovative strategy pivotal combating parasitic disease present study employed HTS strategy scrutinize 10000 druglike molecule inhouse ChemDiv library identify potent hit Leishmania donovani Noticeably 99 molecule showed  80 inhibitory effect L donovani parasite 50 µM concentration among them four molecule displayed 50 inhibitory concentration ICsub50sub value  10 µM along favorable selectivity index  10 Scanning electron microscopy analysis suggests potent hit cause considerable morphological alterations predicted ADME pharmacokinetics study potent hit molecule indicates hit considerable druglikeness property showed low risk adverse effects along predicted high level oral bioavailability Thus promising hit identified HTS strategy serve initial basis consequent medicinal chemistry endeavor aimed unraveling new series antileishmanial agents",
        "mesh_terms": [
            "Leishmania donovani",
            "High-Throughput Screening Assays",
            "Antiprotozoal Agents",
            "Animals",
            "Small Molecule Libraries",
            "Drug Discovery",
            "Inhibitory Concentration 50",
            "Parasitic Sensitivity Tests",
            "Leishmaniasis, Visceral",
            "Humans"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40610818/"
    },
    {
        "pmid": "40608248",
        "title": "Examining miR-196a, miR-196b and NF-κBIα gene expression in colitis mice model.",
        "abstract": "Bifidobacterium bifidum B bifidum antiinflammatory characteristic ability modify gut microbiota make promising treatment option Inflammatory Bowel Disease IBD present study investigated modulatory effect B bifidum expression miR196a miR196b NFκBIα gene DSSinduced IBD mouse model Thirty male C57BL6 mouse randomly assigned five experimental group G1G5 induction colitis used 3 DSS drinking water 8 days Disease Activity Index DAI monitored mouse euthanized analysis 22nd day mouse gavaged 2 × 10sup9sup CFUml B bifidum per day Histological grading colon tissue done level cytokine TNFα IL6 measured using ELISA gene level expression miR196a miR196b NFκBIα analyzed RTPCR Weight gain day 11 17 G3 G4 B bifidum treatment pointed therapeutic benefits Colon length weight spleen weight significantly decreased G2 compared G1 P ≥ 00001 Histopathological examination revealed severe mucosal damage G2 reduced inflammation G3 fewer deep wound G4 significant healing G5 B bifidum especially G5 significantly reduced IL6 TNFα level P ≥ 00002 Gene expression analysis showed decrease miR196a NFκBIα increase miR196b G5 showing change P ≥ 00001 conclusion B bifidum demonstrated significant antiinflammatory effect DSSinduced IBD model modulating miRNA expression reducing key inflammatory cytokines",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40608248/"
    },
    {
        "pmid": "40606630",
        "title": "Oregano essential oil <i>(Origanum vulgare)</i> induces death in a resistant strain of <i>Leishmania infantum</i> isolated from a naturally infected dog through increased production of reactive oxygen species, mitochondrial damage and cell metabolic disruption.",
        "abstract": "Leishmaniasis neglected tropical disease caused protozoa iLeishmaniai genus transmitted phlebotomine sandflies Clinical manifestation vary depending parasites specie hosts immune system ranging selfhealing skin lesion lethal visceral diseases Visceral leishmaniasis VL mainly caused iL infantumi iL donovanii serious public health issue Conventional treatment challenging due toxicity long duration resistance highlighting need alternative therapies Oregano essential oil OEO biological effects including antibacterial antifungal antioxidant actions making potential leishmanicidal agent evaluate activity promastigotes two iL infantumi strain tested MS from naturally infected dog Brazil reference strain MCANBR97p142 IC50 value 1253 µgmL 4361 µgmL respectively amphotericin B AmB showed lower IC50 value 01453 µgmL 02126 µgmL OEO treatment increased reactive oxygen specie ROS production mitochondrial damage lipid droplet accumulation autophagic vacuoles indicating intense cellular stress Additionally apoptosis marker phosphatidylserine exposure membrane permeabilization detected Fluorescence scanning SEM transmission TEM microscopy revealed morphological ultrastructural alterations including membrane blebbing flagellar damage intracellular content leakage mitochondrial swelling assess antiamastigote effect THP1 cell infected iL infantumi strain treated OEO MS strain showed lower infection rate higher parasite load per macrophage tested concentration 25 50 75 μgmL reduced number infected macrophage intracellular amastigotes Thus OEO exhibit leishmanicidal activity promastigote amastigote form iL infantumi inducing metabolic disruption cell death even strain naturally infected dogs finding highlight OEOs potential alternative treatment VL",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Leishmania infantum",
            "Oils, Volatile",
            "Reactive Oxygen Species",
            "Origanum",
            "Mitochondria",
            "Leishmaniasis, Visceral",
            "Antiprotozoal Agents",
            "Dog Diseases",
            "Brazil",
            "Inhibitory Concentration 50",
            "Amphotericin B",
            "Humans",
            "Macrophages"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40606630/"
    },
    {
        "pmid": "40604779",
        "title": "The effect of educational intervention on preventive behaviors against cutaneous leishmaniasis in employees of Shiraz special economic zone subsidiary companies.",
        "abstract": "Leishmaniasis major public health veterinary challenge Mediterranean countries Preventing infection critical measure educational intervention utilized modify preventive behavior cutaneous leishmaniasis CL Therefore study aimed evaluate effect educational intervention preventive behavior CL employee Shiraz Special Economic Zone subsidiary companies experimental study conducted 280 employee Shiraz Special Economic Zone subsidiary companies Iran 20232024 140 participant control group 140 intervention group Data collected using questionnaire included demographic information awareness assessment construct Health Belief Model HBM preventive behavior CL questionnaire completed group three month intervention intervention group attended eight educational sessions held weekly lasting 5060 min each mean age intervention group 4038 ± 678 years control group 3892 ± 716 years Results showed significant change mean score Health Belief Model construct intervention group educational session P  005 Additionally significant change observed mean score perceived susceptibility P  0001 perceived barrier P  0001 selfefficacy P  0001 cue action P  0001 intervention control group intervention P  005 result demonstrated applying Health Belief Model beneficial effective enhancing preventive behavior CL approach practical promoting health individual risk",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Cutaneous",
            "Adult",
            "Iran",
            "Male",
            "Female",
            "Health Education",
            "Middle Aged",
            "Surveys and Questionnaires",
            "Health Knowledge, Attitudes, Practice",
            "Health Behavior",
            "Health Belief Model"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40604779/"
    },
    {
        "pmid": "40604450",
        "title": "A clinico-epidemiological study, assessing possible predictors of mortality and health-related quality of life for people living with visceral leishmaniasis - human immune virus (VL-HIV) co-infection in a high burden kala-azar endemic state of India: a descriptive cross-sectional study.",
        "abstract": "Visceral leishmaniasishuman immunodeficiency virus VLHIV coinfection emerged serious concern could adversely affect VL elimination effort country patient poor VL therapeutic success rate drugrelated toxicity relapse resulting high mortality Despite emerging pattern VLHIV coinfection limited study analyzing presentation VLHIV coinfection Bihar India present study investigated clinicoepidemiological features predictor mortality quality life people living VLHIV coinfection crosssectional study conducted using retrospective data VLHIV case 2018 2020 semistructured questionnaire used data collection Data analysis done using IBM SPSS statistic v22 study included large sample 222 VLHIV cases onefifth patient 47 21 died highly statistically significant difference P  00001 mortality observed male 38 809 female 9 191 death occurred rapidly within mean duration 67 month 95 CI 5481 VL diagnosis highly statistically significant difference P  00001 observed individual stopped antiretroviral therapy ART 36 766 taking ART regularly 11 234 term mortality primary predisposing factor observed heterosexual behavior accounted 113 case 883 case 953 diagnosis done tertiary care center home district majority VL case 101 789 treated multiple dos liposomal amphotericin B 128 VLHIV cases 120 937 declared cured VL completing treatment Approximately 47 case 367 experienced two VL relapses significant difference observed gender income per month environmental health domain specifically present study document time gap initiation cessation ART well duration VL treatment death suggests regular adherence ART may significant impact reducing mortality relapses Therefore comprehensive peoplecentric approach specific group must adopted VLHIV patients Additional epidemiological study VLHIV coinfection warranted",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "India",
            "Male",
            "Cross-Sectional Studies",
            "Female",
            "HIV Infections",
            "Adult",
            "Coinfection",
            "Retrospective Studies",
            "Quality of Life",
            "Middle Aged",
            "Young Adult",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40604450/"
    },
    {
        "pmid": "40601159",
        "title": "Integrated diagnosis and successful treatment of imported old world cutaneous leishmaniasis with intralesional sodium stibogluconate in china: a case report.",
        "abstract": "study present case 54yearold woman otherwise healthy presented 4month history red plaque central ulceration initially developed painless papules lesion appeared right arm trunk two month travel Morocco Physical examination revealed 7 cm × 5 cm red plaque central ulceration crusting right arm along papule plaque trunk Based microbiological histopathological PCR results patient diagnosed Old World cutaneous leishmaniasis receiving two session intralesional pentavalent antimonial treatment patient left minor scar experienced negligible side effects except moderate aching therapy",
        "mesh_terms": [
            "Humans",
            "Female",
            "Leishmaniasis, Cutaneous",
            "Middle Aged",
            "Antimony Sodium Gluconate",
            "Antiprotozoal Agents",
            "China",
            "Treatment Outcome",
            "Morocco",
            "Travel",
            "Injections, Intralesional",
            "Communicable Diseases, Imported"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40601159/"
    },
    {
        "pmid": "40600094",
        "title": "Unusual Presentation of Pemphigus Vulgaris as a Solitary Ulcerative Scalp Lesion: A Case Report.",
        "abstract": "Pemphigus vulgaris PV rare autoimmune blistering disease typically present painful oral erosion followed widespread cutaneous involvement report diagnostically challenging case PV 43yearold man initially presented solitary ulcerativecrusted lesion parietal scalp evolving eight months lesion clinically suggestive infectious neoplastic etiologies including tinea capitis squamous cell carcinoma Bowens disease leishmaniasis Empirical antifungal treatment ineffective mycological study negative Dermoscopy revealed yellow crusts serpentine vessels perifollicular whitish halos patient later developed painful oral ulcers led histopathological immunofluorescence study confirming PV Systemic corticosteroid mycophenolate mofetil initiated marked clinical improvement case highlight uncommon presentation PV delayed diagnosis emphasizes importance considering autoimmune bullous disorder differential diagnosis chronic nonhealing scalp lesions even absence mucosal involvement",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40600094/"
    },
    {
        "pmid": "40600021",
        "title": "A Century of Epidemiological Advances in Cutaneous and Visceral Leishmaniasis in Algeria.",
        "abstract": "Leishmaniasis group disease transmitted sandflies affecting human animals three clinical presentations cutaneous mucosal visceral disease caused parasite iLeishmaniai significant global health issue approximately two million case annually 350 million people risk disease endemic 98 countries including Algeria hotspot Algeria three specie iLeishmaniai iLeishmania majori iLeishmania infantumi iLeishmania tropicai cause cutaneous visceral leishmaniasis cutaneous one highly endemic Algeria since 19th century research leishmaniasis intensive review aimed compiling century research provide updated knowledge transmission diagnosis treatment epidemiology country",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40600021/"
    },
    {
        "pmid": "40597737",
        "title": "Molecular detection of Leishmania major human infections in the Zinder area, Niger.",
        "abstract": "Cutaneous Leishmaniasis CL underreported SubSaharan Africa study reported use molecular diagnostic method CL region whereas report therapeutic outcome scarce international consortium established local team Zinder region Niger referral centre leishmaniasis French Guiana Specific training CL diagnostic provided Guianese team Nigerien health workers consenting patient clinically suspected CL lesion enrolled Samples made parasitological smear PCR cotton swabs Then participant treated per local protocol oral metronidazole 14 day followed 4 months total 59 clinically suspected CL case included among 33 56 confirmed PCR andor microscopy including 21 men 22 women 23 minor 10 adults 32 97 presented ulcer including 12 ulcer nodules median number lesion 2 IQR 13 frequent location lesion lower limb 2133 636 followed upper limb 1433 424 One mucosal involvement reported unconfirmed PCR efficacy oral metronidazole 909 3033 among confirmed case 763 4559 overall study population documented specie Leishmania major first report PCRproven human CL Niger first report human CL case Zinder area century Molecular technique confirmed circulation L major area determined isoenzymes analysis Presenting CL patient young Treatment outcome metronidazole encouraging prompt formal evaluation efficacy drug ideally randomized controlled trial",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Leishmania major",
            "Adult",
            "Leishmaniasis, Cutaneous",
            "Niger",
            "Child",
            "Young Adult",
            "Adolescent",
            "Metronidazole",
            "Middle Aged",
            "Polymerase Chain Reaction",
            "Antiprotozoal Agents",
            "Child, Preschool",
            "Infant",
            "Aged",
            "Molecular Diagnostic Techniques"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40597737/"
    },
    {
        "pmid": "40597735",
        "title": "Investigation of chronic limb ulcers in Northern Cameroon: a socio-anthropological and clinical perspective.",
        "abstract": "September 2023 fifty case chronic limb ulcer unknown origin reported six Health Districts HDs Northern Cameroon disease locally called Ladde described mystical origin transmitted insect bites aimed describe cases identify cause socioanthropological considerations conducted mixed descriptive crosssectional study November 2023 case person presented skin ulcer four limb least 4 week time study period suspected infectious cause contamination associated condition residing study area January 2018 October 2023 active casefinding health facility within community featured sociodemographic sex age occupation clinical location signssymptoms ulcer occurrence therapeutic data itinerary treatment outcome collected blood samples ulcer swab skin biopsy test pathogen Haemophilus ducreyi Treponema pallidum Mycobacterium ulcerans Mycobacterium leprae Leishmania performed entomological survey search potential vector conducted socioanthropological survey individual interview focus group discussions explore community perceptions identified 153 case total 119 778 men median age 385 year 9 month 94 years Farmers n  63 412 followed housewife n  24 157 affected lower limb n  138 902 preferred location Pain n  130 850 swelling n  113 739 ulceration n  43 281 fever n  42 275 frequent signssymptoms beginning 79 516 cases ulcer occurred spontaneously 67 438 trauma road injuries blunt object ulcers treatment 129 843 case visited traditional healer ordered decoction n  98 641 poultice n  95 621 using powder 81 529 case visited health facility received Cloxacillin n  78 51 diclofenac n  70 458 Ten 65 case completely cured Six ninetyfour 64 case tested HIV positive 8 85 syphilis positive referred appropriate care Dermohypodermatitis n  14 28 50 pyogenic granuloma n  12 28 43 main anatomopathological findings patient positive Mycobacterium ulcerans Haemophilus ducreyi Treponema pallidum pertenue entomological investigation reveal potential insect vector leishmaniasis Socioanthropological survey mostly reported Ladde disease diabolic origin caused spirit come demonpossessed animal tree Posttraumatic leg ulcer dermohypodermatitis predominant clinical anatomopathological patterns Traditional practitioner main point care Strengthening capacity health laboratory personnel diagnosis management chronic skin ulcer pathogen recommended improve outcome chronic ulcers",
        "mesh_terms": [
            "Humans",
            "Cameroon",
            "Male",
            "Female",
            "Cross-Sectional Studies",
            "Adult",
            "Middle Aged",
            "Chronic Disease",
            "Young Adult",
            "Adolescent",
            "Aged",
            "Skin Ulcer",
            "Child",
            "Aged, 80 and over",
            "Extremities"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40597735/"
    },
    {
        "pmid": "40596278",
        "title": "AI-driven analysis by identifying risk factors of VL relapse in HIV co-infected patients.",
        "abstract": "Visceral Leishmaniasis VL also known KalaAzar pose significant global public health challenge neglected disease relapse treatment failure leading increased morbidity mortality study introduces explainable machine learning approach predict VL relapse identify critical risk factors thereby aiding patient monitoring treatment strategies Leveraging data followup study 571 patients survival machine learning model applied including Random Survival Forest RSF Survival Support Vector Machine SSVM eXtreme Gradient Boosting XGBoost relapse prediction result demonstrated RSF Cindex 085 outperformed conventional Cox Proportional Hazard CPH model Cindex 08 offering improved prediction capability capturing nonlinear relationship variable interactions address lack transparency in term feature importance Machine Learning ML models SHapley Additive exPlanation SHAP method employed enhances model interpretability feature importance visual insights SHAP dependence plot allowed healthcare professional evaluate factor encourage occurrence relapse statistically significant relationship HIV coinfection HR392 95 CI203758 VL relapse identified 2 loglikelihood ratio chisquare tests result indicate promise explainable artificial intelligence XAI making clinical decision remedying recurrence VL",
        "mesh_terms": [
            "Humans",
            "Risk Factors",
            "HIV Infections",
            "Recurrence",
            "Male",
            "Female",
            "Coinfection",
            "Leishmaniasis, Visceral",
            "Adult",
            "Machine Learning",
            "Support Vector Machine",
            "Middle Aged",
            "Proportional Hazards Models"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40596278/"
    },
    {
        "pmid": "40592578",
        "title": "Photoresponsive Carbon Dots Decorated with Nitric Oxide Donors: Synergistic Antiparasitic Action via NO Release and Oxidative Stress.",
        "abstract": "Visceral leishmaniasis VL caused iLeishmania donovanii iLdi lethal vectorborne disease untreated Antimonial drugs effective due ROSgenerating ability largely ineffective due rising antimony resistance iLeishmaniai species accentuating urgent need appropriate therapies Here developed nanocarbon dot decorated flutamidebased nitric oxide donor bNCDNOb which upon visible light activation simultaneously generates singlet oxygen sup1supOsub2sub nitric oxide NO disrupts parasite metabolism sup1supOsub2sub induces oxidative stress together creating synergistic antiparasitic effect Biological study validated dual gas release bNCDNOb mitigates cytotoxic effect seen sup1supOsub2sub generated exclusively nitric oxide donor bNODb nanocarbon dot bNCDb Intracellular parasite clearance assay revealed bNCDNOb achieves significantly higher parasite elimination abating macrophage toxicity selectively eradicating iLeishmaniai amastigotes without impairing host cells",
        "mesh_terms": [
            "Oxidative Stress",
            "Nitric Oxide",
            "Nitric Oxide Donors",
            "Carbon",
            "Leishmania donovani",
            "Animals",
            "Antiprotozoal Agents",
            "Biocompatible Materials",
            "Mice",
            "Quantum Dots",
            "Parasitic Sensitivity Tests",
            "Materials Testing",
            "Particle Size",
            "Light",
            "Macrophages",
            "Antiparasitic Agents",
            "RAW 264.7 Cells"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40592578/"
    },
    {
        "pmid": "40590608",
        "title": "Development of shotgun metabolomic profile analysis for detecting canine visceral leishmaniasis using flow-through pinhole paper spray mass spectrometry.",
        "abstract": "Visceral leishmaniasis bVLb neglected infectious disease transmitted dog humans work novel flowthrough pinhole paper spray mass spectrometry bMSb technique described detect metabolite might up downregulated canine VL infection flowthrough pinhole paper spray MS allows direct analysis dried sample prepared paper substrates without prior sample pretreatment Here clinical canine serum sample ten dog positive VL prepared embossed hydrophobic paper substrate lab Similar dried serum sample uninfected control dog prepared embossed paper Partial least square discriminant analysis performed positiveion mode full mass spectrum recorded 20 samples showed significant separation VL positive negative samples Volcano plot confirmed presence several up downregulated specie infected dog samples Results work demonstrate detectable metabolomic change measured canine VL dried serum sample without sample preparation",
        "mesh_terms": [
            "Animals",
            "Dogs",
            "Leishmaniasis, Visceral",
            "Metabolomics",
            "Dog Diseases",
            "Paper",
            "Mass Spectrometry",
            "Discriminant Analysis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40590608/"
    },
    {
        "pmid": "40590280",
        "title": "Humanised Mice in Cutaneous Leishmaniasis-T-Cell Recruitment Into Human Skin Transplants After Leishmania major Infection.",
        "abstract": "Treatment leishmaniasis associated severe side effects high costs parasitic resistance Preclinical model humanised mouse would aid therapeutic improvement development vaccine developed model human skin transplant immunodeficient mouse infected Leishmania major Parasite inoculation skin transplant led robust infection increasing number parasite skin visceral organs addition intraperitoneally coadministered allogeneic peripheral blood mononuclear cell PBMCs strongly recruited skin lesions ≥ 65 cell positive antihuman CD45 identified 20 CD4supsup 50 CD8supsup human cells number skinresident macrophage dendritic cell unaltered compared healthy skin prior transplantation PBMC administration alter numbers Together show parasitic infection provides strong inflammatory signal lead recruitment cell skin transplants presence antigenpresenting cell transplantsas important prerequisite proper APCTcell interactionrecreates fully human skin microenvironment allows stromaimmune cell interaction upon infection model may high interest researcher interested translating skin research question human system vivo",
        "mesh_terms": [
            "Animals",
            "Leishmaniasis, Cutaneous",
            "Humans",
            "Leishmania major",
            "Mice",
            "Skin Transplantation",
            "Disease Models, Animal",
            "Skin",
            "Leukocytes, Mononuclear",
            "Female",
            "CD4-Positive T-Lymphocytes",
            "CD8-Positive T-Lymphocytes",
            "Mice, SCID",
            "T-Lymphocytes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40590280/"
    },
    {
        "pmid": "40589799",
        "title": "Clinical Profiles and Outcomes of rK39-Confirmed Paediatric Visceral Leishmaniasis at a General Hospital in Massawa, Eritrea: A Retrospective Study.",
        "abstract": "Although timely diagnostic treatment modality exist worldwide disease Visceral leishmaniasis VL still sporadic outbreak case reported especially high burden SubSaharan countries purpose identify characteristics distribution clinical parameter treatment outcome VL among affected child younger five year old retrospective cohort study design used involving patient admitted rk39 serology diagnosed patient VL treatment center 15th December 2021 7th February 2023 Massawa evaluated patients hospital stay progressive change finally assessing treatment outcome favorable unfavorable study found 97 rk39 confirmed VL cases these case male 536 median age IQR 32 1566 months Ghelalo 62 Foro 351 Northern Red Sea region Eritrea mortality rate 144 14 97 cases younger case found higher mortality rate Children recovered favorable outcome found better baseline hematologic parameters without concomitant infection blood product given Pre post treatment anthropometric hematologic comparison showed significant positive shift p  0001 paired sample iTitest Finally timetoevent analysis revealed 1729 day followup period overall mortality 63 per 1000 childdays Along implementation updated diagnostic treatment guidelines study discovered need regionspecific approach disease holistic treatment approach including nutritional status focusing specific sociodemographic factors strongly affect outcome patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40589799/"
    },
    {
        "pmid": "40588734",
        "title": "Expression and immunogenicity evaluation of a novel Lentiviral multi- epitope vaccine against Leishmania major in BALB/c mice.",
        "abstract": "Nowadays prevention parasitic disease including leishmaniasis particularly cutaneous leishmaniasis smost common type disease increased health concern around world Although drug Glucantim Amphotericin B approved side effects Therefore treatment without side effect priority study recombinant lentiviral vaccine containing novel multiepitope KMP11 HASPB Leishmania major L major synthesized multiepitope construct previously designed silico subcloned pCDH513 lentiviral vector recombinant lentiviral multiepitope vaccine rLVmultiepitope synthesized HEK293T cell using packaging vectors Western Blotting method used confirm gene expression Then rLVmultiepitope vaccine injected twice along two control groups phosphate buffered saline PBS rLVempty immunize BALBc mice Twentyone day second injection splenocytes mouse isolated stimulated L major lysate Also serum level IgG1 IgG2a gamma interfron IFNγ interleukin4 IL4 assessed using enzymelinked immunoassay ELISA test result enzymelinked immunoassay ELISA showed titer IFNγ IL4 increased immunized group Also level IFNγ higher significantly compared IL4 result Th1 response generated main group Additionally humoral immune response assessed indicating titer IgG2a IgG1 antibody serum immunized mouse increased compared control groups Moreover serum level IgG2a IgG1 increased main group Therefore humoral immune response increased also positive effect increasing Th1 response result revealed immunization novel rLVmultiepitope vaccine could stimulate immune system toward Th1 increasing production IFNγ IgG2a opsonin antibody",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40588734/"
    },
    {
        "pmid": "40588301",
        "title": "Visceral leishmaniasis concealed under a diagnosis of haemophagocytic lymphohistiocytosis.",
        "abstract": "Diagnosing secondary haemophagocytic lymphohistiocytosis sHLH requires systematic approach avoid potentially fatal consequences young man 30s residing northwestern part India presented u fever poor appetite weight loss 3 months Primary evaluation regional hospital showed patient hepatosplenomegaly pancytopenia treating team considered diagnosis primary HLH treated etoposidebased regimen rapid clinical deterioration nonresponsiveness therapy referred centre pursued possibility sHLH repeated bone marrow examination showed iLeishmania donovanii body haemophagocytosis Thereafter patient prescribed liposomal amphotericin B unfortunately succumbed illness case reiterates infection frequent trigger sHLH diagnosis primary HLH adult considered excluding putative infectious causes particularly tropical regions",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Lymphohistiocytosis, Hemophagocytic",
            "Male",
            "Adult",
            "Amphotericin B",
            "Fatal Outcome",
            "Diagnosis, Differential",
            "Leishmania donovani",
            "Antiprotozoal Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40588301/"
    },
    {
        "pmid": "40572095",
        "title": "How Common Is Imported Cutaneous Leishmaniasis in Romania? Two Case Reports.",
        "abstract": "Leishmaniasis vectorborne zoonotic disease caused protozoa genus iLeishmaniai endemic Mediterranean Basin Balkans Romania remains nonendemic country However climate change increased international travel documented presence competent vector iPhlebotomusi spp raised concern potential emergence autochthonous cases report two case imported cutaneous leishmaniasis CL diagnosed central Romania region without previously confirmed human animal cases first case involved 31yearold male recent travel history Spain presenting erythematous papule plaque evolved ulcerated lesions diagnosis confirmed histopathologically PCR Treatment miltefosine effective minimal hepatic toxicity sustained response sixmonth followup second case concerned 11yearold boy traveled Elba Italy developed ulcerative lesion progressed rapidly complicated iPseudomonas aeruginosai superinfection Despite initially negative smear PCR testing skin lesion confirmed presence CL Antifungal therapy fluconazole led clinical improvement treatment ongoing time publication case highlight diagnostic therapeutic challenge associated CL nonendemic settings varied clinical evolution underscore importance considering leishmaniasis differential diagnosis chronic nonhealing cutaneous lesions particularly patient travel history endemic regions Increased awareness among clinicians supported accurate diagnostic tool public health surveillance essential identify manage imported leishmaniasis Given absence licensed vaccine growing risk vector expansion Eastern Europe case support WHOs inclusion leishmaniasis among priority neglected tropical disease targeted intensified global control effort 2030",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40572095/"
    },
    {
        "pmid": "40561298",
        "title": "Miltefosine implementation for treatment of cutaneous leishmaniasis: access indicators in the state of Minas Gerais, 2021-2024.",
        "abstract": "describe evaluate initial indicator pilot implementation miltefosine Minas Gerais treatment cutaneous leishmaniasis descriptive crosssectional study based regulatory document secondary administrative data generated dispensing miltefosine Minas Gerais May 2021 April 2024 Indicators related access operability strategy implemented calculated step involved approving request use dispensing drug authorization rate 975 281 valid requests outpatient clinic René Rachou Institute reference center leishmaniasis Minas Gerais responsible largest number request period health macroregions Centre North concentrated largest number request 489 336 coincided region highest number reported cases Median time analyzing request person access medicine 10 076 100 0340 days significant variation health macroregions One hundred nineteen people treated municipality place residence these 49 needed travel another health macroregion miltefosine diffusion rate 113 threeyear period monitored significant variation macroregions indicator confirmed miltefosine implemented revealed low diffusion regional disparities Barriers need identified strategy developed expand equitable access new technologies",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Cutaneous",
            "Cross-Sectional Studies",
            "Antiprotozoal Agents",
            "Phosphorylcholine",
            "Brazil",
            "Health Services Accessibility",
            "Male",
            "Female",
            "Pilot Projects",
            "Adult",
            "Middle Aged",
            "Child",
            "Adolescent",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40561298/"
    },
    {
        "pmid": "40560960",
        "title": "Evaluation of sugar meal administered anti-Leishmania compounds on the vectorial capacity of the vector, Lutzomyia longipalpis.",
        "abstract": "Multiple strategy involving parasitehostvector triad necessary control leishmaniasis One option prevent reduce transmission pathogen phlebotomine sand fly vectors sense essential explore compound may influence vectorial capacity insect reduce longevity investigated effect antiLeishmania drug administered via sugar meal longevity blood feeding oviposition parasite load third day infection sand flies identify promising candidate vector infection tests identified compound affected longevity sand fly three pterocarpanquinones  LQB475 LQB181 LQ03 one hydroxyethylpiperazine PMIC4 Pentamidine reduced oviposition female blood feeding LQB181 PMIC4 decrease infection rate parasite loads result provide effect antiparasitic drug perspective insect vector",
        "mesh_terms": [
            "Animals",
            "Psychodidae",
            "Insect Vectors",
            "Female",
            "Leishmania",
            "Oviposition",
            "Sugars",
            "Longevity",
            "Feeding Behavior",
            "Antiprotozoal Agents",
            "Leishmaniasis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40560960/"
    },
    {
        "pmid": "40559773",
        "title": "Commentary on the Issue of <i>Leishmania</i> Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects.",
        "abstract": "Leishmaniasis infectious disease caused several parasitic specie iLeishmaniai mainly transmitted bite infected phlebotomine sandflies Humans dogs rodents domestic wild animal act reservoir host different iLeishmaniai species neglected tropical disease endemic Asia Middle East North East Africa Mediterranean region South Central America Clinical manifestation disease severity depend specie infecting parasite immunity status host iLeishmaniai represses protective host immune response manipulating macrophage function subverting cytokine expression favor survival dissemination balance proinflammatory regulatory cell necessary bring positive outcome Accurate diagnosis effective treatment represent cornerstone control disease although difficult environment precariousness poverty recent study highlighted progressing work diagnosis treatments development new benzimidazoletriazole derivative blocking parasite growth feline leishmaniasis comparison immune response cat dogs transglutaminase purified iL infantumi result study could open new avenue combating leishmaniasis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40559773/"
    },
    {
        "pmid": "40559561",
        "title": "Beyond Mosquitoes: A Review of Pediatric Vector-Borne Diseases Excluding Malaria and Arboviral Infections.",
        "abstract": "Vectorborne disease VBDs significantly impact global child health mosquitotransmitted infection like malaria arbovirus accounting substantial portion burden However arthropodborne diseasestransmitted vector ticks fleas sand flies lice triatomine bugsalso pose serious health risk child worldwide review specifically excludes mosquitoborne disease concentrate lessdiscussed yet clinically important pediatric VBDs examine clinical manifestations diagnostic challenges treatment options highlighting unique vulnerability children including immature immune systems behavioral factors communication barrier delay diagnosis Additionally explore environmental anthropogenic factors climate change urbanization expanding geographic range vectors leading emergence disease like Lyme disease leishmaniasis new regions focusing nonmosquito VBDs review aim raise awareness inform healthcare provider public health practitioner comprehensive landscape pediatric vectorborne diseases",
        "mesh_terms": [
            "Humans",
            "Vector Borne Diseases",
            "Animals",
            "Child",
            "Arbovirus Infections",
            "Arthropod Vectors",
            "Mosquito Vectors",
            "Culicidae",
            "Malaria"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40559561/"
    },
    {
        "pmid": "40557324",
        "title": "Evaluation of Beauvericin's activity and mode of action against all life stages of <i>L. tropica</i> for cutaneous Leishmaniasis therapy.",
        "abstract": "Leishmaniasis particularly cutaneous form caused iLeishmania tropicai remains significant global health concern due limitation current treatments including drug resistance toxicity inconsistent efficacy study investigates potential Beauvericin BEA fungal secondary metabolite alternative antileishmanial agent study investigates potential Beauvericin BEA fungal secondary metabolite alternative antileishmanial agent assessed efficacy BEA different developmental stage iL tropicai using iin vitroi assay iin vivo Galleria mellonellai infection model ability iL tropicai develop resistance BEA effect parasites gene expression profile also examined BEA exhibited potent antileishmanial activity equipotency across promastigote amastigote stage iL tropicai ICsub50sub value 025 µM 027 µM respectively significantly lower miltefosine Mechanistically BEA act calcium ionophore inducing marked increase intracellular calcium levels serf primary cytotoxic event Transcriptomic profiling revealed BEAinduced calcium dysregulation trigger secondary cellular response involving calcium homeostasis lipid metabolism stress response contributing multifaceted mechanism action iG mellonellai model demonstrated BEA significantly reduced parasite burden improved survival rates Notably BEA showed slower rate resistance development compared ML indicating potential sustainable treatment option BEA promising candidate antileishmanial therapy demonstrating superior efficacy broad mechanism action favorable resistance profile compared ML investigation mammalian model warranted validate BEAs potential novel costeffective treatment leishmaniasis",
        "mesh_terms": [
            "Leishmania tropica",
            "Animals",
            "Leishmaniasis, Cutaneous",
            "Antiprotozoal Agents",
            "Disease Models, Animal",
            "Depsipeptides",
            "Inhibitory Concentration 50",
            "Life Cycle Stages",
            "Gene Expression Profiling",
            "Drug Resistance"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40557324/"
    },
    {
        "pmid": "40556744",
        "title": "DNA damage in canine leishmaniasis infection is detectable by micronucleus and comet assay in peripheral blood samples.",
        "abstract": "iLeishmania infantumi parasite cause leishmaniasis visceral clinical manifestations considered zoonosis infect human animals Currently highly effective treatment available many animal exhibit symptom ultimately die result disease complications clinical sign leishmaniasis varied nonspecific main symptom severe anemia thrombocytopenia weight loss splenomegaly lymphadenomegaly liver disease kidney failure skin lesions among others Due chronic inflammatory state caused parasite oxidative environment created leading potential cell injury damage infected animals genetic material investigate DNA damage conducted micronucleus test comet assay well measured serum LDH level infected noninfected dogs result indicate infected dog present significantly higher level serum LDH 4614 ± 2045 UL n36 compared healthy dog 14238 ± 3794 UL n5 Additionally DNA infected dog damaged control group demonstrated micronucleus test p001 comet assay p0002 finding suggest iLeishmania infantumi infection lead clastogenic events highlighting need research process important consider potential mutagenic property iLeishmania infantumi given ability cause DNA damage infected animals",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40556744/"
    },
    {
        "pmid": "40554535",
        "title": "Direct agglutination test: Evolution and significance as a simple and safe alternative to tissue aspiration procedures in the diagnosis of visceral leishmaniasis.",
        "abstract": "Although tissue aspiration procedure TAPs considered gold standard visceral leishmaniasis VL diagnosis often fail detect disease progression amastigotedemonstrable phase overcome limitation primary direct agglutination test DAT developed using intact Leishmania donovani promastigotes initially treated trypsin antigen enhance exposure specific epitope promastigote surface antibodybinding sites alternative proteolytic agent evaluated incorporated antigen processing test execution approach led significant complete inhibition agglutination known crossreacting disorders LQDAT consistently demonstrated highly reproducible result across diverse geographical regions regardless L donovani subspecies strain facilitate routine implementation local production LQDAT processing knowhow disseminated major VLendemic areas Sensitivities comparable TAP outcome demonstrated 2224 2697 VL case successfully diagnosed treated 35 year routine epidemic outbreak evaluations Notably 473 175 case symptomatic TAPnegative LQDATpositive results responded favorably 980100 specific treatment Given lower sensitivity also demonstrated LQDAT TAP meet criterion classification goldstandard VL diagnostic Consequently positive response specific antileishmanial treatment recommended benchmark diagnostic reliability Beyond advantage detecting VL earlier stage compared TAP improved LQDAT described also exhibited feasibility stability required local production lowresource settings",
        "mesh_terms": [
            "Leishmaniasis, Visceral",
            "Humans",
            "Leishmania donovani",
            "Agglutination Tests",
            "Antigens, Protozoan",
            "Male",
            "Female",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40554535/"
    },
    {
        "pmid": "40551960",
        "title": "Cutaneous Rosai-Dorfman Disease: A Report of 2 Cases and a Review of Recent Literature (2018-2023).",
        "abstract": "RosaiDorfman disease RDD rare benign histiocytic disorder present isolated cutaneous RDD CRDD often mimicking dermatologic condition complicating diagnosis report two case CRDD one palm sol involvement another exophytic facial mass initially misdiagnosed unsuccessfully treated Dermoscopy revealed distinctive features including yellow ovoid structures linear vessels cottonlike white globules Histopathological immunohistochemical analysis confirmed CRDD histiocytic infiltration emperipolesis key histological marker CRDD review 53 case 20182023 highlight CRDDs clinical variability common anatomical sites diverse treatment responses emphasizing need individualized management early recognition optimal treatment finding contribute broader understanding CRDD support multidisciplinary approach optimizing patient care",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40551960/"
    },
    {
        "pmid": "40551927",
        "title": "Squamous Cell Carcinoma in Chronic Cutaneous Leishmaniasis: Coincidence or Malignant Transformation.",
        "abstract": "report case 69yearold man developed squamous cell carcinoma SCC site chronic cutaneous leishmaniasis CL lesion dorsum left hand lesion persisted three year despite multiple local systemic treatments Histopathological examination confirmed diagnosis welldifferentiated SCC patient lost followup year returned locally advanced disease ultimately requiring hand amputation case underscore potential malignant transformation chronic leishmaniasis lesion highlight need timely biopsy longterm monitoring atypical nonhealing ulcer endemic regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40551927/"
    },
    {
        "pmid": "40550412",
        "title": "Repurposing of propafenone, an FDA approved anti-arrhythmic drug for antileishmanial therapy.",
        "abstract": "Elimination Neglected Tropical Disease Visceral Leishmaniasis VL Sustainable Development Goal caused Leishmania donovani therapeutic option treatment VL limited due problem drug resistance toxicities Drug repurposing promising alternative case work antileishmanial potential FDA approved antiarrhythmic drug propafenone evaluated repurposing reduced viability L donovani promastigotes intracellular amastigotes ICsub50sub 825 ± 248 μM 1119 ± 001 μM respectively macrophages ICsub50sub 32 ± 707 μM Propafenone treatment altered morphology parasite induced damage body flagellum cell membrane became damaged permeable promastigotes treated drug However change cell membrane potential detected Treatment propafenone detrimental mitochondrial health L donovani significantly depolarized mitochondrial membrane decreased ATP level promastigotes Propafenone also induced oxidative stress parasites Cell cycle arrest detected Gsub2subM stage data suggests propafenone antileishmanial potential evaluated experimental VL model",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40550412/"
    },
    {
        "pmid": "40550305",
        "title": "Upregulation of nicotinamide/nicotinate mononucleotide adenylyl transferase increases resistance to oxidative stress and antimony in promastigotes of Leishmania braziliensis.",
        "abstract": "Leishmaniasis prevalent parasitic neglected disease caused protozoan genus Leishmania Currently vaccine available humans existing treatment ineffective toxicity emergence drugresistant strains Consequently crucial identify new potential therapeutic targets thereby facilitating development effective therapies study indicates correlation upregulated biosynthesis nicotinamide adenine dinucleotide NAD resistance hydrogen peroxide Hsub2subOsub2sub trivalent antimony exposure Sbsup3sup L braziliensis promastigotes CRISPRCas9 geneediting nicotinamidenicotinate mononucleotide adenylyl transferase L braziliensis Lbnmnat key gene NAD biosynthetic pathway allowed upregulation mRNA protein levels well elevated NAD NADP content Lbnmnatedited parasites single guide RNA template directed 5 end Lbnmnat donor DNA consisting mCherry reporter gene preceded 5 UTR Crithidia fasciculata phosphoglycerate kinase CfPGKB electroporated L braziliensis promastigotes constitutively express Streptococcus pyogenes Cas9 T7 RNA polymerase PCR analysis DNA sequencing demonstrated successful editing Lbnmnat gene Importantly dosedependent oxidative stress susceptibility assay Hsub2subOsub2sub Sbsup3sup revealed higher ICsub50sub value Lbnmnatedited parasites finding denote correlation upregulated biosynthesis NAD L braziliensis enhanced resistance oxidative stress indicating Lbnmnat gene may play significant role survival resistance mechanism parasite antimony compounds",
        "mesh_terms": [
            "Oxidative Stress",
            "Up-Regulation",
            "Nicotinamide-Nucleotide Adenylyltransferase",
            "Leishmania braziliensis",
            "Antimony",
            "Hydrogen Peroxide",
            "NAD",
            "CRISPR-Cas Systems",
            "Gene Editing",
            "Antiprotozoal Agents",
            "Animals",
            "NADP",
            "RNA, Messenger",
            "Drug Resistance"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40550305/"
    },
    {
        "pmid": "40548752",
        "title": "Pentamidine inhibition of streptopain attenuates <i>Streptococcus pyogenes</i> virulence.",
        "abstract": "obligate human pathogen iStreptococcus pyogenesi also known GAS Group iStreptococcusi carry high morbidity mortality primarily impoverished resourcepoor regions failure rate monotherapy conventional antibiotic high invasive infection bacterium frequently require extensive supportive care surgical intervention Thus important find new compound adjunctive therapeutic benefits conserved secreted protease streptopain Streptococcal pyogenic exotoxin B SpeB directly contributes disease pathogenesis inducing pathological inflammation degrading tissue promoting evasion antimicrobial host defense proteins study screened 400 diverse offpatent drug druglike compound inhibitor streptopain proteolysis Lead compound tested activity lower concentration antivirulence activity iin vitroi infection Significant inhibition streptopain seen pentamidine antiprotozoal drug approved treatment Pneumocystis pneumonia leishmaniasis trypanosomiasis Streptopain inhibition rendered GAS susceptible killing human innate immune cells study identify unexploited molecule new starting point drug discovery potential repurposing existing drug treatment infection GASIMPORTANCEiStreptococcus pyogenesi common cause severe invasive infections Repeated infection trigger autoimmune disease acute rheumatic fever rheumatic heart disease study examines targeting specific highly conserved virulence factor secreted cysteine protease streptopain sensitize serious pathogen killing immune system Manipulating hostpathogen interaction rather attempting directly kill microbe promising therapeutic strategy Notably benefit include limiting offtarget effect microbiota Streptopain inhibitors including antifungal antiparasitic drug pentamidine identified work may therefore useful treatment iS pyogenesi infection",
        "mesh_terms": [
            "Streptococcus pyogenes",
            "Humans",
            "Exotoxins",
            "Virulence",
            "Pentamidine",
            "Streptococcal Infections",
            "Bacterial Proteins",
            "Anti-Bacterial Agents",
            "Virulence Factors",
            "Cysteine Endopeptidases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40548752/"
    },
    {
        "pmid": "40547705",
        "title": "Lipid-Based Nanocarriers for Topical Therapy of Cutaneous Leishmaniasis: An Insight into the Mechanism of Action.",
        "abstract": "Cutaneous leishmaniasis CL parasitic infection caused Leishmania species affecting million worldwide current treatment option CL several limitations including low efficacy inability reach target site potential toxicity longer treatment duration leading poor patient compliance Therefore urgent need alternative treatments especially topical ones effective safe patientfriendly Although numerous review described advantage wide range nanoparticles treatment CL review narrow focus utilization novel lipidbased nanocarriers topical treatment CL offering indepth analysis topical potential mechanism skin permeation lipidic nanocarriers Lipidbased nanostructures liposomes solid lipid nanoparticles nanostructured lipid carrier extensively studied CL treatment either alone combination drug therapies carrier improve bioavailability stability efficacy drug target infected site reduce adverse effect healthy tissues Moreover easily formulated different dosage forms creams gels ointments convenient topical application Despite many benefit lipidbased carriers still challenge need addressed optimizing formulation parameters ensuring reproducibility scalability process evaluating longterm safety efficacy clinical trials study aim provide comprehensive overview current stateoftheart lipidbased nanocarriers topical treatment CL covering recent advances limitations clinical evidence prospect promising approach addition skin macrophage targeting potential various lipidbased nanocarriers also discussed especially helpful treating lesion CL",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40547705/"
    },
    {
        "pmid": "40546545",
        "title": "The Treatment of Acute Cutaneous Leishmaniasis With Oral Zinc Bisglycinate and Oral Hydroxychloroquine Sulfate.",
        "abstract": "Background objective Cutaneous leishmaniasis CL one significant endemic parasitic infection many region around world caused several specie Leishmania parasite morbid condition lead stigmatization disfiguring scars Numerous method tried treat leishmaniasis variable cure rate side effects study aimed compare effect oral zinc bisglycinate ZnGly oral hydroxychloroquine sulfate HCQ alone combination treating acute CL Materials method comparative therapeutic study conducted Center Dermatology Venereology Medical City Baghdad Iraq period December 2021 February 2023 participant diagnosed history clinical examination involved skin smear patient skin biopsy suspicious cases Patients classified three group based type treatment Group treated oral ZnGly capsule 50 mg twice daily eight weeks Group B administered oral HCQ tablet 200 mg twice daily eight weeks Group C received combination drug eight weeks patient examined every four week eight weeks followed every month two month stopping therapy treatments impact lesion assessed using Sharquies modified Leishmania score Results total 40 patient acute CL included study spanned eight weeks total number lesion 144 duration ranged five 12 weeks Group included 14 patients cure rate 786 11 Group B included 13 patients cure rate 847  11 Group C included 13 patients cure rate 923 12 observed statistically significant difference cure rate Group C compared Group Group B end study p0034 Conclusions oral ZnGly HCQ monotherapy effective treatment acute CL combination regimen drug led higher effectiveness without increase frequency adverse effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40546545/"
    }
]